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臨床現場即時診断(Point Of Care Testing: POCT)は持ち運びが容易な機器や検査薬を用
いて病気を検査する方法であり、被検者自ら簡単に、その場で、迅速な検査が可能であ
る。そのため、革新的な医療診断手法の開発において大きな期待が寄せられている。スマ
ートフォンは世界中で急速に普及しており、高解像度カメラと通信機能を有するため、
POCTシステムへの導入において多くの利点が考えられる。磁性粒子は生体物質に対
して最も広く利用される標識の１つであり、電磁気力によって制御が可能であり、ス
マートフォンによって撮像ができるなどPOCTへの応用において多くの利点が存在す
る。そこで、本論文では、溶液中の磁性粒子に磁場をかけた際の振る舞いに基づ
く、スマートフォン型の医療診断技術の開発を行った。初めに診断の感度を制限する
非特異的相互作用の理論を紹介し、非特異を排除するために必要な技術を述べる。続
いて、スマートフォンで使用されるイメージセンサーと、実際の溶液中の磁性粒子の
画像認識の観点からの特性を示す。本研究では、溶液内の磁性粒子の画像認識に必要
な要件を導き出し、約400nmの解像度下、磁性粒子の光学追跡がスマートフォンにお
いて可能となった。4つの診断プロトコルが開発し、1つは磁性粒子と画像認識に基づ
いており、他の3つは磁性粒子の光学追跡に基づいている。最後に、提案された診断
プロトコルの実用化に関する問題と、これらの問題に対処するため、今後の研究の方
向性について述べる。 
 
 
Abstract 
The United Nations has listed improving healthcare in developing countries as a major 
area of focus of its sustainable development goals, which, if met, will improve the quality 
of life of billions of people across the world. As of today, the healthcare systems in 
developing countries are crippled by the lack of availability of infrastructure in the form 
of hospitals as well as human resources in the form of doctors. Conventional medical 
diagnostics technologies, developed in the previous century, are unsuitable for use in 
resource constrained settings that these countries face. Success stories in the domains 
of financial services and e-governance, achieved on the back of rapidly proliferating 
mobile telecommunications technology has inspired the development of next generation 
‘point of care’ medical diagnostics technologies (POCT). 
 In this thesis, I describe the development of smartphone based medical 
diagnostics systems based on magnetic particles as labels. While previous approaches 
in literature have tried to miniaturize conventional technologies to interface with a 
smartphone, I have adopted a different approach by designing diagnostics systems 
from the ground up, specifically to work with smartphones under the constraints found in 
the developing world. 
I present an overview of the constraints on healthcare systems in a developing 
country and the reasons why conventional medical diagnostics technology is unable to 
meet these constraints. I introduce a new architecture to guide the development of point 
of care medical diagnostics systems which can successfully meet the requirements of 
modern medical diagnostics systems. Magnetic particles (MPs) are introduced and the 
properties of MPs used in this study are discussed. Fluorescent magnetic nanoparticles 
(f-MNPs) and their advantages over micrometer sized particles are discussed. I then 
describe the various forces acting on a magnetic particle in a liquid, analyze them 
quantitatively and explain the theoretical basis of non-specific interactions, which limit 
the sensitivity of several diagnostics protocols. Building upon this discussion, I propose 
the design of an actuator comprised of micrometer sized electrodes, which employs 
three dimensional electromagnetic forces to eliminate non-specific interactions and 
enhance the probability of specific interactions. 
Subsequently, I discuss the details of the experimental setup used in this study. I 
then explain the need for automating data analysis in point of care diagnostics and 
introduce algorithms for automated detection and counting of magnetic particles from 
smartphone images with software. I then introduce an algorithm for optical tracking of 
MPs with sub-micron resolution in smartphone videos. The problem of optical tracking is 
introduced and various challenges in tracking a large number of MPs are discussed. I 
describe my solutions to these problems and the implementation details of the tracking 
software developed for this study. 
I propose two POCT systems based on the methods of actuation and optical 
tracking discussed above. The first system is based on f-MNPs as labels and utilizes a 
smartphone camera for their fluorescent imaging. Images obtained from the smartphone 
are uploaded to a remote server and analyzed automatically, while the results are 
shared with various stakeholders. The second system is based on micrometer sized 
MPs and utilizes optical tracking to infer the concentration of biomolecules. 
Experimental results showing calibration curves and limits of detection of these 
protocols are presented. The advantages and limitations of each protocol is discussed. 
 Finally, I discuss directions for future work in this field of research in the near and 
long term and propose a new parameter for evaluating POCT technologies. 
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1. The problem: The ultimate 
goal of this research 
1.1 Introduction 
 The research presented in this thesis concerns the development of medical 
diagnostics technologies. I have used the principles of physics, electronics and information 
science to develop the said technologies. In this chapter, I present the need for medical 
diagnostic technologies in developing countries. The inability of conventional technology to 
meet these requirements is discussed. Finally, the specific contributions of this research 
are summarized. This chapter is a self contained summary of the problem being solved, 
the limitations of existing technologies, an outline for the solution and my contribution. 
1.2 Sustainable development goal #3 
 The United Nations World Health Organization (WHO) has outlined a set of 17 
goals, called sustainable development goals (SDGs) to be achieved by 2030[1] in order to 
improve the lives of people all across the world. These include goals towards eliminating 
poverty, hunger and gender inequality while promoting quality education, sanitation and 
clean energy. The 17 SDGs are shown in figure 1-1. 
The third goal among these is: 
Goal 3: Ensuring healthy lives and promote well-being for all at all ages 
There are 13 specific targets to be achieved under this goal. The targets relevant to my 
research are[3]: 
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Figure 1-1. The 17 sustainable development goals (SDGs) [2]
Target 3.2: By 2030, end preventable deaths of newborns and children under 5 years of 
age. 
Target 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected 
tropical diseases and combat hepatitis, water-borne diseases and other communicable 
diseases. 
Target 3.8: Achieve universal health coverage, including financial risk protection, access 
to quality essential health-care services and access to safe, effective, quality and 
affordable essential medicines and vaccines for all. 
Target 3.D: Strengthen the capacity of all countries, in particular developing countries, 
for early warning, risk reduction and management of national and global health risks. 
 It is clear from the above points that a major thrust for improving healthcare across 
the world is being focused on in developing countries and great emphasis is being given to 
prevent deaths of newborns and deaths due to ‘global health risks’ such as epidemics and 
communicable diseases. Rapid and accurate diagnosis is the first step in providing 
healthcare to diseased individuals. The research presented in this thesis can help in 
achieving the above outlined targets (3.2, 3.3, 3.8, 3.D) by enabling rapid, low-cost and 
accurate medical diagnosis during public health crises. Before explaining how next 
generation medical diagnostics can help in achieving these targets, I will first describe 
conventional medical diagnostics technologies and the challenges in achieving these 
targets in developing countries, taking the example of India. 
1.3 Conventional medical diagnostics technologies 
 Here I discuss some conventional medical diagnostics technologies. The discussion 
is divided into two parts. First, commercially available technology called ELISA is 
described. Then, several alternative technologies have been described which have been 
proposed to replace ELISA. 
1.3.1 Enzyme Linked ImmunoSorbent Assay (ELISA) 
 ELISA is a mature biosensing technology[4] which is commonly used for clinical 
diagnostics tests as well as in industrial settings for quality control. 
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Figure 1-2. Schematic of key steps in ELISA
A schematic of the ELISA protocol is shown in figure 1-2. The setup consists of a reaction 
well, commonly on a 96-well plate. In the simplest form of ELISA, the surface of the 
reaction well is functionalized with antibodies and the sample containing antigens is 
introduced. An incubation time of several hours is required to allow the antibodies and 
antigens to interact with each other. After the incubation time, another set of antibodies 
with fluorescent enzymatic biological labels are added to the reaction well and the solution 
is allowed to incubate. After the second incubation step, the excess antibodies are washed 
away. Finally, detection is performed by exciting the surface of the reaction well with the 
appropriate citation wavelength (usually in the ultraviolet region). The fluorescence 
intensity from the residual captured enzymatic tags is measured by commercial plate 
readers, which are based on photomultiplier tubes (PMTs). More advanced variations of 
ELISA, based on magnetic particles and imaging have also been proposed [5]. 
ELISA machines are bulky, expensive and require a laboratory environment, electricity and 
a skilled operator to use the machine. Figure 1-3 (a) shows an ELISA plate reader 
recommended for medical diagnostics by United Nations International Children’s 
Emergency Fund (UNICEF). UNICEF procures this machine at a cost of 8,000 US 
dollars[6]. This is prohibitively expensive for use in rural areas of developing countries. 
For a comparison, the per capita GDP of India is only about 2,000 US dollars. Although 
accurate estimates about rural GDP per capita are not available, considering the vast 
divide between urban and rural areas, the per capita GDP in rural India is likely to be 8-10 
times less than the cost of an ELISA machine. This is why, as I will describe in later 
sections, such conventional technologies are not available in rural parts of India. Figure 
1-3(b) shows a 96-well plate being loaded into the reader. A human hand is shown for 
scale. It can be seen that not only is this device prohibitively expensive for use in rural 
areas of developing countries, but is bulky and cannot be taken out of the laboratory. Thus, 
it becomes necessary for poor people to travel to hospitals, which may be located 
hundreds of kilometers away. 
 The limitations of ELISA have been known for a long time and thus various 
alternative technologies have been proposed as alternatives. Next, I discuss a few of 
these newly proposed technologies. 
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Figure 1-3. (a) A photograph of an ELISA plate reader recommended by UNICEF. This machine 
costs 8,000 USD[6] (b)  A 96-well plate being loaded into a plate reader with human hand for 
scale.[7]
(a) (b)
1.3.2 Hall effect sensors for medical diagnostics 
 Magnetic particles are frequently used as labels for bio-receptors. Thus, several 
magnetic biosensors have been proposed for medical diagnostics. Our laboratory (Sandhu 
Laboratory) at Tokyo Institute of Technology proposed Hall effect based sensors for 
medical diagnostics. 
 When a conductor carrying an electric current is placed in a magnetic field 
perpendicular to the direction of the current, a transverse voltage develops in the 
conductor in a direction perpendicular to both the magnetic field as well as the current. 
This is due to the effect of Lorentz force experienced by the current carriers in the 
conductor. Since the Lorentz force is given by , where q is the 
charge of the carrier,  is the electric field which causes the current flow,  is the velocity 
of the carrier and  is the magnetic field This is known as the Hall effect and was 
discovered by Edwin Hall in 1879. Hall effect sensors are commonly used in auto motives, 
motors and smartphones.  
Our laboratory[8] developed Indium-antimonide (InSb) micro-Hall sensors for the 
detection of magnetic micro and nanoparticles. As shown in figure 1-4, an alternating 
magnetic field was applied horizontally and a DC magnetic field was applied vertically 
(in z-direction). The Hall sensor achieved very high sensitivity and detection of a single 
2.8 μm magnetic particle was possible with the proposed sensor. Although Hall sensors 
provide reliable detection of micro particles, they are unable to detect nanometer sized 
particles. This is due to the intrinsic limitations of the sensitivity of the Hall effect. Thus, 
more sensitive magnetic biosensors based on other magnetic phenomena have been 
proposed.
⃗F = q( ⃗E + ⃗v × ⃗B )
⃗E ⃗v
⃗B
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Figure 1-4. Schematic of magnetic particle detection by Hall sensors. (a) A permanent 
magnet is placed above the Hall element in z direction and an AC field Hac(x) is applied 
along x direction. A lock-in amplifier is used to measure the transverse voltage signal with 
the same phase as that of the applied field. (b) Schematic of the transduction 
mechanism. The vertical field induces a dipole moment in the bead in z direction. On 
application of the horizontal field, the magnetic moment vector oscillates about its mean 
position, thereby inducing a transverse voltage signal in the hall element. Source: [8]
1.3.3 Giant magnetoresistance (GMR) based medical 
diagnostics 
 The Magnetoresistive (MR) effect, discovered by W. Thompson in 1857, relates to 
the change in electrical resistance of a material in the presence of an external magnetic 
field. Albert Fert ad Peter Grunberg[9] discovered that in thin films of alternating 
ferromagnetic and non-magnetic layers, the electrical resistance changes significantly on 
application of magnetic field. This is called the giant magnetoresistance effect for which 
Fert and Grunberg were awarded the Nobel prize in physics in 2007. The GMR effect is 
more sensitive than the Hall effect in that smaller magnetic fields can be measured. Thus, 
nanometer sized particles which have significantly smaller magnetic field than micrometer 
sized particles are ideal candidates for detection via GMR sensors. Figure 1-5 shows a 
schematic of the principle of transduction in GMR biosensors. As shown in figure 1-5 (b), 
the magnetic field of the nanoparticle induces a field in the so-called ‘sensing layer’ of the 
GMR sensor. The induced magnetic field effects a change in the resistance of the sensing 
layer. A sensing current is applied across the sensing layer and the voltage is measured, 
which is the electrical signal of interest. It is noteworthy that GMR sensors in general suffer 
from various sources of noise such as thermal drift as well as some intrinsic noise such as 
pink noise. Thus, they are always used in a wheatstone bridge configuration as shown in 
figure 1-5 (a). As a result, the number of GMR sensors required for a single detection is at 
least four. In a multiplexed setup, the cost and complexity of fabrication of GMR sensors 
increases rapidly as four sensors are required for every detection. 
 GMR sensors have excellent sensitivity but have the following limitations: 
- The cost of fabricating GMR sensor is quite high. 
- GMR sensors suffer from large noise such as Johnson noise[10] 
- These sensors can detect only magnetic signals. Thus, non-magnetic contaminants 
present in the sensing area cannot be detected. 
 Although GMR sensors for medical diagnostics have been proposed since 1998 
[11], industrial efforts to bring them to the market has been very limited. In 2012, Nokia 
hosted the so called ‘Nokia Sensing XChallenge’[12], a $2.25 million competition in which 
leading scientists from all around the world proposed next generation medical diagnostics 
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(a) (b)
Figure 1-5. Principle of GMR biosensors (a) Wheatstone bridge configuration 
used by GMR sensors to cancel out noise and thermal drift effects. (b) 
Schematic of magnetic field induced in the sensor in proximity to a magnetic 
particle. This field decays rapidly as the distance from the sensor surface to 
particle increases.
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Figure 1-6. Principle of SPR biosensor. (a) Initially, the dielectric surface has a refractive 
index n and is functionalized with antibodies. (b) After the analyte is bound to the 
antibodies, the refractive index and hence the propagation instant of the SPW changes. 
This can be picked up via prism coupling, waveguide coupling or grating coupling.
Figure 1-7. A photograph of ‘SPR-PLUS’ platform for medial diagnostics from Xantec 
Bioanalytics [16]
technologies and produced prototypes for their ideas. A GMR based biosensor[13] was 
awarded one of the five ‘Distinguished awards’ of the competition. This is the closest that 
GMR sensors have come to adoption by the industry. Since the end of this competition, 
while more papers have been published using this device for research purposes[14], there 
is no indication that GMR sensors are being adopted by industry for clinical diagnostics. 
1.3.4 Surface plasmon resonance 
 Surface plasmon resonance (SPR) biosensors exploit the electromagnetic 
phenomenon of surface plasmon polaritons to detect small variations in the properties of 
the sensing surface. A surface plasmon wave (SPW) is a transverse magnetic (TM) 
electromagnetic wave propagating along the boundary between a dielectric and a metal. 
Since the wave is TM, the magnetic vector is parallel to the interface whereas the electric 
vector is perpendicular to it. The propagation constant of a surface plasmon wave can be 
expressed as[15]: 
                                             (1.1) 
where  is the angular frequency, c is the speed of light,  are dielectric constants of 
the metal and dielectric respectively. Gold and glass are the most common metal and 
dielectric used for SPR biosensors. 
Figure 1-6 shows the principle of SPR based transduction. In figure 1-6(a), initially the 
metal surface is functionalized with antibodies and the dielectric has an initial refractive 
index  and a propagation constant β. The analyte solution containing complimentary 
antigens are introduced into the solution and allowed to interact with the surface. The 
interaction of antibodies and antigens shifts the refractive index of the dielectric surface. 
Since the majority of the SPW intensity is concentrated within the dielectric, a change in its 
refractive index causes a large change in the propagation constant of the SPW. It can be 
shown that the change in propagation constant is proportional to the change in refractive 
index of the dielectric. Thus, the concentration of analyte in the solution has been 
transducer into an electrically measurable signal. The detection in SPR based biosensors 
is usually carried out via prism coupling, waveguide coupling or grating coupling. 
 In contrast to most of the methods discussed in this section, SPR biosensors have 
the advantage that they are label-free i.e. they do not use labels for detection of bio-
receptors. However, SPR based diagnostic technology has inherent disadvantages as 
SPR sensors are bulky and expensive due to the requirement of a precise reference light 
source, liquid pumps to pump liquids with controlled velocity and personal computer to 
analyze the results. Thus, SPR based diagnosis devices are currently available for use in 
laboratories by trained professionals, but not for use in rural areas with no laboratories or 
access to electricity and running water. Figure 1-7 shows the photograph of a 
commercially available SPR sensing platform from Xantec Bioanalytics. This system 
requires electricity from a wall supply, is bulky and can only be operated by trained 
professionals. 
β =
ω
c
ϵMϵD
ϵM + ϵD
ω ϵM, ϵD
n
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1.3.5 Superconducting Quantum Interference Device (SQUID) 


 SQUID is one of the most sensitive magnetometers available today. The principle of 
operation of SQUID is based on superconducting loops containing Josephson junctions. 
The Josephson effect is a phenomenon by which Cooper pairs in superconducting 
materials can tunnel across a superconductor-insulator-superconductor interface. Figure 
1-8 shows the schematic of the simplest variant of a SQIUD biosensor. The biosensor 
consists of a current source which produces a constant bias current of . The sensor has 
two Josephson junctions denoted by x’s in the figure, across a superconducting coil. When 
no external magnetic field is present, the current is divided equally among the two halves 
of the SQUID sensor. However, when an external magnetic field is present due to a 
magnetic nanoparticle label, the currents in the two arms are not equal and a shielding 
current  is developed which tries to reduce or increase the magnetic flux passing through 
the coil so as to make it equal to an integer multiple of the magnetic flux quantum 
, where h is the Planck’s constant and e is the charge of a proton. The 
screening current induces a voltage across the input and output terminals of the 
superconducting loop which can be measured to infer the magnetic field. SQUID 
biosensors have been applied for extremely sensitive detections of magnetic 
nanoparticles[18]. While SQUID sensors are extremely sensitive to magnetic fields, they 
are constrained by the high cost, large size of the equipment as well as the requirement of 
cryogenic conditions and skilled personnel for operation of the equipment. Figure 1-9 
shows a photograph of a SQUID system. Although SQUID is not a leading contender for 
medical diagnostics technology to be used in developing countries, I am mentioning it in 
this section to further underscore the fact that conventional medical diagnostics 
technology is expensive, bulky and unsuitable for use in developing countries. 
Now that I have provided several examples of conventional medical diagnostics 
technologies in use and under development, I will next describe the state of healthcare in 
2Ib
Is
ϕ0( = h /2e)
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Figure 1-8. Schematic of a SQUID biosensor.
developing countries. Since any medical diagnostics technology has to be able to work 
under these real world conditions, this analysis will help the reader to understand the 
challenges that need to be overcome to achieve the vision of ‘healthcare for all’ described 
in SDG #3 by the UN. To keep this discussion realistic and fact based, I have chosen to 
describe the state of healthcare in my home country, India as I am quite familiar with the 
rural healthcare system in my country. India is the fifth largest economy in the world with a 
population of 1.27 billion people. The trends and lessons learnt from the example of India 
are applicable in many other developing countries across the world. 
1.4 Healthcare in India 
 On one hand, the majority of growth in the world’s population is taking place in the 
developing countries; and on the other the developed countries face the challenge of an 
ageing population. Thus, there is an acute need for making healthcare accessible to all in 
both: the developing and the developed countries. While the social and economic status of 
the people are very different across these two types of countries, there are remarkable 
similarities in the problems faced by the healthcare system. In this section, I will present 
the current status of healthcare system in India where I am from. In particular, I will focus 
on the challenges in achieving the targets outlined in SDG #3. Although, I am focusing on 
the example of India, yet the characteristics of the healthcare system presented are similar 
across the rest of the developing world. 
1.4.1 Availability of hospitals 
 In public healthcare, the availability of medical facilities is measured by the number 
of hospital beds available, rather than the number of hospitals. The number of hospital 
beds available in public hospitals in India is approximately 740,000 as per the Ministry of 
Health and Family Welfare [19]. Accounting for the population of India this is just 0.56 beds 
per 1,000 people. The world average is 2.75 beds per 1,000 people while developed 
countries have multiple times the average (for example, Japan has 9 beds per 1,000 
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Figure 1-9 A photograph of a SQUID magnetometer system [17]
people[20]). Not only is there a divide between developing and developed countries, even 
within a developing country such as India, there is a large divide between rural and urban 
healthcare systems. For example, among the 740,000 hospital beds available across the 
country, approximately two-thirds of them are in urban areas and only one third in rural 
areas[19]. This is in stark contrast to the demography of the country which is about two-
thirds rural and one-third urban, as shown in figure 1-10. Thus, rural people get access 
to roughly 4 times fewer hospital beds per person than urban people. This presents a 
major challenge for public healthcare in India as a majority of the rural population has to 
travel to the closest available urban center in order to access even the most basic 
healthcare. This leads to the following problems: 
When infants get infected, they often go undiagnosed and untreated. This is because 
parents are unable to travel long distances to hospitals to get them diagnosed every time 
infants show symptoms of being unwell. For many of the poorest people who are 
inevitably employed in the informal economy (of course, without medical benefits), the 
long travel to hospitals requires at least a day’s leave from work, which means loss of 
wages. Thus, the choice between lost wages and potential risks to a child’s health is a 
tough one to make for many parents. 
Epidemics are not detected in time to contain their spread. If a large number of people 
get infected, only a few of them go to hospitals to get themselves diagnosed. Thus, 
public health officials who are themselves located far away from the centers of outbreak 
get incomplete, indirect and delayed information about the outbreak of epidemics and 
communicable diseases. 
1.4.2 Availability of doctors 
 WHO recommends a minimum of 1 doctor for every 1000 people for a country in 
order to provide effective public healthcare. Due to the limited availability of quality 
education, the availability of doctors has been historically severely limited in India. In the 
last few years, improved availability of medical education has improved the number of 
qualified doctors available in the country. If alternate forms of medicine are excluded, the 
number of doctors in India is currently just about 1 million and the doctor to population ratio 
is about 0.77:1000, well below WHO recommendations. This ratio is not expected to reach 
the minimum recommended 1:1000 until 2024 [22]. Moreover, the urban-rural divide in 
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Figure 1-10. Urban rural divide in India. The 70% rural population is served by just 39% of 
hospital beds and 20% of doctors available in the country[19, 21].
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infrastructure discussed above is even more stark in the availability of personnel and staff. 
A majority of doctors (80%) of India live in urban areas[21], as shown in figure 1-10. Thus, 
only about 200,000 doctors serve about 900 million rural population of India i.e. only 0.22 
doctors for every 1000 people. In fact, rural people get access to roughly 9 times fewer 
doctors per person than urban people. In developing countries such as India, educated 
people aspire to live in big cities since urban areas offer a better standard of living, also 
living in a big city is associated with upward social mobility. This leaves the rural population 
severely underserved. The few doctors who do live in rural areas, where they are in high 
demand, find it far more lucrative to operate private clinics. These private clinics often 
prioritize monetary profit over quality healthcare. Thus, healthcare from such clinics is not 
affordable. 
 The above discussion paints a very grim picture of healthcare in rural India. In order 
to combat the lack of trained medical professionals, people in India have depended on two 
alternatives. The first alternative is a vast public healthcare system staffed by uneducated 
and semi-literate public healthcare workers and the second alternative is traditional 
systems of medicine called Ayurveda, Unani and Siddha. A discussion on the traditional 
Indian medicine is beyond the scope of this thesis, but I explain the role of semi-literate 
public healthcare workers in rural India. 
1.4.3 Health care (Anganwadi) centers 
 In 1970s, the condition of healthcare in India was even more grim than that 
presented above. Infant mortality, maternal deaths due to child delivery and malnutrition 
were very high. Against this backdrop, the Government of India decided to start public 
healthcare centers where rural women would provide basic public health services, 
primarily aimed at providing care to pregnant women, infants, vaccination to young 
children and pre-school education. These centers are known as Anganwadi centers 
(AWCs; the word anganwadi means a courtyard shelter in Indian languages). Each AWC is 
operated by three healthcare workers[23] who are all from the same neighborhood which 
they are serving. Thus, AWC workers have very close contacts with the people they serve 
and they understand the individual needs of their patients much better than a doctor does. 
Figure 1-11 (a) shows a photograph of an AWC near my home in Sikar district of 
Rajasthan state in India. Figure 1-11 (b) shows the six services provided by the AWC. 
These are: 
1. Nutritious food to pre-school kids. 
Page 17
(a) (b)
Figure 1-11 (a) Photograph of an AWC near my home in Sikar, Rajasthan, India. (b) A board 
outlining the six services offered at the AWC. Blue box indicates services 3 to 6 relevant to my 
research, which are related to healthcare.
2. Pre-school education 
3. Nutrition and healthcare counseling 
4. Vaccination 
5. Health checkups 
6. Referral to hospitals if the patient cannot be treated by the AWC. 
 There are 1.3 million such AWCs in operation in India today which are operated by 
approximately 4 million healthcare workers. Although AWC workers are themselves poor 
and often illiterate, they have played a large part in reducing maternal and infant mortality 
as well as successfully eliminating highly contagious diseases such as polio from India[24]. 
Thus, while most AWC workers lack the skills and knowledge of doctors and trained 
medical staff, they have proved themselves to be invaluable for providing targeted medical 
care for those most in need of it. It is also important to note that all of these 4 million AWC 
workers are already located in rural areas. Thus, the number of AWC workers in rural 
India is 20 times that of doctors! (4 million AWC workers v/s 0.2 million doctors) This 
research aims to empower these AWC workers to function as medical diagnosticians and 
provide healthcare in locations where hospitals are limited and doctors do not want to 
work. 
1.5 Leapfrogging in telecommunications 
 In economics, the term leapfrogging refers to a fundamental shift in technology 
which enables progress that could not have been achieved with incremental improvements 
to conventional technology[25-27]. For example, in developing countries such as India 
landline telephones were accessible only to a small fraction of the population (primarily 
urban) as they were expensive to install. As a consequence, services like broadband 
internet were also accessible to a small fraction of the population. The fraction of Indian 
population with access to landline phones peaked at 4.4% in India in 2005 and have been 
falling ever since[28]. Several government policies during the 1980s and 1990s were 
focused on reducing the cost of landline telephones and making them available in rural 
areas. However, concerns about making landline phones available to rural areas became 
redundant with the advent of mobile telecommunications. With wireless communication 
technology, a single cell tower could serve up to tens of thousands of customers located in 
densely populated areas. Thus, economies of scale were leveraged by industry to make 
mobile communications much cheaper than landline communications had ever been. 
Mobile phones, especially smartphones equipped with camera, Wi-Fi and third and fourth 
generation (3G/4G) communication, allowed rural population of India to leapfrog from 
having no communication capabilities to having the latest mobile phone communications 
technology while skipping landline phone technology altogether. According to the latest 
data, the number of mobile connections in India is about 1.16 billion[29] which is a 
penetration rate of 91% (over 20 times the maximum fixed telephone penetration ever 
achieved). This has resulted in opening up a large market for telecommunication industry. 
The resulting economies of scale and market competition have transformed the landscape 
of communication in favor of end users and as a result, Indian customers enjoy the 
cheapest mobile data rates in the world at $0.26 (26 yen) per gigabyte, as shown in figure 
1-12. 
 This revolution in telecommunications technology has further enabled leapfrogging 
in other areas like financial services (such as peer to peer money transactions without the 
use of banks, micro-credit loans to small businesses without a collateral), e-commerce 
(such as enabling rural artists to sell their art internationally and enabling people in rural 
areas to buy products from anywhere in the world) and governance (such as elimination of 
corruption in delivery of public services by making services available online in an entirely 
automated fashion, eliminating the need for interaction with government officials). 
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 The crux of my research is that smartphones can enable leapfrogging in medical 
diagnostics and serve orders of magnitude more people in developing countries than 
conventional medical diagnostics technologies. Experience in telecommunications, 
commerce, finance and governance in India shows that large strides in progress are 
achieved by fundamental shifts occurring due to new technology rather than incremental 
improvements in conventional technologies. It is expected that this trend will be replicated 
in the field of medical diagnostics. Rapid improvements in medical diagnostics will be 
achieved by technologies which are designed from the ground up specifically for 
use with smartphones, rather than by miniaturizing conventional technologies like 
ELISA, GMR or SPR to interface with a smartphone. 
 To this end, I will present two medical diagnostics systems based on smartphones 
in this thesis which are designed with this philosophy, take advantage of internet 
communication and can be used by anyone with minimal training. Thus, AWC workers can 
be trained to use the medical diagnostics systems which I will describe. The large number 
of public healthcare workers along with ready availability of smartphones can help India 
and other such developing countries to serve large parts of underserved populations. 
Although I have focused on India, similar public health institutions exist in several 
developing countries as does mobile phone connectivity. Thus, this research can have a 
great impact in achieving the targets (3.2, 3.3, 3.8 and 3.D) outlined under SDG #3 on 
a global scale. 
1.6 An outline of the solution 
 The challenges faced by patients of conventional medical diagnostics systems are 
summarized in figure 1-13. The specific problems which impact the lives of millions of 
people are: 
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Figure 1-12. The cost of mobile data across the world. Source: cable.co.uk
Hospitals are often located hundreds of kilometers away. Thus, a hospital visit requires 
one to travel long distances. 
Hospital visits are expensive for the poorest section of the population 
People in rural areas are employed informally and there are no provisions for healthcare 
or paid leaves. Thus, spending time away from work leads to loss of wages. 
Conventional medical diagnostics technologies require a long time (several days) to test 
the sample and deliver the results. Thus, there is a long delay in the diagnosis due to the 
time required to travel as well as to deliver the test results.  
	 A mobile phone enabled medical diagnostics system contains the following 
essential components: 
A diagnostics chip where biomolecular reaction occurs. 
A smartphone equipped with a camera which can record photographs and videos. 
A cloud computer which can analyze results of a test and send the results to the patient 
as well as to public health officials. 
A public health worker who can perform the test as well as remotely located doctors who 
can act on the information provided by test results and make recommendations to the 
patient remotely. 
A schematic of such a system is shown in figure 1-14. The benefits of this system for the 
patient are: 
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Figure 1-13 Challenges faced by patients under conventional healthcare system in 
developing countries.
Tests can be done without traveling to the hospital. Moreover, smartphone based 
diagnostics methods do not require a long time to perform he test. Thus, results are 
available in a few minutes, rather than days. 
Smartphone based tests can be administered at a lower cost than conventional tests. 
Since there is no need for the patient to travel, there are additional savings in cost. 
Public health workers such as AWC workers are located in every neighborhood, close to 
the patients. A visit to the AWC does not require one to take time off from work. Thus, 
there is no loss of wages to the poorest section of the people. 
Since the results of the tests are shared with doctors and health administrators, they can 
provide medical advice remotely. 
When public health authorities have access to the medical status of people in near real-
time, public health risks such as an outbreak of epidemics and contagious diseases can 
be identified very quickly and action can be taken in time to prevent their spread and 
save lives. 
 The most important diseases which should be detectable by such a diagnostics 
system are common airborne, waterborne diseases as well as diseases caused by insects 
breeding in unsanitary environments. For example, in the case of India, the five most 
common diseases causing child mortality are[30, 31]: 
Pneumonia  
Diarrhea  
Cholera  
Page 21
Figure 1-14. A schematic of a smartphone based medical diagnostics system comprising 
a diagnostics chip, internet connected smartphone, a public health worker, a cloud 
computing based data analysis system as well as remotely located doctors.
Malaria, and 
Typhoid 
 The most common diagnostics technology used to detect these diseases is 
ELISA[32, 33] and low-cost diagnostics tests are usually not available. In the absence of 
access to such diagnostics technology, sometimes inaccurate tests are used in developing 
countries which can lead to misdiagnosis and thus potentially cause harm to healthy 
individuals, For example, for typhoid, several low-cost tests such as typhidot, Widal and 
TUBEX tests have been in use in developing countries. However, these tests have been 
shown to have very low sensitivity and specificity for typhoid detection[34, 35]. The 
availability of low-cost and highly sensitive diagnostic tests would prevent premature 
deaths of children below the age of five, who remain the worst affected demographic due 
to these diseases. 
 Another scenario in which rapid diagnostics would be critical for public health is 
epidemics. As the world is getting more and more connected, epidemics originating in one 
part of the world spread extremely quickly to other parts. For the purposes of this 
discussion, I would like to classify epidemics into two categories: novel and recurring 
epidemics. A case of a novel epidemic is in the news recently. A new strain of virus, named 
as 2019 Novel Coronavirus (209-nCOV) has been the cause of a very recent epidemic 
originating in the city of Wuhan in China[36]. As of the time of writing, more than 800 
people have been found to be infected with this disease in China alone, and the infection 
has already spread to U.S., Japan, Taiwan, Thailand, Singapore and Saudi Arabia[37]. 
Currently, diagnosis of this disease is being performed by isolating the virus from a blood 
sample, sequencing its DNA and comparing the sequence with that of 2019-nCOV 
provided by the Chinese public healthcare authorities.  
 If such a disease were to originate in a small remote village, rather than a big city, 
smartphone based medical diagnostics test would not be able to diagnose it since there is 
very little information about such an infection in the scientific community. Antibodies or 
biomarkers for such new diseases have to first be discovered and only then they can be 
used for conventional or smartphone based medical diagnosis. 
 The other type of epidemic is a recurring epidemic. A pertinent example of this kind 
of disease is the Ebola virus disease (EVD), which killed more than 11,000 people in Africa 
between 2013 and 2016[38]. Contrary of 2019-nCOV, EVD is a very old disease which has 
been known to the scientific community since the first outbreak of EVD in Democratic 
Republic of Congo in 1976[39]. Yet, about 40 years after this epidemic became known, the 
public healthcare systems in the north African countries were unable to prevent its spread 
when a new outbreak occurred in 2014, primarily because infected individuals were not 
diagnosed on time and continued to live and interact with healthy individuals, thereby 
spreading the disease. Since a vaccine or medicine for EVD is not known[40], the best 
course of action from a public health perspective is rapid diagnosis and isolation of 
infected patients. Smartphone based rapid, low-cost diagnostics tests can prevent the 
spread of epidemics by diagnosing infected individuals quickly and alerting public health 
officials about the outbreak through cloud computing based notification system. 
1.7 Objectives of this research 
 I have discussed the key features of a smartphone based medical diagnostics 
system in very general terms until now. In closing this chapter, I mention the specific 
technical objectives and contributions of this research. Some technical terms used below 
will be introduced in later chapters. The specific objectives of my research were: 
Development of smartphone based point of care medical diagnostics protocols 
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 Conventional medical diagnostics technologies require bulky equipment, skilled 
professionals and long time to provide results. My aim is to develop portable, rapid, low-
cost and highly sensitive medical diagnostics protocols for quantitative detection of 
biomolecules. Diagnostics technologies with these features are called point of care testing 
(POCT) technologies. I aim to use smartphones as a platform to develop POCT 
technologies i.e. the protocol should take advantage of smartphone features such as 
camera, communication and processing to enable rapid diagnostics. 
Development of fluorescent magnetic nanoparticle based POCT system for 
quantitative detection of biomolecules 
 Fluorescent magnetic nanoparticles have several advantages as biomolecular 
labels. My aim is to develop a smartphone based POCT system which uses fluorescent 
magnetic nanoparticles as labels to enable highly sensitive quantitative detection of 
biomolecules. 
Development of diagnostics protocols based on optical tracking of the dynamics 
of magnetic particles 
 Studying the dynamics of magnetic particles on a surface can reveal information 
about the biomolecular interaction of the surface with the particles. This potential has not 
been effectively used in previous literature. I aim to develop a diagnostics protocol based 
on optical tracking of the dynamics of magnetic particles which can achieve rapid and 
highly sensitive quantitative detection of biomolecules with a smartphone. 
1.8 Contributions of this research 
 Finally, I describe the contributions of my research. This makes this chapter a self 
contained introduction to the thesis, so that a reader can assess the problem being solved, 
an outline of the solution and originality of my research from this chapter alone. 
 In this work, I report the development of smartphone based point of care medical 
diagnostics systems utilizing magnetic particles as labels. My work takes advantage of the 
tremendous improvements in smartphone cameras over the past few years, driven by 
trends in consumer photography, which have made modern smartphones capable of 
detecting micrometer and nanometer sized particles via light microscopy and fluorescence 
microscopy respectively. I have built upon these capabilities of smartphones and 
developed methods for actuation of magnetic particles over a large area as well as for their 
detection and tracking with sub-micron resolution. I propose two types of POCT 
diagnostics systems: 
1.8.1 Fluorescent magnetic particles based POCT system 
 Fluorescent magnetic nanoparticles (f-MNPs) are promising labels for biosensors 
due to their high surface area to volume ratio, magnetic and fluorescence properties. The 
POCT system based on f-MNPs as labels consists of three key components: 
A protocol for detection of prostate specific antigen (PSA) by fluorescent imaging of f-
MNPs. 
A digital image processing algorithm for determining the concentration of PSA via 
fluorescent images of f-MNPs obtained with a smartphone. 
A shared ‘cloud server’ platform for performing the analysis and communicating the 
results to designated users. 
The proposed method achieves a limit of detection of 100 pg/mL in 2.5 minutes (30 
seconds for actuation, 1 minute for washing and 1 minute for data analysis). This is an 
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order of magnitude faster than previously reported methods for detection of PSA by a 
smartphone. 
1.8.2 Magnetic micro particles based POCT system 
	 Magnetic micro-particles are well resolved in images obtained by light microscopy. 
Thus a series of images of the substrate surface taken in quick succession (a video) 
contains information about the dynamics of each particle which can reveal information 
about the interaction of particles with the sensing area. I propose a POCT biosensing 
system based on magnetic micro-particles with two key components: 
A three dimensional actuation mechanism for magnetic particles which promotes specific 
interactions and inhibits non-specific interactions simultaneously. The actuator is based 
on application of dielectrophoretic forces on particles, due to which the particles exhibit 
harmonic oscillations. 
An algorithm for high resolution optical tracking of magnetic particles in a video taken 
from a smartphone. The optical tracking algorithm is based on template matching for 
spatial localization of particles and a Kalman filter based motion model for accurate 
temporal association of particle trajectories across the frames of a video. 
The proposed method achieves a limit of detection of 1 nM for biotin in 9 minutes (2 
minutes for actuation and 7 minutes for optical tracking). This is the first report of a 
smartphone based biosensing protocol using optical tracking of magnetic particles. 
 I have described that conventional medical diagnostics technologies are unsuitable 
for use in rural areas due to their large size (figures 1-3, 1-7 and 1-9) and cost (8,000 US 
dollars). To complete the discussion on the advantages of smartphone based medical 
diagnostics technologies in such areas, I am presenting the size and cost of the 
smartphone based diagnostics system developed in my research. Figure 1-15 shows a 
prototype diagnostics system developed in this research. The proposed system is much 
smaller than a conventional diagnostics technologies and costs about $20 excluding 
smartphone, battery and lens. 
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(a) (b)
Figure 1-15 A prototype of the small medical diagnostics system developed in this study. A 
500 yen coin is shown for scale. (a) The system is powered with a mobile power bank and 
consists of a current application circuit (b) A 3D printed microscope along with a smartphone 
is used to take 4K videos of the biosensing chip (not visible in these images). The video is 
then uploaded to a remote ‘cloud’ computer where they are analyzed and the results are sent 
back to the user.
1.9 Organization of this thesis 
 This chapter was a non-technical introduction to the field of medical diagnostics. 
The remaining chapters of this thesis will be technical in nature and are organized as 
shown in figure 1-16. 
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Chapter 1 
The problem: The ultimate goal of this research
Chapter 2 
Introduction to biosensing
Chapter 3 
Introduction to magnetic particles
Chapter 4 
Development of hardware components used in the 
experimental setup
Chapter 5 
Development of software for automating 
the data analysis
Chapter 6 
Results and Discussion: Smartphone based point of care 
diagnostics system with florescent magnetic 
nanoparticles
Chapter 7 
Results and Discussion: Smartphone based point of care 
diagnostics system with magnetic micro-particles and 
optical tracking
Chapter 8 
Conclusion and future work
Figure 1-16. Organization of this thesis
1.10 References 
[1] Sustainable Development Goals, https://www.un.org/sustainabledevelopment/ 
[2] ESA and the Sustainable Development Goals, http://www.esa.int/Enabling_Support/
P r e p a r i n g _ f o r _ t h e _ F u t u r e / S p a c e _ f o r _ E a r t h /
ESA_and_the_Sustainable_Development_Goals 
[3] Goal 3: Ensure healthy lives and promote well-being for all at all ages, https://
www.un.org/sustainabledevelopment/health/ 
[4] Engvall, E. and Perlmann, P., 1972. Enzyme-linked immunosorbent assay, ELISA: III. 
Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-
coated tubes. The Journal of Immunology, 109(1), pp.129-135. 
[5] Holt, P.S., Gast, R.K. and Greene, C.R., 1995. Rapid detection of Salmonella enteritidis 
in pooled liquid egg samples using a magnetic bead-ELISA system. Journal of food 
protection, 58(9), pp.967-972. 
[6] ELISA, reader, 8 channel, https://supply.unicef.org/s0001312.html 
[7] The principle and method of ELISA, https://ruo.mbl.co.jp/bio/e/support/method/
elisa.html 
[8] Sandhu, A., Sanbonsugi, H., Shibasaki, I., Abe, M. and Handa, H., 2004. High 
sensitivity InSb ultra-thin film micro-hall sensors for bioscreening applications. Japanese 
journal of applied physics, 43(7A), p.L868. 
[9] Binasch, G., Grünberg, P., Saurenbach, F. and Zinn, W., 1989. Enhanced 
magnetoresistance in layered magnetic structures with antiferromagnetic interlayer 
exchange. Physical review B, 39(7), p.4828. 
[10] Freitas, P.P., Ferreira, R. and Cardoso, S., 2016. Spintronic sensors. Proceedings of 
the IEEE, 104(10), pp.1894-1918. 
[11] Baselt, D.R., Lee, G.U., Natesan, M., Metzger, S.W., Sheehan, P.E. and Colton, R.J., 
1998. A biosensor based on magnetoresistance technology. Biosensors and 
Bioelectronics, 13(7-8), pp.731-739. 
[12] Transforming Personal Health: The Nokia Sensing XChallenge, https://
www.herox.com/blog/163-transforming-personal-health-the-nokia-sensing-xch 
[13] Choi, J., Gani, A.W., Bechstein, D.J., Lee, J.R., Utz, P.J. and Wang, S.X., 2016. 
Portable, one-step, and rapid GMR biosensor platform with smartphone interface. 
Biosensors and Bioelectronics, 85, pp.1-7. 
[14] Ng, E., Yao, C., Shultz, T.O., Ross-Howe, S. and Wang, S.X., 2019. Magneto-
nanosensor smartphone platform for the detection of HIV and leukocytosis at point-of-care. 
Nanomedicine: Nanotechnology, Biology and Medicine, 16, pp.10-19. 
Page 26
[15] Elghanian, R., Storhoff, J.J., Mucic, R.C., Letsinger, R.L. and Mirkin, C.A., 1997. 
Selective colorimetric detection of polynucleotides based on the distance-dependent 
optical properties of gold nanoparticles. Science, 277(5329), pp.1078-1081. 
[16] SPR-PLUS, https://www.xantec.com/products/spr_biosensors/sprplus.php 
[17] Superconducting Quantum Interference Device Magnetometer, https://
physics.missouristate.edu/SQIDM.htm 
[18] Oisjoen, F., Schneiderman, J.F., Zaborowska, M., Shunmugavel, K., Magnelind, P., 
Kalaboukhov, A., Petersson, K., Astalan, A.P., Johansson, C. and Winkler, D., 2009. Fast 
and sensitive measurement of specific antigen-antibody binding reactions with magnetic 
nanoparticles and HTS SQUID. IEEE Transactions on Applied Superconductivity, 19(3), 
pp.848-852. 
[19] Hospitals in the Country, https://pib.gov.in/PressReleasePage.aspx?PRID=1539877 
[20] Hospital beds (per 1,000 people), https://data.worldbank.org/indicator/
SH.MED.BEDS.ZS 
[21 ] 80 pe r cen t o f Ind ian doc to rs l oca ted in u rban a reas , h t tps : / /
economictimes.indiatimes.com/industry/healthcare-biotech/80-per-cent-of-indian-doctors-
located-in-urban-areas/articleshow/53774521.cms?from=mdr 
[22] Kumar, R. and Pal, R., 2018. India achieves WHO recommended doctor population 
ratio: A call for paradigm shift in public health discourse!. Journal of Family Medicine and 
Primary Care, 7(5), p.841. 
[23] Anganwadi, https://en.wikipedia.org/wiki/Anganwadi 
[24] The Role of the Anganwadi Worker in Polio Eradication in Bihar, India: From 
Awareness Generation to Service Delivery, https://www.researchgate.net/publication/
282335896 
[25] Leapfrogging, https://en.wikipedia.org/wiki/Leapfrogging 
[26] Leapfrogging Tech Is Changing Millions of Lives. Here’s How, https://
singularityhub.com/2018/05/06/leapfrogging-tech-is-changing-millions-of-lives-heres-
how/

[27] How leapfrogging can help developing countries surge ahead, https://
www.centreforpublicimpact.org/cleared-for-take-off/

 [28] Number of fixed telephone subscriptions per 100 inhabitants in India from 2000 to 
2018, https://www.statista.com/statistics/733525/fixed-telephone-subscriptions-per-100-
inhabitants-in-india/ 
[29] We Don’t Have Enough Doctors in Rural India. That’s Why We Need Telemedicine. 
http://bwdisrupt.businessworld.in/article/We-Don-t-Have-Enough-Doctors-in-Rural-India-
That-s-Why-We-Need-Telemedicine-/14-06-2017-120121/ 
[30] Water-Borne Diseases in India, https://en.reset.org/blog/water-borne-diseases-india 
Page 27
[31] Rai, S.K., Kant, S., Srivastava, R., Gupta, P., Misra, P., Pandav, C.S. and Singh, A.K., 
2017. Causes of and contributors to infant mortality in a rural community of North India: 
evidence from verbal and social autopsy. BMJ open, 7(8), p.e012856. 
[32] Laboratory Methods for the Diagnosis of Vibrio cholerae, Centers for Disease Control 
and Prevention, https://www.cdc.gov/cholera/pdf/Laboratory-Methods-for-the-Diagnosis-of-
Vibrio-cholerae-chapter-7.pdf 
[33] Spencer, H.C., Collins, W.E., Chin, W. and Skinner, J.C., 1979. The enzyme-linked 
immunosorbent assay (ELISA) for malaria. The American journal of tropical medicine and 
hygiene, 28(6), pp.927-932. 
[34] Keddy, K.H., Sooka, A., Letsoalo, M.E., Hoyland, G., Chaignat, C.L., Morrissey, A.B. 
and Crump, J.A., 2011. Sensitivity and specificity of typhoid fever rapid antibody tests for 
laboratory diagnosis at two sub-Saharan African sites. Bulletin of the World Health 
Organization, 89, pp.640-647. 
[35] Mehmood, K., Sundus, A., Naqvi, I.H., Ibrahim, M.F., Siddique, O. and Ibrahim, N.F., 
2015. Typhidot-A blessing or a menace. Pakistan journal of medical sciences, 31(2), 
p.439. 
[36] Novel coronavirus (2019-nCoV), https://en.wikipedia.org/wiki/
Novel_coronavirus_(2019-nCoV) 
[37] 2019–20 Wuhan coronavirus outbreak, https://en.wikipedia.org/wiki/2019–
20_Wuhan_coronavirus_outbreak 
[38] Factbox: WHO international public health emergencies, https://www.reuters.com/
article/us-china-health-who-emergency-factbox/factbox-who-international-public-health-
emergencies-idUSKBN1ZL1S4 
[39] Ebola virus disease, https://www.who.int/news-room/fact-sheets/detail/ebola-virus-
disease 
[40] Experimental therapies: growing interest in the use of whole blood or plasma from 
recovered Ebola patients (convalescent therapies). https://www.who.int/mediacentre/news/
ebola/26-september-2014/en/ 
Page 28
2. Introduction to biosensing 
2.1 Introduction 
 The United Nations has identified ageing population across the planet as one of the 
most important issues in its ‘Overview of Global Issues’[1]. Further, it is noteworthy that the 
number of people aged 65 or above exceeded the number of children under 5 years of age 
in 2018 for the first time in history[2]. These statistics underscore the fact that access to 
healthcare is expected to be one of the most important concerns for developing countries 
in the coming decades. This has motivated a large body of research in developing rapid, 
low cost and sensitive devices for medical diagnostics. In this chapter, I will introduce the 
concept of a biosensor and establish a terminology for discussing various aspects of the 
biosensing system. Building on the discussion in the previous chapter, I describe the need 
for point of care biosensors and introduce a new architecture for such biosensors. I then 
analyze the potential of smartphones for point of care biosensing and show that they are 
an attractive platform for development of next generation point of care biosensors. Finally, 
I perform a survey of previous research on smartphone based biosensors. 
2.2 What is a biosensor? 
 A sensor is a device used to measure one or more properties of a system or 
environment of interest. For example, temperature sensors are used in automobiles to 
monitor the combustion process in the engine. When the system of interest is a biological 
system and the property of interest is the amount of certain types of biological markers, the 
sensor which enables these measurements is called a biosensor. Examples of biological 
systems includes cells, tissues, blood and saliva etc., while examples of biological markers 
include cell morphology, proteins or antibodies corresponding to specific diseases. In this 
work, we will restrict ourselves to using liquid systems and molecular biomarkers. Thus, 
cells and tissues and detection of their related properties are outside the scope of this 
study. 
 For a liquid biological sample where a molecule is the marker of interest, the 
components of a conventional biosensing system is given in figure 2-1. 
The bioreceptor (generally an antibody or antigen) is a complimentary molecule to the 
biomolecule  of interest. The biological interaction between complimentary molecules is 
converted into an electronic signal by a transducer. Supporting electronic circuitry is used 
to reduce the noise in the readout of the transducer and the results are then displayed on 
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Figure 2-1. Components of a conventional biosensing system.
a screen. Some examples of each of the major components in the above figure are shown 
in Table 1. 
Next, I will discuss these components in detail. 
2.2.1 Bio-receptors and labels 
A bio-receptor (say, A) is a molecule which can interact with the molecule of interest (say, 
B) and produces a signal which can be detected externally. Notably, the reaction of a 
bioreceptor is specific i.e. no other molecule (say, C) can interact with A to produce the 
signal. Bio-receptors on their own are insufficient for electronic detection of bimolecular 
interactions due to their small size. Thus, biomolecular labels are used to tag specific bio-
receptors so that the presence of the bioreceptor can be detected by the presence of tags. 
Bio-receptors may thus be distinguished on the basis of their labels. 
2.2.1.1 Bio-receptors

 Antibodies (also known as immunoglobulins) are proteins produced by the human 
body in response to foreign agents. The function of an antibody is to bind to a specific type 
bacteria or virus and enable its destruction. Notably, the defining characteristic of an 
antibody is its specificity in binding to its complimentary molecule, called an antigen. 
Figure 2-2 shows the structure of an antibody. The structure of an antibody can be divided 
into two major parts: heavy chains (H-chains) and light chains (L- chains). The H-chains 
constitute the so-called ‘constant region’ of the antibody which is common in all types of 
antibodies. The front end of the H-chains consist of L-chains which varies among 
antibodies and is thus called variable region. The variable region forms the binding site 
where the antibody attaches to antigens. The specific structure of the variable region 
determines the binding properties of the antibody, forming the so called lock and key 
binding mechanism. 
Table 2 lists various examples of antibodies and antigens. Among those listed, the Avidin-
Biotin binding system and prostate specific antigen (PSA) and corresponding antibody 
anti-PSA are used in this work for verification of proposed medical diagnostics protocols. 
While strictly speaking, avidin and biotin are not antibody and antigen, their interaction is 
one of the strongest known non-covalent interactions found in nature. Thus, it is commonly 
used as a model for biological interactions.  
Table 1. Examples of components of a biosensing system
Bioreceptor Transducer Electronics
Antibodies Magnetoresistive sensor Wheatstone bridge
Antigens Hall effect based sensor Lock-in amplifier
Enzymes optical imaging sensor Analog front end
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2.2.1.2 Biological labels

 The most commonly used labels for bio-receptors are radioisotopic labels, 
enzymes, fluorescent tags or nanoparticles. The most commonly used illogical labels are 
introduced briefly below: 
Enzymes are macromolecular biological catalysts which are most commonly used in 
Enzyme linked Immunosorbent Assay (ELISA). Enzymatic labels can interact with a 
substrate (a solution) such that the results of those interactions can be observed 
externally. In the most common form in ELISA, the enzyme causes a change in color of 
the solution which is observed with optical sensors. 
Fluorescent labels are most commonly used in the form of quantum dots (QDs). As the 
name suggests, the fluorescent labels attach selectively to antibodies and are detected 
in a fluorescent image. [6] 
Micro-particles composed of polymers are widely used as biological labels for bio-
receptors. There are various types of particle based labels depending on their size, 
shape and magnetic properties: 
Size: The size of the particles can vary over a wide range, from a few micro-meters to 
a few hundred nanometers. Smaller sized nanoparticles offer greater surface area to 
volume ratio for immobilization of biological receptors, but may require specialized 
transducers for sensing. 
Table 2. Examples of antibodies and antigens
Antibody Antigen
Immunoglobin G (IgG)[3] Rabbit anti-mouse (RAM) IgG
anti-PSA [4] Prostate specific antigen (PSA)
Avidin [5] Biotin
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Figure 2-2. Structure of an antibody and its binding site.
Magnetism: Magnetic nano-particles can be encapsulated within larger polymeric 
particles, which imparts magnetic properties to the composite particle. Such composite 
‘magnetic particles’ can be manipulated with the application of eternal magnetic fields. 
Fluorescence: Fluorescent chemical complexes can be encapsulated within polymer 
particles to produce fluorescent particles. Fluorescence is critical for detection of 
nanometer sized particles since they cannot be observed optically. 
Magnetic particles form the mainstay of the work presented in this thesis and are 
discussed in detail in the next chapter. 
2.2.1.3 Label free Biosensing

 Although biological labels are commonly used along with bio-receptors, certain 
biosensing transducers allow direct detection of bio-receptors in a label-free fashion. 
Notable examples of label free detection methods include surface plasmon resonance 
(SPR) and guided mode resonance (GMR) biosensors. 
2.2.2 Transducers 
There are various types of transduction mechanisms which can be exploited for detection 
of biological labels: 
The change in color of the solution due to the interaction of an enzyme with its substrate 
can be observed with microplate readers.  
The change in electrical conductivity of the medium between fixed electrodes can be 
used to measure the concentration of bio-receptors provided conductive particles (such 
as gold) are used. [7] 
Direct observation of micro meter sized particles can be performed with optical 
microscopy. 
The scattering and absorption properties of nanoparticles can enable their detection[8].  
The change in refractive index of a substrate by nanoparticles can be observed by 
spectroscopic measurements. 
The change in optical properties of metal surface known as surface plasmon resonance 
(SPR) can be used to directly detect antibodies on the surface. This method is ‘label free’ 
in that no biological labels are required. As I will discuss, this has the advantage that 
non-specific interactions between label and sensing surface do not limit the sensitivity of 
the sensing method. 
2.3 The need for point of care biosensors 
In the previous section, I introduced the constituent elements of a conventional biosensor 
and provided examples of each. The paradigm for biosensing was conceived in the 
previous century when rapid advances were made in various medical diagnostics 
technologies and tests for previously undetectable diseases were discovered. This way of 
designing biosensors poses several limitations: 
Highly skilled personnel are necessary to operate conventional equipment such as 96-
well plate readers of ELISA. 
The time required for performing the tests is very long. It typically takes several hours for 
a patient to receive the results of a conventional test such as ELISA. 
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The cost of equipment such as incubation systems and plate readers is quite high thus, 
their availability is limited to hospitals and pathology laboratories. This presents a 
challenge as most of developing countries have limited infrastructure to support 
procurement and operation of conventional equipment. 
The results of the diagnostics test are not readily shared between patients and doctors. 
Access to information about the spread of a disease can be critical in case of outbreak of 
an epidemic in order to target the response to the most affected regions. 
Thus, while biosensors developed in the previous century had to address the 
problem of accurate and reliable detection, the next generation of biosensors will 
have to address the problem of scale as well as speed. Thus, an ideal biosensor 
needs to have the following characteristics in order to address the healthcare needs of an 
ageing population in the 21st century: 
The biosensor should be low cost. This typically involves a disposable strip/substrate to 
be used in conjunction with a non-disposable analysis equipment. 
The biosensor should provide results quickly. For the best experience of patients, results 
should be available in 10 minutes or less. 
The biosensor should be easy to use such that unskilled patients can perform their tests 
on their own and do not need to be trained. 
The biosensor should offer increased access to the patients by virtue of being integrated 
with existing technologies and devices commonly used by people across the world. For 
example, smartphones are ubiquitous across the world and are an attractive technology 
for integration with biosensors. 
2.4 A new architecture for point of care biosensors 
 Biosensors designed with the above objectives in mind enable testing at the ‘point 
of care’ or bedside by the patient rather than in a laboratory by a technician. Thus, such 
types of biosensors are called point of care testing (POCT) biosensors. From the above 
discussion, it is clear that existing biosensing technologies cannot be modified retroactively 
to achieve the stated objectives and that next generation POCT biosensors should be 
designed from the ground up. Thus, I propose a new architecture for POCT biosensors to 
facilitate and guide the development of next generation of biosensors in figure 2-3. The 
proposed POCT biosensing system has two additional components compared to a 
conventional biosensor: 
Data Analyzer: In addition to bio-receptors and transducers, the POCT biosensor requires 
a data analyzer module which can perform ‘post-processing’ of the data to extract valuable 
information from the collected data. Note that the data analyzer is in addition to any noise 
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Figure 2-3. Overview of components of a POCT biosensor.
reduction circuitry which forms a part of the biosensor. In particular, the noise reduction 
and processing circuitry described in figure 2-1 process the signals while the 
measurements are being carried out whereas the data analyzer performs analysis after the 
data has been collected (hence the term post-processing). This has a few advantages for 
biosensing: 
Post processing does not need to be performed in real-time and can be performed by at 
a remote location such as on a cloud server. 
With the rise of technologies such as big data mining and artificial intelligence it may be 
possible to extract information out of data which was not envisaged at the time of 
collection of the data. For example, scans of retinal images of patients have been shown 
to contain information about cardiovascular risk factors such as age, gender, smoking 
status and systolic blood pressure[9]. Such associations are surprising even to human 
experts and may be discovered by only big data mining, thereby allowing healthcare 
experts to offer new insights from existing data. 
Post-processing is necessarily performed in software. Thus, while the hardware of a 
biosensor cannot be modified once it has been introduced into the field, enhanced 
functionality can be introduced into a biosensor with a software update. 
Real-time communication: The results of a diagnostic test need to be communicated 
among various stakeholders such as patients, doctors and policy makers in order to 
ensure rapid response by public healthcare system in the case of outbreak of an epidemic. 
Thus, next generation POCT sensors necessitate the integration of a real-time 
communication module. The communication module may work in conjunction with data 
analysis module when, for example, data obtained from the sensor needs to be uploaded 
to a remote server for analysis before the results are received back. 
2.5 Smartphone as a biosensing platform 
 Smartphones have been a defining technology for the first two decades fo this 
century. The adoption of smartphones grew at more than 30% year on year during the 
early part of this decade and has now plateaued. As of 2018, among the top 50 countries 
with the most smartphone penetration about two-thirds are developing countries[10]. 
Smartphones enable three important functions which are suitable for biosensing: 
Cameras: Most smartphones are equipped with high resolution cameras. The 
complementary metal oxide semiconductor (CMOS) image sensors in smartphone 
cameras enable capturing of details under low light conditions. Moreover, users have 
access to raw image data as well as to compressed images and videos produced by the 
integrated image signal processor (ISP). Thus, both types of data could be used 
depending on the analysis method used. Notably, most modern smartphones are 
equipped with the ability to record 4K video streams (3840 pixels x 2160 pixels). 
Communication: Since the primary function of smartphones is communication, modern 
smartphones are equipped with latest communication technologies such as 4G long term 
evolution (LTE), Wi-Fi (802.11 a/b/g/n/ac/ax) and Bluetooth (Bluetooth 4.0, 5.0 and BLE). 
These high speed communication channels an be used to send raw data collected from 
the biosensor and receive information about the results of data analysis or vice versa. 
Processing: The most important component of an embedded computing device such as 
a smartphone is the power efficient reduced instruction set (RISC) processor. In addition 
to RISC processors, recent smartphones also contain several application specific 
domains such as graphics processing units (GPUs) to accelerate specific workloads 
such as massively parallel matrix multiplication which enables inference for neural 
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networks. Thus, data processing algorithms designed to take advantage of such 
specialized accelerators can perform previously infeasible data analysis locally on the 
smartphone. 
Thus, it is clear that smartphones are equipped with several features for development 
of POCT biosensors as shown in table 3. Smartphone cameras can serve as low noise 
sensors, high speed processors can function as data analyzer and 4G/802.11 protocols 
can enable high speed communications. 
Thus, throughout the rest of this thesis I will focus on the development of smartphone 
based biosensors for POCT applications. 
2.6 Previous literature on smartphone based biosensors 
 The potential of smartphones for medical diagnostics has long been recognized by 
researchers all across the world. Smartphone based biosensors developed in literature are 
primarily of two types: 
Conventional biosensors with a smartphone interface. These include well-known 
technologies such as surface plasmon resonance (SPR)[11], Enzyme linked 
immunosorbent assay (ELISA)[12], giant magnetoresistance (GMR)[13], which have 
been developed independently of smartphones but were then retroactively miniaturized 
and modified to interface with smartphones. 
Biosensors developed specifically for use with a smartphone. These are technologies 
which were developed from the beginning for use with smartphones. Examples of such 
technologies include breath analyzers for lung function testing and smartphone based 
urinalysis kit[14]. 
The biosensing methods most relevant to this research are SPR, ELISA and GMR. I have 
already described the miniaturization of GMR biosensor and their limitations in section 
1.3.3. Here, I will describe research on smartphone based ELISA and SPR biosensors. 
2.6.1 Smartphone based ELISA 
 The steps involved in an ELISA based test are described in section 1.3.1 (figure 1-2 
and 1-3). At the end of an ELISA test, a 96-well plate reader is used to detect the intensity 
of fluorescent markers, and thus the concentration of biomarker of interest. Berg et. al.[12] 
at University of California, Los Angeles have demonstrated a miniaturized 96-well plate 
reader which integrates with a smartphone. A schematic of the plate reader is shown in 
figure 2-4. It consists of a 3D printed smartphone attachment which holds a 96 well plate 
and illuminates it with 24 blue LEDs. The light is transmitted via the wells and collected by 
an array of 96 individual optical fibers (one for each well). The optical fibers are bundled at 
one end into a 12x8 matrix which is then imaged with the camera of the smartphone. The 
Table 3. How smartphones can enable POCT biosensing
Requirement of POCT biosensor Function in smartphone
Low noise transducer/sensor High resolution (up to 4K) camera
Data analyzer High speed processor with GPUs
Communication 4G, 802.11 ac, BLE
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image is transmitted to a server and analyzed remotely. The results of the analysis are 
transmitted back to the user in about 1 minute. The researchers analyzed four types of 
biomarkers: mumps IgG, measles IgG, herpes simples IgG virus 1 and 2 (HSV-1 and 
HSV-2). The analysis consisted of qualitative classification i.e. whether a sample indicates 
disease or no disease, rather than quantitative analysis of the concentration of biomarkers. 
They obtained a classification accuracy of 99.6%, 98.6%, 99.4% and 99.4% for detection 
of mumps, measles, HSV-1 and HSV-2 respectively. 
 This study represents the potential of ELISA to be miniaturized and integrated with 
a smartphone. However, there are two specific limitations of this approach: 
One of the major limitations of ELISA is that a long time of 12-24 hours is required for 
incubation of sample for the biomolecular reaction to occur. Incubators are large and 
expensive equipment which are available only in laboratories. The plate reader is useful 
only after the incubation step is complete. While the proposed 96-well plate reader 
successfully miniaturizes the equipment for obtaining and analyzing ELISA plate images, 
from the point of view of practical use an incubator is still required. Thus, the proposed 
plate reader cannot successfully miniaturize ELISA tests unless further advances are 
made in miniaturizing biological incubators. The authors do not discuss the possibility of 
miniaturizing incubators. 
The image analysis software produces a binary output i.e. whether a disease is present 
or absent. This is often not enough for medical tests and for certain biomarkers, a 
quantitative measurement is necessary for the doctor to provide informed medical advice 
to patients. While the authors state that the proposed plate reader can obtain 
quantitative results, their experiments show that quantitative readout of the smartphone 
based plate reader can differ by as much as ±20% from a commercial 
spectrophotometer for all four biomarkers tested (figure 5 in the paper). Thus, the 
authors prefer to state qualitative results and do not show calibration curves or limits of 
detection of the biomarkers being studied. 
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Figure 2-4. Schematic of smartphone based 96-well plate reader demonstrated by Berg et. al. 
Source: [12]
2.6.2 Smartphone based SPR 
 SPR is one of the most sensitive methods of biomolecular detection available today. 
SPR biosensors are frequently used for extremely sensitive detections. Guner et. al. from 
Bilkent University, Turkey and Stanford School of Medicine, USA, have proposed a 
smartphone based SPR biosensor for rapid medical diagnostics. A schematic of the 
proposed biosensor setup is shown in figure 2-5. It consists of a 3D printed attachment 
which houses an LED light source and collimating optics. A sensor chip, containing a 
microfluidic channel is inserted into the smartphone attachment and the sample of interest 
is flowed at a rate of 50 µL/min through the channel for 5 minutes. The light from LED is 
incident on the sensor chip and the reflected light is imaged by the smartphone camera. 
The authors used this setup to detect mouse IgG and obtained a limit of detection (3σ) of 
20 nM within 5 minutes.  
 The results of this study are significant towards miniaturization of SPR biosensors. 
However, there are a few limitations of the proposed approach: 
The biosensor proposed in the study, as shown in figure 2-5 is not complete. An external 
peristaltic pump is used for controlled flow of liquids through the microfluidic channel. 
This presents a significant limitation for application of this biosensor for point of care 
since a pump for highly precise flow of sample is likely to be bulky and at the very least 
would require a walled power supply. The authors do not discuss the possibility of 
miniaturizing the pump. 
The sample volume required for conducting the test is quite large. It is estimated that the 
total sample volume required to carry out the test is 250 µL (50 µL/min for 5 minutes). 
The biosensing system I have developed can work with about two orders of magnitude 
less volume of sample. 
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Figure 2-5. Schematic of smartphone based surface plasmon resonance biosensor by Guner 
et. al. Source: [11]
 It is important to note here that the limit of detection obtained is relatively large for 
an SPR based biosensor. The authors do not mention the limit of detection of IgG 
obtained. An analysis of figure 5(b) of the paper shows that the 3σ limit of detection of IgG 
would be about 20 nM. This shows that while sensitivities well into pico-molar ranges have 
been reported for SPR based biosensors, when an SPR biosensor is modified to work with 
a smartphone, the sensitivity of the sensor is reduced. Thus, one should be aware that 
smartphone based biosensors have inherent limitations due to the limits of the camera or 
miniaturized hardware and one should not expect state of the art biosensing systems to 
retain their sensitivity as they are integrated with smartphones. 
 I have described smartphone based biosensors most relevant to my research. 
These biosensors were obtained by miniaturizing well-known state of the art medical 
diagnostics technologies to interface with a smartphone. In both the examples discussed, 
key components of the biosensing pipeline were not miniaturized. For example, in ELISA a 
biological incubator was still required to complete the test, not to mention that the time 
required for incubation was also the same as conventional ELISA (typically 24 hours). In 
SPR, a peristaltic pump was required to flow the liquid through a channel at a precise rate. 
Thus, while certain components of the biosensing pipeline were miniaturized, the resulting 
systems were still not suitable to be used for real world applications. 
 As I will describe, starting from chapter 3, in this research I have adopted a different 
way of solving the problem. Rather than trying to miniaturize existing technologies, I have 
designed point of care biosensing systems which use new modalities of sensing and do 
not require any equipment other than what I explicitly state. In keeping with the spirit of 
leapfrogging, I expect that over the long term, this approach of solving the problem will be 
more successful than trying to make incremental changes to conventional technologies 
such as ELISA or SPR. 
2.7 Summary

 In this chapter, I have introduced the basics of biosensing. I began by introducing 
the constituent components of a biosensor i.e. bio-receptors, labels and transducers. The 
limitations of conventional biosensors were identified and key components of next 
generation biosensors were identified. I introduced a revised architecture to guide the 
development of next generation of biosensors. Specifically, the requirements of data 
analysis and communication were emphasized in order to realize the benefits of point of 
care testing. A clear view of these requirements allows us to identify smartphones as a 
promising platform for development of next generation POCT biosensors. I then reviewed 
existing literature on smartphone based biosensors which miniaturize existing technologies 
such as ELISA and SPR. I found that while parts of the sample processing pipeline are 
successfully miniaturized, vitally important components such as incubators and pumps are 
not. Therefore, this renders these technologies unsuitable for use in, say rural India, where 
they are needed the most. 
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3. Introduction to magnetic 
particles

3.1 Introduction 
 In the previous chapter, I discussed various aspects of a biosensor and identified 
micro and nanoparticles as one of the most suitable labels for biosensing. One of the 
major advantages of magnetic particles (MPs) is the ability to manipulate their motion with 
the application of external magnetic fields. Thus, a large body of work on MP based 
biosensing focuses on development of actuators for efficiently manipulating MPs. In this 
chapter, I begin with a brief overview of the particles used in this research. Their properties 
are discussed from the point of view of their manipulation as well as detection. I then 
discuss the physics of the motion of micro-meter sized particles suspended in a solution. 
This allows the reader to understand the theoretical basis for the problem of non-specific 
interactions which limit the sensitivity of biosensing protocols over and above the 
limitations imposed by sensor noise and experimental errors. I have developed an actuator 
for three dimensional electromagnetic actuation of particles based on the physics of 
motion of particles. Variations on the actuation scheme are discussed and various 
potential use cases are identified. 
3.2 Introduction to magnetic particles 
 As discussed in the previous chapter, polymer micro particles have been in use as 
labels for bio-receptors. There are several types of polymer particles depending on their 
size magnetic and fluorescent properties as shown in table 1. 
These properties can be combined in various ways to synthesize different types of 
particles depending on the type of biosensor and transduction mechanism used for 
detection. Thus, the following types of particles can be synthesized: 
Superparamagnetic micro particle (MPs), 
Magnetic nanoparticles (MNPs), 
Fluorescent magnetic nanoparticles (f-MNPs), 
Fluorescent non-magnetic nanoparticles (f-NMPs). 
In this research I have used all the above types of particles. However, I am mostly 
interested in magnetic micro-meter sized particles (MPs). The physical principles for 
manipulation and control of various types of particles are discussed in the next chapter. 
However, here I provide examples of all the types of particles used in this study. 
Table 1. Types of polymer particles
Property Value/type
Size ≥ 1.0 μm or < 1.0 μm
Magnetism Non-magnetic

Ferro-magnetic

Superparamagnetic
Fluorescence Non fluorescent

Fluorescent
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3.2.1 Dynabeads M-280 Streptavidin

 Dynabeads are well known magnetic particles in the literature and are one of the 
most common types of magnetic beads used for development of magnetic particles based 
biosensors. The M-280 Streptavidin variant of dynabeads are uniformly sized particles of 
size 2.8 µm each with superparamagnetic iron oxide nanoparticles of size 8-15 nm. These 
particles are categorized as magnetic micro-particles (MPs) as per the classification 
discussed above. These particles are readily observed by optical microscopy and can be 
easily imaged on a smartphone. Figure 3-1 shows a schematic of the structure of a 
dynabead as well as an SEM image showing the uniformity of their size and morphology. 
 
3.2.2 Dynabeads MyOne Streptavidin C1 
 The MyOne category of dynabeads are 1.0 µm in diameter and just like dynabeads 
M-280, consist of a polymer matrix in which superparamagnetic iron oxide nanoparticles 
are embedded. These particles are large enough to be observed by optical microscopy 
and can be imaged on a smartphone. 
3.2.3 FG beads (prostate specific antigen)

 FG beads derive their name from the polymer poly-(styrene-co-glycidyl 
methacrylate) (PGMA) which comprises them. They are 200 nm in diameter and are thus 
not observable with optical microscopes. Europium (Eu3+) complexes embedded within the 
polymer matrix impart them fluorescent properties. The excitation wavelength is around 
365 nm and the emission wavelength for fluorescence is around 615 nm. A detailed 
description of characterization of these particles is provided in [2]. Notably, these particles 
are ferromagnetic in nature since the iron oxide cores are approximately 40 nm in size. 
Thus, these particles tend to form clusters in the presence of magnetic fields. Figure 3-2 
(a) shows the structure of the beads observed by transmission electron microscopy (TEM). 
Figure 3-2 (b) shows the fluorescence from FG beads under illumination from an ultraviolet 
light source. There were two types of FG beads used in this study. The first kind was 
functionalized with prostate specific antigen (PSA). 
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Figure 3-1 (a) Schematic of structure of a dynabead M-280. The structure consists of 
several superparamagnetic iron oxide nanoparticles embedded in a polymeric matrix. The 
surface of the polymer is functionalized with streptavidin. (b) A scanning electron 
microscope image of dynabeads provided by the manufacturer [1] showing the uniformity of 
size and surface morphology.
3.3 Forces on magnetic particles in a solution

 Consider a micro sized particle suspended in a liquid just above a solid substrate. A 
AC or DC magnetic field is applied in an arbitrary direction such that it has components in 
all directions. Similarly, a AC electric field is applied in an arbitrary direction. The particle is 
in motion due to the applied forces. In this most general scenario, the particle experiences 
the following types of forces: 
Gravitational force 
Buoyancy force due to liquid 
Thermal/brownian force 
van der Waal’s force 
Electrostatic force from the substrate 
Drag force due to resistance from liquid medium 
Magnetic force 
Electromagnetic force (Dielectrophoretic force) 
We consider each of these forces in detail. The mathematical notation used in the rest of 
this section is as follows: 
Radius of a particle is denoted by r or R. 
Density of the particle is denoted by  followed by a subscript denoting the material. 
3.3.1 Gravitational and buoyancy force

 Polystyrene is the most commonly used polymer for synthesis of magnetic particles. 
The density of pure polystyrene is about 1.05 g/cm3[4]. If the particles are magnetic, the 
iron oxide core introduces additional weight. The density if iron (III) oxide (Fe2O3) is 5.24 g/
cm3. Thus, a magnetic bead constituted out of a polymer of density  which has an 
outer radius R and contains N magnetic cores, each of radius r and density  is given 
by: 
ρ
ρpoly
ρmag
Page 42
Figure. 3-2 (a) TEM image of FG beads [3], and (b) Fluorescence from FG beads under 
illumination from ultraviolet light
(a) (b)
           (3.1) 
The above analysis ignores the contribution of surface functionalization to the density. 
Based on the data provided by the manufacturers, the densities of MPs used in this study 
is given below: 
The data regarding density of FG beads is not available from the manufacturer. Thus, the 
density stated in table 2 was calculated assuming that each nanoparticle contains an 
average of 5 iron oxide cores of size 40 nm each. This was deduced from an observation 
of the TEM images published by the manufacturer (figure 3-2(a) and [3]). 
 As is well known, the buoyancy force due to a liquid medium of density  on an 
object of volume V is given by , where g is the gravitational constant. 
Thus, in the presence of only gravitational and buoyancy forces, the particle experiences a 
net downward force given by . 
3.3.2 Brownian force

 The well-known brownian motion was shown by Albert Einstein to be caused due to 
random motion of molecules of the liquid in which a particle is suspended. Brownian 
motion of particles is usually modeled as a random walk with equal probability of motion in 
all directions. However, a mathematically equivalent formulation of Brownian motion can 
be made in terms of Newtonian mechanics, where a stochastic force acts on a particle for 
a characteristic time scale[7]. Specifically, the random force can be stated as: 
           (3.2) 
where  is the Boltzmann constant, T is the temperature of the medium, R is the radius of 
the particle,  is the dynamic viscosity of the liquid medium,  is a random vector drawn 
from a gaussian distribution with zero mean and unit variance, and  is the characteristic 
time scale. This formulation is very useful for performing Monte-Carlo simulations of the 
behavior of the system provided that the characteristic time scale is much smaller than the 
time scale over which the particle is simulated. For the purposes of biosensing, one is 
interested in time scales of a few seconds to tens of seconds. Thus, I have kept the 
characteristic time to be at least six orders of magnitude below this scale. Figure 3-3 
shows a simulation of one dimensional browning motion performed for the three types of 
particles used in this research. 
From the simulations it is observed that smaller particles have a tendency to exhibit larger 
drift from the mean position for the same amount of time. Thus, for example, in this 
simulation, the 200 nm FG beads have drifted away by more than ten micron from their 
initial positions, whereas the largest particles of 2.8 µm diameter have not drifted more 
than a few microns during the same time. This can also be understood by the fact that 
ρMP =
( 4πR33 − N 4πr33 )ρpoly + N 4πr33 ρmag
4πR3
3
= ρpoly +
Nr3
R3
(ρmag − ρpoly)
Table 2. Densities of particles used in this study
Name (size) of particle
Dynabeads M280 (2.8 μm) 1.3 [5]
Dynabeads MyOne (1.0 μm) 1.8 [6]
FG beads (180 nm) 1.28
Density,  (g/cm3)ρMP
ρmed
Fbuoyancy = Vρmedg
Fgravity = VMP(ρMP − ρmed)g
⃗FBR = ⃗R 12πkBTRμfΔt
kB
μf ⃗R
Δt
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similar thermal motion of surrounding molecules produce much larger amplitude of motion 
in smaller particles than in larger ones. 
3.3.3 van der Waal’s force

 van der Waal’s force is the name given to electromagnetic interaction between 
dipoles or induced dipoles of two atoms. If the atoms or groups of atoms belong to two 
different objects, it results in a net force of attraction or repulsion between the two objects. 
The van der Waals force between a spherical particle and a flat substrate can be 
calculated using Hamaker’s formula given as[8] 
                      (3.3) 
where R is the radius of the particle, z is the vertical separation between the particle and 
the substrate,  is the unit vector along z direction.  is the Hammier constant of the 
particle of material 1 on a substrate of material 2 in a medium of material 3.  is the 
characteristic wavelength of interaction and is assumed to be 100 nm. For a particle with 
polystyrene surface on a substrate of silicon dioxide in water, the Hamaker constant is 
found to be 3.4x10-21 J. Since this interaction is electromagnetic (and thus conservative) in 
Fvdw = −
A132R
6z3 [ 11 + 14z /λret ] ⃗ez
⃗ez A132
λret
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Figure 3-3. Simulation of one dimensional brownian motion for FG beads, dynabeads (1μm) and 
dynabeads (2.8 μm). A representative result of several runs of Monte Carlo simulations is shown.
nature, the corresponding energy potential due to van der Waal’s interaction can be 
obtained as 
                       (3.4) 
where . Since the Hamaker constant is positive, the van der Waal’s force is 
attractive in nature. Thus, the particle tends to get attracted to the surface and can interact 
with the surface in spite of not having any specific chemical or biological agent of 
interaction. Thus, this kind of interaction is called non-specific interaction. This plays an 
important role in several biosensing systems as non-specific interactions introduce 
systemic noise in the biological system and limit the sensitivity of biosensors over and 
above the inherent limitations and noise present in any electronic sensor itself. 
On its own the expression for the force due to van der Waal’s interactions is difficult to 
interpret. However, the corresponding expression of potential energy allows us to predict 
when non-specific interactions assume important in a system. Generally, thermal forces 
tend to move the particle around, while van der Waal’s forces tend to attract the particle 
towards the substrate. When the energy scale of interaction due to van der Waal’s forces 
exceeds that due to thermal interactions ( ), non-specific interactions become too 
Uvdw =
A132R
6 [b ln( 1 + bzbz ) − 1z ]
b = 14/λret
≈ kBT
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Figure 3-4. Simulation of potential of van der Waal’s interaction between the various 
particles used in this study and a silicon dioxide substrate. Non-specific interactions become 
significant for particles at 24 nm (dynabeads, 2.8 μm), 13.5 nm (dynabeads 1 μm) and 4.7 nm 
(FG beads 200 nm).
large to be ignored. Figure 3-4 shows a simulation of the potential of van der Waal’s 
interaction between the various particles used in this study and a silicon dioxide substrate. 
As the separation between the particle and the substrate decreases, it is observed that 
van der Waal’s interactions take over thermal ones. For the largest 2.8 µm particles, this 
transition occurs at about 24 nm, for 1 µm particles it occurs at 13.5 nm and for 200 nm 
particles it occurs at 4.7 nm. These calculations serve to show that non-specific 
interactions become significant at separations of the order of 100 nm. 
3.3.4 Electrostatic force

 The surface charges present on the substrate as well as the particle can induce 
attraction or repulsion among them. I have not considered this force in my calculations for 
the following two reasons: 
The substrates as well as particles used in our experiments were all functionalized with 
biomolecules, such as streptavidin, biotin or PSA. Thus, the charges due to the 
biomolecules are expected to be dominant over induced charges. 
Previous experimental studies have shown that the surface charges on particles at pH 
ranging from 5-7 are close to zero (figure 2 of [8]). Thus, the electrostatic force is not 
expected to play a significant role in the motion of magnetic particles. 
3.3.5 Drag force due to resistance from the liquid

 It is well known that a solid object moving through a fluid (liquid or gas) experiences 
a force due to the inertia of the medium. This force manifests itself as air resistance in fast 
moving everyday objects. In the context of biosensing, this force is important as it places a 
limitation on the speed of magnetic particles. The drag force on a particle of radius R, 
moving with a velocity v in water (of viscosity ) is given by[8] 
                     (3.5) 
The drag force is thus, proportional to the velocity of the particle and opposite in direction. 
3.3.6 Magnetic force

 There are two important sources of external force which can be applied to 
manipulate the particles in a biosensing system. The first of these are magnetic forces. 
The magnetic force on a magnetic particle due to an external field is given by: 
                     (3.6) 
where  is the volume of the bead,  is its magnetic susceptibility,  is the external 
magnetic field and  is the permeability of free space. It is important to note that magnetic 
forces depend on the gradient of magnetic field, as well as its absolute value and thus 
High Gradient Magnetic separation Systems (HGMS) have attracted a lot of attention in 
literature [9]. Our laboratory has previously worked extensively on simulation and design of 
micro-current line patterns for manipulation of magnetic nanoparticles. I found that circular 
current coils were more effective in application of high gradient magnetic fields than the 
widely used linear current lines[10]. However, it is to be noted that magnetic fields on their 
own have a limited capture cross section a few tens of square microns. In the previously 
mentioned study, for example, I designed a high optimized current line pattern for 
biosensing with an effective capture cross section of 20 µm x 20 µm. 
η
⃗F drag = − 6π ηR ⃗v
⃗F m = Vb χm ⃗∇ ( |
⃗B |2
2μ0 )
Vb χm ⃗B
μ0
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3.3.7 Dielectrophoretic forces

 It is well known that an electric dipole in an electric field experiences a force 
proportional to the gradient of the electric field. If the field is strong enough, dipoles can be 
induced in an otherwise electrically neutral material which then experience a force as 
described above. This force is known as dielctrophoretic (DEP) force. The DEP force on a 
particle of radius R in an external AC electric field of frequency  is given by[11, 12] 
                    (3.7) 
where,  is the externally applied electric field and CM( ) is the Clausius-Mossotti factor 
given as 
                                   (3.8)  
where  is the relative permittivity of the medium (in this case, water),  is the relative 
permittivity of the particle (in this case, polystyrene) and * denotes the complex conjugate. 
Please note that the expression  in equation 3.7 is a tensor and the force (a vector) is 
the result of the dot product of a vector with a tensor. Similar to the expression for 
magnetic force, the dielectrophoretic force depends on the magnitude as well as the 
gradient of the electric field. 
The above discussion allows us to construct a complete description of the various forces 
acting on a particle suspended in a liquid medium. Figure 3-5 shows a free body diagram 
of a particle in the liquid showing the directions of various forces described in this section. 
ω
⃗F dep = 2πR3CM(ω) ⃗E ⋅ ⃗∇ ⃗E⃗E ω
CM(ω) =
ϵ*m − ϵ*p
ϵ*m + 2ϵ*p
ϵm ϵp
⃗∇ ⃗E
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Figure 3-5. Free body diagram of a magnetic particle suspended in a liquid.
3.4 Three dimensional electromagnetic actuation

 The previous discussion has prepared us to discuss the first novel aspect of the 
biosensing scheme proposed in this work. Here, I will describe a novel scheme for three 
dimensional actuation of magnetic particles. To motivate our discussion, I recollect the 
following about forces on a magnetic particle: 
Removal of non-specific interactions requires reproducible can lead to erroneous output 
of a biosensor and limit its sensitivity. 
Magnetic forces can be used to externally manipulate magnetic particles but the capture 
cross-section of electromagnetic actuators is limited. 
Electro-static forces can be used to manipulate magnetic particles in addition to 
magnetic forces. 
Several methods for the removal of non-specific interactions have been studied in 
biosensing literature ranging from mechanical washing[13] to automated washing by DC 
electric[14] and magnetic fields[15]. I note that previous studies have used either small 
sensing area and particles of large size or moment, so that one force is dominant in the 
system and thus the proposed scheme implicitly assumes such particles. For example, in 
a study by Luis et. al. [14], the authors have shown their results only on large 2.8 µm 
dynabeads. I have established in the previous section that such large particles show little 
brownian motion and are much denser than the surrounding medium. Thus, these particles 
readily sink to the surface of the substrate and hence, vertical forces are not necessary to 
bring them down. If the same study were to be conducted with 1 µm, 500 nm or 200 nm 
particles, the number of particles interacting with the surface would be markedly lower. 
Thus, the following constraints should be followed in designing an actuator for reducing 
non-specific interactions: 
The forces applied should be well-controlled and reproducible. 
The sensing area of the proposed scheme should be as large as possible. 
The proposed actuation scheme should allow for three dimensional actuation of 
particles, so that interactions can be induced as well as inhibited in all three dimensions. 
The proposed scheme should allow for tuning the forces depending on the size of the 
particle. 
These objectives are achieved by a dual actuation scheme as described below: 
3.4.1 Vertical magnetic actuation

 As described earlier, magnetic forces are well understood and several biosensing 
protocols in literature have been developed to take advantage of high gradient magnetic 
field systems. Permanent magnets have been the mainstay of magnetic field based 
manipulation of magnetic particles. Although electromagnets based on current lines have 
been explored in literature, the small size of electromagnetic systems limits their capture 
cross-section. Thus, in the proposed actuation scheme, I use permanent magnet to create 
a weak magnetic field in order to draw small particles to the surface and enhance the 
interaction of magnetic particles with the surface. Specifically, I approximate the field of the 
permanent magnet with as a weakly varying magnetic field of near constant magnitude  
and gradient . Thus, the expression for magnetic force reduces to 
                          (3.9) 
B0
∂Bz /∂z
Fm =
Vb χ
μ0
B0(∂B /∂z)
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This expression is valid for a given value of (z, ) provided the variation in z is much 
smaller than the dimension of the magnet. Typical bar magnets are the size of a few 
centimeters. I will use this approximation in a range of about 100 µm. Thus, within this 
range, the magnet serves as a source of constant vertical force on the magnetic particle. 
3.4.2 Horizontal dielectrophoretic actuation

 Elementary electromagnetic theory tells us that for an electromagnetic plane wave 
propagating in free space, the magnitudes of electrical and magnetic fields are related as 
, where c is the speed of light. Thus, the magnitude of electric field is 
approximately eight orders of magnitude larger than that of the magnetic field. This 
motivates us that for the same amount of current, DEP forces, which are electric in nature 
are expected to create much higher forces for reducing non-specific interactions. This is 
the key observation which allows us to increase the sensing area by three orders of 
magnitude from magnetic force based actuation schemes. To take advantage of the DEP 
forces over a large area, I propose the design shown in figure 3-6. The design is simple as 
it contains four electrodes arranged in a square pattern. Each electrode is 560 µm long 
and 10 µm wide. The points B and C are electrically connected with cables of much 
smaller resistance than the electrodes. Thus, the points B and C are considered to be at 
the same electric potential. Similarly, points Q and R are connected. Thus, the electrodes 
form a pair of resistors, one in each direction x and y. Two sinusoidal currents of amplitude 
B0
| ⃗E | = c | ⃗B |
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Figure 3-6. Schematic of the proposed DEP actuator. AB, CD, PQ and RS are micro-current 
lines, each 10 μm wide and 560 μm long. The points B and C are electrically connected. 
Similarly, Q and R are connected.
 and frequency , period T( ) is applied in both directions with a  phase 
difference between the currents in the two directions. 
 On application of sinusoidal current, the electric and magnetic fields in the system 
are expected to be sinusoidal in time. Maxwell’s equations for electromagnetic fields for 
this system acquire the form 
                     (3.10) 
           (3.11) 
                   (3.12) 
        (3.13) 
The quantities have usual meanings, and  which represents the surface charge density.  
From equation 3.10, it can be seen that  
            (3.14) 
where A is the magnetic vector potential such that . 
Thus,  
                             (3.15) 
                                (3.16) 
for some scalar function V. Plugging this expression into 3.11, I get 
  
Thus, 
       (3.17) 
Since, , the above equation can be rearranged as 
        (3.18) 
The above equations do not have unique solutions for  and V and given any solution 
( ,V), the functions ( ,V’) are valid solutions to the above equations, provided 
  
  
for any scalar function . 
 Under Lorenz gauge,  is chosen such that . Thus, taking 
the divergence of equation 3.16 on both sides and dropping the primed superscript, we get 
 
  
  
In the sensing area of the actuator there are no charge sources, thus . Thus, 
                    (3.19) 
I0 ω = 2π /ω π /2
∇ × ⃗E = − ∂ ⃗B
∂t
= − iωμ0 ⃗H
∇ × ⃗H = ⃗J + ∂ ⃗D
∂t
= ⃗J + iωϵ0 ⃗E
⃗∇ ⋅ ⃗B = 0
∇ ⋅ ⃗D = ρ ⟹ ∇ ⋅ ⃗E = ρ /ϵ0
ρ
∇ × ⃗E = − iωμ0 ⃗H = − iω(∇ × ⃗A )⃗B = ⃗∇ × ⃗A
∇ × ( ⃗E + iω ⃗A ) = 0
⟹ ⃗E + iω ⃗A = − ∇V
∇ × ⃗H = ⃗J + iωϵ0( − ∇V − iω ⃗A ) = ⃗J + ω2ϵ0 ⃗A − iωϵ0 ∇V
∇ × (∇ × ⃗A ) = μ0 ⃗J + ω2μ0ϵ0 ⃗A − iωμ0ϵ0 ∇V
∇ × (∇ × ⃗A ) = ∇(∇ ⋅ ⃗A ) − ∇2 ⃗A
∇2 ⃗A + ω2μ0ϵ0 ⃗A + μ0 ⃗J = ∇(∇ ⋅ ⃗A + iωμ0ϵ0V )⃗A
⃗A ⃗A′ 
⃗A′ = ⃗A + ∇λ
V′ = V −
∂λ
∂t
= V − iωλ
λ
λ ∇ ⋅ ⃗A′ + iωμ0ϵ0V′ = 0
∇ ⋅ ⃗E + iω∇ ⋅ ⃗A = − ∇2V
⟹ ∇ ⋅ ⃗E + iω(−iωμ0ϵ0V ) = − ∇2V
⟹ ∇2V + ω2μ0ϵ0V = − ∇ ⋅ ⃗E = − ρ /ϵ0
ρ = 0
∇2V +
ω2
c2
V = 0
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Here, I make the approximation that the frequency of interest is small, such that 
. Hence, the equation 3.19 reduces to Laplace’s equation 
                                  (3.20) 
This can also be obtained by the equivalent assumption that magnitude of magnetic field is 
much smaller than that of the electric field. The boundary conditions for equation 3.20 are 
obtained as 
                         (3.21) 
where  is the resistivity of the electrode material, W is the width of the electrode and d is 
the thickness (thus,  is the area of cross section of the electrode). Solving the 
Laplace equation with these boundary conditions allows us to simulate the forces on 
magnetic particles in the sensing area. 
 Figure 3-7 shows a simulation of the potential energy of DEP forces. For 
simplification of illustration, I am showing only the case when current is applied along y 
direction (i.e. current along x direction is zero). It is found that when the current is positive 
along y direction, the potential energy surface has a gradient in the x direction. This 
implies that a force is present along the positive x direction. Any particles present in the 
sensing area will thus drift towards the positive x direction. On the other hand, when the 
direction of the current in the electrode changes during the second half of the sinusoidal 
period, the gradient in the potential energy surface changes direction, creating a force in 
the negative x direction and changing the drifting direction of the particles. Similarly, when 
currents are applied in x direction, forces are created in y directions. As a result, when both 
forces are simultaneously present in the system, the particles will exhibit harmonic 
oscillations in two dimensions. It is noteworthy that these DEP forces are primarily 
horizontal in the entire sensing area and acquire a non-trivial vertical component only near 
the electrodes themselves. 
3.4.3 Combined motion

 We have described previously how magnetic forces due to weak field of a 
permanent magnet act primarily in the vertical direction whereas those due to 
dielectrophoretic forces act primarily in the horizontal direction. When a magnetic particle 
is suspended in a medium and both types of forces are applied simultaneously, then 
c2 > > ω2V
∇2V = 0
V(x) =
ρx
W . d
ρ
W . d
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Figure 3-7. Simulation of electric potential energy in the sensing on application of currents. (a) 
When current is positive along y and (b) when current is negative along y direction.
ignoring brownian motion, the particle will experience an average downward force as well 
as a horizontal harmonic force. The motion of the particle in such a case can be is a spiral 
as shown in figure 3-8. The vertical magnetic force, in addition to gravitational force, 
accelerates the interaction of the particle with the surface. This is especially necessary for 
smaller sized particles which would otherwise take a long time for interaction with the 
surface. After reaching the surface, horizontal forces prevent the particle from interacting 
non-specifically with the surface by constantly keeping the particle in motion. Any force 
required to stop the particle motion would necessarily have to be larger than the DEP 
force. Therefore, the DEP forces are applied such that they are greater than the estimated 
van der Waal’s forces from equation 3.3. Here the motion has been exaggerated for ease 
of illustration. 
 For the sake of completeness, I would like to mention that the length of the 
electrodes was chosen to maximize the sensing area for the given field of view of the 
optical setup. I will show in Chapter 7, the sensing area achieved by this approach is about 
three orders of magnitude larger than that reported by purely magnetic forces. 
3.4.4 The originality of this method of actuation

 As stated before, several methods have been proposed in literature for actuation of 
magnetic particles such as mechanical washing[13], washing via DC electric[14] and 
magnetic forces[15]. The method closest to my method is the one proposed by Liu et. al in 
[14]. They used DC electric fields to move 2.8 µm magnetic particles across a sensing 
area defined by two electrodes and sensed the particles stuck in the sensing area with 
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Figure 3-8. Schematic of three dimensional actuation of the magnetic particle under combined 
dieletrophoretic as well as magnetic forces. The red dots represent various locations of the 
particle. The vertical forces accelerate the interaction of the particle with the substrate, while the 
horizontal forces prevent the particle from non-specific interactions after it comes into contact 
with the surface.
spin valve magnetic sensors. The actuation method I have proposed is more suitable than 
their approach in the following ways: 
The method proposed in this thesis uses AC dielectrophoretic actuation whereas Liu et. 
al. have used DC dielectrophoretic actuation. DC actuation forces the particles to move 
across a sensing area over to the other side, whereas AC actuation makes the particles 
oscillate harmonically wherever they are, without moving them across the sensing area. 
As I will show in chapter 5, the harmonic dynamics of the particles is utilized for 
biosensing by optical tracking of the particles in a video, rather than just detecting the 
mere presence or absence of particles in an area. 
The actuation method used by Liu et. al. can actuate particles only in one direction 
(perpendicular to the linear electrodes), whereas my method can actuate the particles in 
all three dimensions. 
It should be further noted that the size of the particles used by Liu et. al. is very large (2.8 
µm) and thus the particles precipitate immediately. Smaller particles do not precipitate 
quickly and thus would not be detectable by spin valve sensors embedded underneath 
the sensing surface. Thus their approach is applicable only to large particles whereas the 
actuation method presented in this section can work with nanometer as well as 
micrometer sized magnetic particles. 
3.5 Summary

 In this chapter, I discussed the properties of magnetic particles in detail. I began by 
providing an overview of the various types of particles used in this research which range 
from 200 nm fluorescent particles to 2.8 µm magnetic particles. Then, I described the 
various forces acting on a particle suspended in a medium in detail. I discussed 
gravitational and buoyancy force, brownian force, van der Waal’s forces, electrostatic 
forces, magnetic forces as well as dielectrophoretic forces. A discussion of van der Waal’s 
forces allows the reader to understand the theoretical origins of non-specific interactions 
which limit the sensitivity of biosensing systems. Finally, I describe the design of a novel 
actuator for three dimensional actuation of magnetic particles by combining both magnetic 
and dielectrophoretic forces. This actuation method achieves three orders of magnitude 
more sensing area than that achieved by purely magnetic forces. 
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4. Development of hardware 
components used in the 
experimental setup

4.1 Introduction 
	 In the previous two chapters, I have established the importance of smartphones as 
a platform for development of point of care medical diagnostics systems and introduced a 
method for three dimensional actuation of magnetic particles suspended in a solution. In 
this chapter, I introduce the experimental setup used throughout this study. I will cover the 
motivations behind the design of the components used in the experiments and the 
improvements in reproducibility and reliability which result from these designs. 
The experimental setup consisted of the following components: 
Substrate with micro fabricated current line pattern described in the previous chapter 
Reaction well fabricated from poly dimethyl siloxane (PDMS) 
Printed circuit board (PCB) for application of current 
Optical components for magnification 
Smartphone 
Current source 
I now describe the design and fabrication of each component in detail below. 
4.2 Micro fabricated current line pattern 
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Figure 4-1. Schematic of fabrication of current line patterns with 
photolithography and electron beam deposition.
	 The current line pattern was fabricated with conventional photolithography followed 
by electron beam deposition of metals. I used Si/SiO2 as well as Si3N4 substrates for the 
experiments reported, with identical fabrication protocol for both types of substrates. A 
schematic of the fabrication process is shown in figure 4-1. Negative photoresist (AZ5214-
E) was spin coated on the substrate as shown in figure 4-1 (b). This was followed by photo 
exposure of the substrate under a mask with an ultra-violet light source (i-line, 365 nm) as 
shown in 4-1 (c). Development of the substrate leads to formation of ridges in the 
substrate where metal electrodes can be deposited. Electron beam deposition of titanium 
(thickness: 100 nm) and gold (thickness: 100 nm) is performed next as shown in figure 4-1 
(e). Finally, lift off is performed for removal of excess photoresist and metal. This results in 
the fabrication of electrodes 200 nm in thickness. 
4.3 PDMS reaction well 
 Polydimethyl siloxane (PDMS) is a well known polymer used in contact lenses and 
medical devices. In our experimental setup, the reaction well for containing the sample 
under analysis was fabricated with PDMS. The steps required for fabrication of the 
reaction well are: 
Commercially available PDMS (Silpot 184) and its hardening agent were mixed in a ratio 
of 10:1 (5 mL: 0.5 mL). 
The resulting viscous fluid was de-gassed in a vacuum chamber for 3 minutes. 
The degassed fluid was poured over a clean acrylic substrate of size 70 mm x 70 mm. 
The acrylic substrate was placed on a hot plate and heated at 120℃ for 10 minutes to 
allow solidification of the PDMS. 
The solidified PDMS was transferred along with the acrylic substrate onto a commercially 
available laser cutter where square reaction wells of outer side 4 mm and inner side 2 
mm were cut into the solid PDMS. 
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Figure 4-2. A photograph of solidified PDMS with an array of 11x11 (total of 121) 
reaction wells cut into it. Some reaction wells have been removed.
The laser cutter contains a 40 W continuous CO2 laser and operates with pulse width 
modulation at a pulse frequency of 1000 Hz, duty cycle 50% and head travel speed of 10 
mm/s. Once the reaction wells have been cut into the PDMS, individual reaction wells can 
be removed and attached onto the silicon dioxide substrates. 
 Figure 4-2 shows a photograph of 121 reaction wells cut into solidified PDMS on the 
70 mm x 70 mm substrate. Some wells have been removed. The thickness of the PDMS 
was measured to be 0.75 mm and the volume of the reaction well was found to be 3.0 µL. 
Thus, the PDMS reaction well ensures that a constant volume of approximately 3 µL is 
under analysis. Figure 4-3 shows a photograph of the substrate after the attachment of 
the reaction well.

	 While large scale fabrication of regularly shaped reaction wells is not a scientific 
achievement on its own, it is a critical step for making the biosensor easy to use and 
ensuring reproducibility of results. Thus, it is a minor originality of this research.

4.4 PCB for current application 
	 In figure 4-3, the eight exposed gold pads for making contacts with other circuits 
are visible. Each pad is approximately 1 mm x 1.5 mm in size. In electronics, contacts 
between integrated circuits and external circuits is often performed via soldering. Soldering 
is a well known and mature technology by which two or more metals are joined together by 
a filler metal (called solder). This technique is highly dependent on the materials involved 
with the most commonly used materials being alloys of copper, zinc or aluminum. 
However, gold is not compatible with soldering materials and thus, soldering cannot be 
used to connect the actuator with the current source. 
 To solve this problem, in academic research, silver paste is commonly used for 
making contacts along with a conductive material such as copper tape. I found that this 
method of making contacts was  
(a) unreliable,  
(b) time consuming as it took approximately 30 minutes to an hour to create contacts, and 
(c) often resulted in mechanically weak connections which would break during the 
experiment, thus wasting time and materials.  
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Figure 4-3. A photograph of the actuator after attachment of the reaction well.
To solve this problem, I developed a method for making contacts which 
(a) does not use a consumable item such as silver paste,  
(b) is fast (takes 1minute or less), and 
(c) results in mechanically robust contacts.

	 Our method consists of two parts a printed circuit board and a 3D printed 
mechanical holder. The PCB is 30mm x 30 mm, consists of two layers and its design is 
shown in figure 4-4. 
This design contains eight vias for connecting spring loaded pogo pins. The area 
corresponding to reaction well in the middle of the pattern is milled out during the 
manufacturing process, creating a window for observation of the sample. Using the 
notation introduced in figure 3-6, the vias corresponding to points B and C are connected 
internally within the PCB. Similarly, the vias corresponding to points Q and R are 
connected. Thus, the PCB receives current from four terminals (labelled as ‘XCOIL’ and 
‘YCOIL’) and distributes it to the eight terminals. It should be noted that the X and Y 
branches of the PCB are independent of each other, and thus currents can be applied to 
the two axes of the actuator independently of each other. 
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(a) (b)
Figure 4-4. Design of the two layer PCB used for making contacts with the actuator. (a) 
top side, and (b) bottom side.
(a) (b) (c)
Figure 4-5. Schematic render of the 3D printed holder for mechanical alignment of the 
substrate with the PCB. (a) Top view of the holder with four notched, wide base screws, 
(b) Perspective view of the holder, and (c) Mechanical arrangement of the holder with the 
PCB described above.
	 The second part of the contact assembly consists of a 3D printed holder. The 
design of the holder is shown in figure 4-5. The holder consists of a central well with 
alignment markers for alignment of the actuator pads with the PCB as shown in figure 4-5 
(a). The holder is designed to house the PCB and the substrate within it as shown in figure 
4-5 (c). Four screws printed with the holder are used to apply light pressure on to the PCB 
so that the spring loaded pogo pins are under tension and the contact of the pins with the 
substrate is robust. The screws contain a notch for insertion and removal of the PCB.

	 Figure 4-6 shows a photograph of the current application setup. The PCB and 
holder are lightly pressed against each other by four screws. Creating contacts requires 
placing the substrate inside the substrate well and aligning the pads of the substrate with 
alignment markers. The PCB is then inserted into the slot meant to house it. The screws 
are tightened in order to apply light pressure. This setup allowed us to create robust 
contacts between the actuator and the power supply within 1 minute. The design of the 
PCB was performed in AutoDesk Eagle[1]  software whereas the design of the holder was 
performed in AutoDesk Fusion 360[2] CAD software.

	 As with the fabrication of PDMS wells, fabrication of 3D printed chip holder and 
PCB is not a new scientific result but it is extremely important step to make this method 
practical for use in real world applications. The design I have come up with has the 
advantage that there are no consumable items as in the case of silver paste contacts or 
soldering. The holder and PCB are reusable and the pogo pins used are rated for use at 
least 200,000 times. While I have not tested it so many times, the same holder and PCB 
have been used about 500 times in our lab and do not show any signs of wear or tear. 
Thus, this is an extremely robust setup for making contacts and is also a minor 
originality of my research.
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Figure 4-6. A photograph of the current application assembly. The PCB is mounted on a 
holder which also houses the substrate. Four 90° jumper pins are soldered onto the 
PCB and wires are drawn from each to be connected to the current source.
4.5 Optical setup 
 All the optical measurements reported in this study were obtained by a smartphone 
mounted on the eye piece of a microscope (Olympus BX-51). Thus, the objective lens of 
the microscope was used but the high resolution microscope cameras (such as Olympus 
DP 71, also available on the microscope) were not used. The optical setup thus, consists 
of an objective lens (20x magnification, numerical aperture 0.45), an eyepiece (10x) and 
the smartphone. The limit of resolution of the system is determined by the objective lens 
and is calculated as 
                 (4.1) 
assuming a minimum wavelength of 400 nm for observation. Thus, single fluorescent 
particles of diameter 200 nm were not observable with optical measurements. A schematic 
of the optical setup is shown in figure 4-7. The substrate is imaged with an objective lens 
and the light is reflected by a mirror into the eye piece. The eye piece focuses the light a 
few millimeters from the surface of the lens. An adapter is mounted on the eyepiece which 
can adjust the separation between the camera and the eye piece. The separation is 
adjusted before start of the experiment to obtain a good focus. 
4.6 Smartphone 
 The smartphone used in this study was an iPhone 6S Plus (Apple Inc.). The 
smartphone features a camera with a 4K image sensor (2160 x 3840 pixels). Videos were 
recorded by a commercially available application called ‘Filmic Pro’. All the videos were 
recorded at 24 frames per second. Thus, the measurements reported do not require any 
features other than a 4K camera. The per-pixel spatial resolution of the videos obtained 
was 0.4 µm i.e. each pixel in the video represented a square area of 0.4 µm x 0.4 µm on 
the substrate. 
Δx =
0.61λ
NA
=
0.61 × 0.40
0.45
≈ 0.54μm
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Figure 4-7. Schematic of the optical setup for observation with a smartphone.
4.7 Current source 
 We used a two channel programmable function generator (WF1974, NF 
Corporation) as the current source. The two channels of the function generator were used 
to apply currents in x and y directions respectively. The frequency was kept at 0.5 Hz in all 
measurements (unless otherwise mentioned) and the amplitude of the sinusoidal voltage 
was adjusted to obtain a current with amplitude 30 mA (peak to peak amplitude 60 mA). 
 A photograph of the complete experimental setup with the above components is 
shown in figure 4-8. One of the eye pieces of the microscope was covered with tape to 
reduce the effect of ambient light on our measurements. 
4.8 A portable experimental setup 
 The results presented throughout this thesis are based on the experimental setup 
described in previous sections and shown in figure 4-8. However, towards the end of my 
research, I have worked to miniaturize the experimental setup. Here I will present some 
preliminary results of a miniaturized experimental setup. 
 Figure 4-9 shows a 3D CAD design of a miniaturized experimental setup, consisting 
of a small microscope. The microscope allows adjusting the focus by moving the dial in 
vertical direction. A tube containing a magnifying lens fits into the annular ring (not shown 
in figure 4-9 to avoid excessively cluttering the figure). The chip holder and PCB assembly 
described in section 4.4 fits onto a base which contains a mechanism based on nuts and 
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Figure 4-8. A photograph of the complete experimental setup.
bolts (not shown) to adjust the position of the chip. The design shown is partly based on an 
open source microscope design from [3]. 
 Similar to the microscope, the function generator for application of current can also 
be miniaturized. In fact, several low-cost function generators are available off the shelf. 
The current prototype uses a low cost function generator based on XR-2206 function 
generator chip[4]. 
 A complete prototype of the small, portable point of care diagnostics system is 
shown in figure 4-10. The cost of this experimental setup is estimated to be about 2000 
yen ($20) when assembled in a laboratory. This does not include the cost of the 
smartphone, mobile power bank or lens. This cost is expected to come down as more 
units are manufactured after commercial adoption of the biosensor. 
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Figure 4-9. A CAD design of the miniaturized optical setup. The 3D printed chip holder 
described in section 4.4 as well as the PCB are placed on the stage of a 3D printed 
microscope. The setup allows adjustment of the focus as well as adjustments to the 
position of the chip holder with a hexagonal but and bolt mechanism. 
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(a)
(b)
Figure 4-10 A prototype of the portable medical diagnostics system. A 500 yen coin is 
shown for scale. (a) The system is powered with a mobile power bank and consists of a 
current application circuit (b) A smartphone mounted on a 3D printed microscope is used to 
take 4K videos of the biosensing chip (not visible in these images). The video is then 
uploaded to a remote ‘cloud’ computer where they are analyzed and the results are sent 
back to the user.
4.9 Summary 
 In this chapter, I introduced the experimental setup used in this research. I began by 
explaining the method for micro-fabrication of current line. In order to reduce variability in 
experimental conditions and ensure reproducibility, I fabricated PDMS reaction wells and a 
printed circuit board for creating robust contacts quickly. The optical setup used in this 
study has a diffraction limited resolution of 0.54 µm. Finally, I presented preliminary results 
of a miniaturized portable experimental setup. 
4.10 References 
[1] Eagle PCB Design Software, https://www.autodesk.com/products/eagle/overview 
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[3] USB microscope Focus stack, https://www.thingiverse.com/thing:2945251 
[4] XR-2206 Datasheet, https://www.sparkfun.com/datasheets/Kits/
XR2206_104_020808.pdf 
Page 64
5. Development of software for 
automating the data analysis 
5.1 Introduction 
	 This chapter focuses on methods for automated optical detection of magnetic beads 
in smartphone camera images with software. I first introduce the need for automating data 
analysis in the context of point of care diagnostics. The methods for optical detection are 
classified into two types: (a) detection of micrometer sized magnetic particles, and (b) 
detection of nanometer sized fluorescent magnetic nanoparticles (FG beads, 200 nm). A 
method for accurate detection of beads in images allows us to sequentially analyze 
several frames in a video and track the positions of the particles in each frame. I explain 
the limitations of previous approaches particle tracking methods and my solutions. I also 
show experimental results of tracking of particles in a smartphone video. While position 
tracking algorithms have been developed in many areas of engineering, I use the 
algorithm developed in this chapter to demonstrate for the first time a point of care 
biosensing protocol based on tracking of magnetic particles in smartphone videos. 
5.2 The need for automating data analysis 
 In the first chapter, I showed that the number of public health workers in a 
developing country is much more than the number of doctors. For example, in the case of 
India, the number of public health workers is 20 times that of professional doctors. The 
objective of ‘healthcare for all’ laid out under sustainable development goal (SDG #3) can 
be achieved only if these public health workers are enabled to operate as diagnosticians. 
Previous experience has shown that when trained well, these workers are quite effective in 
successfully executing stated policy objectives like eradication of polio virus. However, 
public health workers have their own sets of challenges which may not be readily apparent 
to scientists developing next generation medical diagnostics technologies: 
Public health workers are often extremely busy as they serve several hundred children 
and patients every day. 
Workers are often uneducated. Some workers are even illiterate, meaning that they are 
unable to read or write their own name, never mind anything else. 
Public health workers have several duties apart from administering tests and providing 
medicines. 
In a public health emergency such as the outbreak of an epidemic, several hundred 
patients may need to be tested in a short span of time. 
Thus, any steps that can be adopted to reduce the workload of these workers should be 
adopted in the very design of the biosensing technology. Two specific steps which can go 
a long way towards reducing the workload of public health workers are: 
The data analysis should be completely automated. The workers will not understand 
even the basics of magnetic particles and their significance. Thus, they should not be 
involved in obtaining actionable information once raw sensor data has been collected. 
The data collected as well as test results should be available as soon as possible to 
various stakeholders involving not only patients but also doctors and public health 
officials located far away. 
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 I have implemented both these steps in the design of the biosensing systems that I 
am going to describe in the coming chapters. Specifically, I have used image and video 
processing algorithms to automate data analysis with software. Moreover, I have 
developed a system which integrates the smartphone with a remote ‘cloud’ computer. The 
data obtained by the smartphone is automatically uploaded to the remote computer, which 
triggers an automatic analysis of the raw data. The results obtained are shared with the 
patients, doctors and public health officials. This is performed automatically in software 
without the healthcare worker needing to even press an ‘upload' button. 
 In the rest of this chapter, I will describe the algorithmic details of automated data 
analysis methods I have developed. This will include automated detection of micrometer 
sized particles in an image, automated detection of fluorescent particles in an image as 
well as optical tracking of particles in a video. 
5.3 Detection of micrometer sized particles 
	 Consider an image of magnetic particles taken from a smartphone camera as 
shown in figure 5-1. In this example, 2.8 µm beads are imaged. A small part of the full 4K 
video frame is shown for ease of illustration. There are four steps required to accurately 
detect positions of magnetic particles in the image in an automated way as described 
below. 
5.3.1 Grayscale conversion 
 The first step is to convert the color image into a gray scale image which shows the 
intensity of light at each point and discards the color information. The result of conversion 
of the above image into grayscale is shown in figure 5-2. 
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Figure 5-1. An image of 2.8 μm particles taken from a smartphone. This image will be 
used to illustrate the steps for detection of particles in smartphone images. Scale bar for 
this image is not drawn as the image processing is demonstrated on the image and 
scale bar will act as noise.
5.3.2 Template matching 
 From the original image as well as the grayscale image, it is clear that the magnetic 
particles are well resolved and the sizes and shapes of all the particles are uniformly 
similar. This allows us to perform template matching with a known photograph (a template) 
of the particle we want to detect. Mathematically, template matching is equivalent to a 
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Figure 5-2. Grayscale of the above image.
Figure 5-3. Results of template matching in the above image.
convolution or cross-correlation with a kernel specified by the template[1]. Locations where 
the pattern being matched is present will have a higher cross-correlation with the 
template , resulting in a high output whereas empty locations will have a very small or no 
correlation with the template, resulting in low output. After performing the convolution, the 
result is normalized to lie between 0 and 1. Thus, the cross-correlation results can be 
interpreted as the probability that a particle is present at the given location. The result of 
matching the above image with a template of the particle is shown in figure 5-3. 
5.3.3 Thresholding 
 As can be observed in figure 5-3, the results of template matching contain a lot of 
noise. This is expected and can be mitigated by choosing only the locations where the 
probability of finding a particle is very high. For example, I chose a threshold of 0.8 and 
choose locations where the probability of finding a particle is at least equal to the 
threshold. The results of the thresholding operation are shown in figure 5-4. 
5.3.4 Non-maximal suppression (NMS) 
 The result obtained in the previous step contains very little or no noise and the 
locations of the particles are clearly identified. However, it may contain false positives. This 
can be understood from the fact that while the pixel corresponding to the center of a 
particle is likely to have a high output, pixels just adjacent to the center may also show a 
big output. This can lead to a single bead being counted multiple times during detection. To 
avoid this, non-maximal suppression (NMS) is used. The NMS algorithm divides the 
positions obtained after thresholding and discards locations which have a smaller output 
than their immediate neighbors within the radius of the particle. Thus, only points with the 
maximal outputs are identified and non-maxima are suppressed. In the example above, 
after thresholding 307 pixels were identified as containing beads. However, only 80 
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Figure 5-4. Result of thresholding the above output and choosing 
locations where the output is greater than 0.8 (probability > 80%).
candidates remained after non-maximal suppression. This example illustrates that NMS 
plays an important role in accurate detection and counting of particles in an image. The 
results obtained after non-maximal suppression are shown in figure 5-5. Green circles 
have been drawn around the centers of the beads identified. It can be seen that the 
method accurately detects almost all the particles present in the image. The false 
negatives occur for beads which are out of focus and thus have a low cross-correlation 
output. 
 Although the method was illustrated for 2.8µm sized particles, the algorithm for 
detection of 1 µm sized particles is the same with the appropriate choice of template. 
5.4 Detection of fluorescent nanoparticles 
	 As compared to micro-meter sized particles, the images of fluorescent 
nanoparticles are markedly different. The sizes as well as luminosity of the particles are 
not uniform for all the particles. Thus, template matching cannot be used to estimate the 
locations of particles in the image. Figure 5-6 shows an example of image of fluorescent 
magnetic nanoparticles (f-MNPs) captured with a smartphone. It can be seen that the 
illumination from the light source is not uniform across the image. While this can be 
improved with better experimental setup, in practice the illumination of the substrate is 
never uniform enough to ensure equal luminosity and apparent size of fluorescing 
particles. Thus, the algorithm for automated detection and counting of f-MNPs is slightly 
different from the one described earlier. The detection method contains two steps. 
5.4.1 Estimation and removal of background 
 In the first step, the distribution of background illumination from the light source is 
estimated. This estimated background is subtracted from the original image. The steps are 
summarized as follows: 
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Figure 5-5. Locations of parties identified after non maximal 
suppression, shown with green circles.
Morphological erosion of the image with a kernel, K. 
Morphological dilation of the image with the same kernel, K. The output of this operation 
is the estimated background. 
Subtraction of the background from the original image to obtain an image with near 
uniform background illumination. 
Mathematically, the grayscale erosion of an image  with a kernel  is defined as[2] 
          (5.1) 
Here the minimum is taken over all positions  where K is defined. 
Similarly, the dilation of an image  with a kernel  is defined as 
             (5.2) 
Thus, the background B is estimated to be 
                                           (5.3) 
The erosion step suppresses the edges of small objects[3] in the image such as f-MNPs 
but large structures, such as the background illumination are left unchanged. However, 
since the erosion step chooses the minimum of the intensity in a neighborhood around 
each pixel, the output of the erosion step has a lower intensity than that of the original 
image. The next step of dilation restores the intensity of the estimated background to that 
in the image. Although the equations 5.1 and 5.2 are defined only for grayscale images, in 
software implementation, I have performed this step for all three channels of the image. 
Thus, the estimated background is a full color (RGB) image. 
The process described by equation 5.3 is also called morphological opening of the 
image[2]. The choice of the kernel K is important to get a good estimation of the 
background. The size of the kernel should be significantly larger than the size of a 
fluorescent particle. However, it should be significantly smaller than the size of the image 
so as to be able to capture variations in the background illumination which occur at those 
I K
(I ⊖ K )(x) = min
y∈K
[I(x + y) − K(y)]
y
I K
(I ⊕ K )(x) = max
y∈K
[I(y) + K(x − y)]
B = (I ⊖ K ) ⊕ K
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Figure 5-6. An image of fluorescent magnetic nanoparticles taken with a smartphone. Similar to 
figure 5-1, a scale bar is not being shown for this image.
scales. In all the experiments, I chose K to be a flat circular element with a diameter of 200 
pixels. Therefore the variable y in equations 5.1 and 5.2 is bounded as . 
Figure 5-7 (a) shows the estimated background of the image in figure 5-6. It can be seen 
that the estimated background is more intense near the center and decreases in intensity 
near the edges. On subtraction of the estimated background with the original image, an 
image with near uniform illumination across the image is obtained, as shown in figure 5-7 
(b). Please note that, this is a pixel wise subtraction i.e. (figure 5-7(b)) = (figure 5-6) - 
(figure 5-7(a)). 
5.4.2 Thresholding and NMS 
 The output of background removal is thresholded in a similar way as that for 
micrometer sized particles. Since the f-MNPs used in this study fluoresce red in color, 
most of the intensity of the image is in the red channel of the image. The red channel is 
normalized to have a value between a minimum of 0 and a maximum of 1. A threshold is 
applied to discard noise and peaks corresponding to the individual particles are obtained. I 
used a modest threshold of 0.25 in all experiments with fluorescent images. Finally, the 
candidate locations of the f-MNPs are filtered via non-maximal suppression which was 
explained in section 5.2.4. This removes duplicates and false positives. The resulting 
locations are identified as the locations of f-MNPs. 
 Figure 5-8 shows the outputs of these two steps. As shown in figure 5-8 (b), most of 
the f-MNPs in the image are correctly identified. In total, 3,628 f-MNPs were identified in 
the image shown. However, f-MNPs near the right edge of the image which have very low 
illumination were not identified. Although no algorithm can perform perfectly for all possible 
images, the algorithm outlined in this section performs quite well for the images of 
fluorescent magnetic nanoparticles obtained from a smartphone. Since the parameters 
such as threshold and kernel size are kept constant across all experiments, any errors 
arising due to limitation of the algorithm are systemic errors and are constant for all 
experiments. 
1 ≤ y ≤ 200
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Figure 5-7. (a) Background illumination profile of the image in figure 5-6 estimated with 
morphological opening of the image. (b) uniformly illuminated fluorescent image 
obtained after removal of background from the original image.
(a) (b)
5.5 Optical tracking algorithm 
 In the previous section, I explained the process of identification of locations of 
magnetic particles in an image. A sequence of images, as that present in a video, can 
provide additional information about the motion of the particles and has advantages for 
biosensing. 
5.5.1 Advantages of tracking 
 Figure 5-9 shows a schematic of a typical magnetic particle based biosensing 
protocol. The protocol contains two steps. In the first step, the particles are actuated with a 
suitable force which induces their interactions with the a designated sensing area. The 
surface is assumed to be functionalized with antibodies and the surface of magnetic 
particles are assumed to be functionalized with the complimentary antigens. In figure 
5-9(a), I assume that images of the sensing area are obtained at the beginning and end of 
the protocol and some final state is observed. In this case, all the information regarding the 
dynamics of the particles during the process is lost. Alternatively, in figure 5-9 (b), I 
assume that a video of the process is recorded and optical tracking is performed to reveal 
information about the dynamics of the particles. Three types of particle motions are 
relevant to biosensing: 
(a) Particles which are actuated, move away from their initial positions and are then 
captured in the sensing area can be identified by tracking. Their initial motion and 
subsequent capture suggests a strong possibility that the interactions of these particles 
with the surface are specific i.e. biological in nature.  
(b) Particles which are in the sensing area in the final state after the protocol, but are 
moving are clearly not stuck to the surface even though they are located in the sensing 
area. These particles can be identified and ignored while counting the number of 
particles interacting with the surface. 
(c) Particles which never move throughout the process are more likely to be stuck to the 
surface due to non-specific interactions. These particles can be optionally ignored 
during calculation of number of particles interacting biologically with the surface. 
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(a) (b)
Figure 5-8. (a) Candidate locations of f-MNPs identified after thresholding (b) Locations 
of f-MNPs identified after non maximal suppression in (a)
In biosensing literature based on imaging of magnetic particles, the nature of interactions 
of magnetic particles are difficult to infer. Thus, various protocols involving washing of non-
specifically interacting particles from the sensing area have been proposed[4-6]. However, 
obtaining information about the dynamics of particles allows us to identify non-interacting 
and non-specifically interacting particles without the need for washing. 
5.5.2 Limitations of existing approaches 
 Tracking the locations of objects in the presence of noisy measurements has very 
broad applications ranging from pedestrian avoidance in self driving cars[7] to control of air 
traffic[8]. Thus, algorithms for estimation of positions and velocities of objects have been 
developed in control theory and statistics. Tracking of particles in ‘stacks’ of time-lapse 
microscopic images has been used to study the dynamic processes occurring in living 
cells by light microscopy as well as fluorescent microscopy[9]. Similarly, tracking of 
magnetic particles in dark field images has been proposed as a method for studying the 
dynamics of particles with a functionalized surface[10], called tethered particle motion 
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(a)
(b)
Figure 5-9. Schematic of a magnetic particle based biosensing protocol showing the 
advantages of optical tracking (a) In this case, I assume that images of the sensing area 
are obtained in the beginning and end of the protocol, (b) This shows the case when a 
video of the whole process is recorded and optical tracking is performed to reveal 
information about the dynamics of all the particles.
(TPM). In principle, the algorithms[11] developed for particle tracking by these researchers 
can be applied for tracking of particles in a video obtained from a smartphone. However, 
there are two differences compared to the data analyzed with these approaches: 
As mentioned in Chapter 3, the sensing area of the actuator designed in this study is 560 
µm x 560 µm. This is a large area and the resulting video contains a large number of 
particles, typically 8,000 to 10,000 particles. 
The type of motion studied in a large body of literature is limited to either brownian 
motion or motion with constant velocity and the tracking algorithms make explicit 
assumptions about the motion of particles. As discussed in Chapter 3, magnetic particles 
in the actuator perform harmonic oscillations. Thus, assumptions about constant velocity 
of Brownian motion are not valid. 
For example, a recent thorough review[12] of various particle tracking methods considered 
linear motion with constant velocity throughout the video as the most challenging scenario 
for benchmarking the performance of various tracking algorithms developed in literature. 
These assumptions make already available particle tracking tools unsuitable for 
performing particle tracking in smartphone videos. 
 For example, our videos are over 2 times longer (240 frames v/s 100 frames), 
contain 10 times the number of particles (≈ 10,000 v/s ≈1,000), and contain 31 times 
more data (2160x3840 pixels v/s 512x512 pixels) in each frame than the most 
challenging scenario used by [12] (Table 2 of [12]). Thus, open source tools such as 
the well known ImageJ[13] software, which implement these algorithms were found to be 
unsuitable for our experiments. Thus, I developed my own software to address these 
challenges. 
5.5.3 Kalman filter based motion model  
 Particle tracking involves two steps: 
(a) Detection of locations of particles in a frame (spatial localization), and 
(b) Linking the position of each particle in the frame to its position in the previous frame 
(temporal association). 
 Spatial localization has already been discussed in sections 5.2 and 5.3. Here, I 
discuss the algorithm for temporal association of trajectories of particles across frames. I 
have solved the problem of temporal association by modeling the motion of each particle 
in the video with a 4-state Kalman filter. Kalman filter is a well-known algorithm for 
estimating quantities based on noisy measurements and a control model. Mathematically, 
the Kalman filter is described by the following system of equations: 
                               (5.4) 
      (5.5) 
                         (5.6) 
The notation and explanation of all these quantities is given in the table 1. The state 
transition matrix, F takes the form 
X =
px
py
vx
vy
Xt|t−1 = FXt−1 + But + ν
zt = HXt + ω
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           (5.7) 
where  is the time interval between observations. The videos are recorded at 24 frames 
per second. Thus, . The control input model matrix is assumed to 
be zero to simplify the estimation of state transition. During measurements, the entire state 
may not be observable. For example, in our case, the measurements correspond to the 
position of a particle but the velocity of the particle is not directly measured. Thus, only a 
part of the state is observed in measurements and the observation model takes the form 
                (5.8) 
The noise variables  and  are assumed to be drawn from multi-variate gaussian 
distributions with zero mean and respective covariance matrices. Specifically,  
and . The values of  and  are empirically determined and kept constant 
across all experiments. 
 The motion model of the particle described above is used in the following way. At 
each time step, for a given particle, we predict its position using equation 5.5. A nearest 
neighbor search is carried out in the spatial location centered around the predicted 
position. The bead position obtained by spatial localization step which is closest to the 
predicted position is assigned as the position of the particle in the current frame. The 
position of the particle predicted by the model is usually not exactly the same as that 
observed by spatial localization. The difference between the two is called residual error 
and is used to update the velocity estimated by the model for the next time step. The 
update is controlled by a weighing factor called Kalman gain. The whole algorithm can 
thus be divided into two parts: 
Prediction step: 
        (5.5) 
        (5.9) 
Update step: 
                       (5.10) 
                (5.11) 
                     (5.12) 
                    (5.13) 
              (5.14) 
F =
1 0 Δt 0
0 1 0 Δt
0 0 1 0
0 0 0 1
Δt
Δt = 1/FPS = 1/24s
H = [1 0 0 00 1 0 0]
ν ω
ν ∼ N(0,Q)
ω ∼ N(0,R) Q R
Xt|t−1 = FXt−1 + But + ν
Pt|t−1 = FPt−1|t−1FT + Q
y = z − HXt|t−1
St = HPt|t−1HT + R
K = Pt|t−1HT S−1
Xt|t = Xt|t−1 + Ky
Pt|t = (I − KH )Pt|t−1
Table 1. Notations used in Kalman filter
Symbol Name of quantity Explanation
State vector The state vector at time t contains the positions and 
velocities of the particle in x and y at that time step.
Estimated state vector The analytical estimate of state vector at time t, before 
the measurement is taken into account.
Updated state vector The updated state vector after the measurement from 
spatial localization step is taken into account.
Xt|t
Xt|t−1
X
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 The calculation of Kalman gain requires a few intermediate variables. First the 
residual error is calculated from equation 5.10. Two intermediate variables called prior 
residual covariance and posterior residual covariance are calculated. The prior residual 
covariance is calculated before the calculation of the Kalman gain  as in 5.11 whereas the 
posterior covariance is calculated after the Kalman gain has been updated with the results 
of measurements as in 5.14. Equation 5.12 shows the calculation of the Kalman gain. 
Once the Kalman gain has been calculated, the state vector  is updated with the residual 
error weighted by the Kalman gain as in equation 5.13. This operation updates the 
estimate of velocity in the model, and the model can keep up with the changing velocity of 
the magnetic particle at each time step. The derivation of equations presented in this 
section is outside the scope of this thesis and is available in the paper by Rudolf 
Kalman[14], in which he proposed this algorithm.  
 A schematic of the complete tracking algorithm including the steps involved in 
spatial localization of particles in an image as well as temporal association of trajectories 
of particles across frames is shown in figure 5-10. 
5.5.4 Implementation details 
	 The tracking algorithm outlined in the previous section was implemented in Python 
programming language. Images and videos were handled using the well known OpenCV 
State transition matrix
Control input model
Control vector The control vector represents the external force applied 
to the magnetic particle.
Process noise covariance 
matrix
Process noise covariance matrix represents the 
uncertainty in prediction of the state by eq. 5.5.
Measurement The measurement obtained from a sensor, in our case 
the output of the spatial localization step.
Observation model
Measurement noise Measurement noise represents the noise in the output of 
the sensor. In our case, this is due to the noise in the 
image sensor.
Residual error The vector representing the error in the position 
predicted by the model and that observed by spatial 
localization.
prior residual covariance This is a intermediate variable used in the calculation of 
Kalman gain.
posterior residual covariance This is also an intermediate variable used to calculate 
Kalman gain.
K Kalman gain
Symbol Name of quantity Explanation
The Kalman gain weighs how much the velocity should 
be updated based on measurements. If  is small the 
state transition model is trusted more than the 
measurements and vice versa.
Δt
y
The control input model maps the control vector  to the 
state  and is assumed to be zero in our case.
u
X
B
zt
P
ω
The state transition matrix maps the previous state  
to the next state .
Xt−1
Xt
F
ν
The observation model maps the full state  to the 
measurement .
X
z
S
ut
H
X
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[15] library developed by Intel for computer vision applications. The following details make 
our implementation fast and memory efficient:

Some parts of the program involving array operations were written in Cython language 
which was then translated into an equivalent program in the C programming language 
and compiled into a binary file. The compiled binary functions run efficiently on any 
hardware. 
The program reads video frame sequentially from the video and only one frame is kept in 
memory (RAM of the computer) at any time. Thus, large 4K videos can be analyzed with 
a small memory footprint. 
The program takes advantage of GPU acceleration to perform matrix operations such as 
template matching and particle association. 
The process noise covariance and measurement noise covariance matrices (  and  
from section 5.4.3) are dependent on the image sensor and are the same for all particles. 
Thus, in our implementation the  and  matrices corresponding to models for all the 
particles share the same physical memory address, which reduces memory 
consumption. 
	 Writing the program took a lot of time and effort. In order to reduce the burden for 
other researchers working in this field, I developed a graphical user interface (GUI) so that 
Q R
Q R
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Figure 5-10. Schematic of the tracking algorithm used in this study. Template matching 
is used to calculate the probability of a particle being present for each pixel in the 
image. Locations with low probability are discarded by thresholding and non-maximal 
suppression (NMS) is used to eliminate duplicates. A motion model based on Kalman 
filter predicts the location of the particle in this frame. A nearest neighbor search in the 
locations identified by NMS is used to associate the particle to its location in the current 
frame. The location of the particles thus associated is used to update the parameters of 
the motion model corresponding to the particle. This process is repeated iteratively for 
each frame of the video for each particle in the frame. The end result is a reconstruction 
of the trajectory of each particle across the duration of the video.
others may use the program without requiring any experience in programming. A 
screenshot of the GUI is shown in figure 5-11. The user can choose the video to be 
analyzed, the template for template matching step and set the threshold for filtering out 
noise from the output of template matching. In addition, the software can optionally crop 
and trim the video as per the parameters set by the user. GPU acceleration and parallel 
processing are used to speed up the tracking of the video. It should be noted that both the 
python programming language and OpenCV library are available free of cost, even for 
commercial use. Thus, the program developed in this research may be deployed 
commercially without incurring any licensing cost. To motivate further research in particle 
tracking based biosensing, we plan to release the tracking software publicly on an open 
source platform in the near future. 
5.6 The originality of the algorithms presented 
 Computer vision is a vast area of research which seeks to develop algorithms to let 
machines ‘see’ and make meaningful inferences about the real world. There is a large 
body of research in the fields of signal processing, image processing and robotics which 
was available to me in order to automate data analysis, as I set out to do. However, most 
of these fields are far removed from the domain of biosensing. Thus, the large body of 
research in computer vision focuses on processing images of everyday objects such as 
people, cars, chairs, streets, trees etc. There is very little research specifically on 
processing images or videos of magnetic particles obtained with a microscope. As 
described earlier, the small volume of research on particle tracking also focuses only on 
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Figure 5-11. A screenshot of the graphical user interface developed to allow use of the 
tracking program without knowledge of programming.
fluorescent tags which exhibit very simple types of motion and was insufficient for my use. 
The algorithms described in this chapter were not invented by me. My contribution is to 
apply existing algorithms from various domains such as self driving cars, robotics and 
statistics to point of care biosensing. I scanned a large body of literature in computer 
vision, analyzed various algorithms in their applicability for analyzing images and videos of 
magnetic particles and implemented them in an efficient software which can be used by 
anyone and further which is integrated with a cloud computer, so that data can be 
uploaded and results obtained without having to understand the algorithmic details. Some 
specific examples of well known algorithms are: 
Template matching is a popular signal processing method used in a wide range of 
applications, from image processing to the detection of gravitational waves by LIGO[16]. 
This algorithm was used in the analysis of micrometer sized particles as the particles 
have uniform properties, so that they all look alike. 
Non-maximal suppression (NMS) is one of the most fundamental algorithms used in 
computer vision to eliminate duplicates in software processing. The use of NMS made 
sure that a magnetic particle is not counted multiple times. 
Morphological erosion and dilation are algorithms used for varied applications such as 
analysis of social media networks as well as that of three dimensional magnetic 
resonance imaging scans of the human brain[17]. Morphological opening was used to 
estimate background of the illumination in fluorescent images, so that imperfections in 
the optical setup do not lead to erroneous estimation of the number of fluorescent 
particles in the image. 
 Kalman filter is the most ubiquitous algorithm in statistics and control theory and is 
used for applications ranging from tracking location of a GPS receiver to tracking 
pedestrians in a self driving car and robotics[18, 19]. The Kalman filter algorithm was 
applied to track particles across frames of  video. This is mathematically equivalent to 
the ‘data association’ problem faced by a robot as it moves through it surroundings. 
 In summary, I have applied pre existing algorithms from various disciplines of 
mathematics and computer science to the problem of point of care diagnostics. The 
resulting software based on these algorithms successfully automates the task of data 
processing and is integral to the point of care diagnostics systems described in the 
following two chapters. 
5.7 Examples of particle trajectories 
 Here, I show some examples of trajectories of particles obtained after actuation as 
described in Chapter 3 and tracking as described in the previous section. The 
experimental setup described in the previous chapter was used. A 3 µL solution containing 
dynabeads (diameter 2.8 µm) were dropped onto a substrate and sinusoidal currents of 
amplitude 30 mA were applied in both arms of the actuator with a phase difference of 𝜋/2 
between the two. The resulting video was analyzed using the algorithm outlined in section 
5.4. Figure 5-12 shows a small area of the full 4K frame showing the trajectories of several 
particles 10 seconds after the start of application of current. From this figure, it is observed 
that most particles show regular, periodic oscillations about a mean position. Two particles 
labelled as P and Q show different types of motions. While particle Q shows regular, 
sinusoidal motion as expected from theoretical simulations, particle P is seen to remain 
localized to a point. Thus, it can be inferred that the particle P is attached to the surface 
whereas particle Q is not attached to the surface after 10 seconds. Here, I again 
emphasize that this inference is only possible due to the knowledge about the dynamics of 
both particles provided by particle tracking. A single image the substrate surface taken 10 
seconds after the start of application of current would not allow us to draw this conclusion. 
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Further information about the oscillations of these particles can be obtained from figure 
5-13 (a) showing the position of both particles with time for 60 seconds. It is seen that the 
trajectory of particle Q is sinusoidal in nature. The amplitude of the motion of particle P is 
about 5 µm. However, the particle P does not appear to move at all. The variations in the 
position of particle P are of the order of a single pixel and the mean position drifts by a few 
pixels over the duration of a minute. However, the standard deviation in the motion of the 
particle over 10 seconds is ≈ 0.32 pixels. The fast fourier transform (FFT) of the 
trajectories shown in figure 5-13(a) is shown in figure 5-13 (b). Specifically the normalized 
amplitude of the FFT as a function of the frequency is shown on a logarithmic scale. The 
FFT for particle Q shows a strong peak at a frequency of 0.5 Hz, confirming that the 
particles exhibit harmonic oscillations at the frequency of the applied electric field. 
 
5.8 Summary 
	 In this chapter, I introduced methods for automated optical detection of magnetic 
beads in smartphone camera images with software. Detection of micrometer sized 
magnetic particles, and that of nanometer sized fluorescent magnetic nanoparticles were 
discussed separately since fluorescent images have different characteristics from images 
of micro meter sized particles obtained by light microscopy. The detection of particle 
positions in an image was then extended to sequences of images i.e. videos. A particle 
tracking algorithm was developed which involves detection of particle locations as well as 
temporal association of trajectories of particles across the frames of a video. I then 
described some implementation details which make our algorithm fast and memory 
efficient and finally provided an example of trajectories of particles obtained after harmonic 
oscillation and tracking. 
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Figure 5-12. Motion of magnetic particles observed after applying current for 10 
seconds. The trajectories of particles are shown in green color and were obtained after 
tracking. It is noteworthy that the trajectory of point P is found to be localized a point 
while Q is one of the many particles exhibiting harmonic oscillations.
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Figure 5-13. A graph of the y-position of particles P and Q for 60 seconds. (a) Position 
v/s time for both particles. P is shown in green color whereas Q is shown in red. (b) The 
normalized amplitude of the fourier transform (FFT) v/s frequency are shown on a log-
log scale. The FFT for particle Q shows a strong peak at 0.5 Hz confirming that the 
particles exhibit harmonic oscillations at the frequency of the applied field.
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6. Results and Discussion: 
Smartphone based point of care 
diagnostics system with fluorescent 
magnetic nanoparticles 
6.1 Introduction 
 Fluorescent magnetic nanoparticles (f-MNPs) have several advantages as labels for 
detection of biomarkers. Specifically, the advantages are  
(a) high surface area to volume ratio,  
(b) ability to be actuated by magnetic fields, and  
(c) fluorescent properties which enables their observation with smartphones. 
 I would like to emphasize here that the low magnetic moment of nanometer sized 
magnetic particles makes it difficult to detect MNPs with magnetic sensors such as GMR 
and Hall sensors[1, 2]. Thus, fluorescence is the critical property which enables optical 
detection of f-MNPs with fluorescence microscopy. In recent years, smartphone cameras 
have greatly improved in sensitivity to low light conditions. As I showed in chapter 5, 
smartphone cameras can resolve single or a few f-MNPs with weak fluorescence intensity 
in still images. I have built upon this capability of smartphone cameras to develop a 
smartphone based point of care (POCT) diagnostics system which utilizes f-MNPs as 
magnetic labels. The proposed biosensing protocol is specifically designed to enable 
sharing of diagnostics information in scenarios such as outbreak of epidemics in remote 
locations, where along with rapid diagnosis, real-time reporting of the status of individuals 
can enable the public health resources to be targeted to individuals and regions where 
help is most needed. We demonstrate the effectiveness of this system by demonstrating 
the detection with prostate specific antigen (PSA) with a smartphone. 
 I first provide a brief overview of the biosensing protocol which contains three key 
components. I then explain the importance of making measurements in dry conditions for 
real world scenarios, the experimental methods and the results obtained. Finally, I discuss 
the advantages and limitations of the biosensing protocol presented in this chapter. 
6.2 Real world scenario: An epidemic 
 The biosensing system described in this chapter is motivated by the real world 
scenario: There is a possibility of an epidemic outbreak in a rural village in Africa or India. 
Public health workers need to conduct tests on hundreds or even thousands of people in a 
few hours and relay the information to doctors located remotely, so that they can 
determine whether this village has been affected by the epidemic outbreak. 
What would be the requirements from a point of care testing system used in this scenario? 
 There are a few requirements based on our previous discussion: 
The system should offer results quickly, in a few minutes. 
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Since multiple workers need to conduct tests, it would be highly beneficial if the protocol 
could be broken down into steps which could be conducted by different people. For 
example, one person could be only mixing solutions, while another person could be only 
washing sensing chips while another person could be only taking images. 
Data analysis should be automated. 
Results should be conveyed to the patients and remotely located doctors quickly, in near 
real time. 
Spatial map of the results should be created and be visible to public health officials, so 
that the outbreak can be prevented quickly. 
 The point of care testing system presented in this chapter fulfills all these 
requirements. The system is based on fluorescent magnetic nanoparticles and 
smartphone. The whole protocol takes less than 3 minutes to complete. It can be broken 
down into steps which are mutually decoupled from each other. Thus, different people 
could be processing multiple samples simultaneously i.e. one person does not have to 
perform the whole biosensing procedure for a given sample, it can be done by different 
people. This is enabled by dry measurements described below. The algorithm for 
analyzing fluorescent images described in Chapter 5 is implemented on a cloud computer, 
so that images obtained by the smartphone are synced to the cloud and analyzed 
automatically without the healthcare worker having to upload images manually. The cloud 
based image analysis system can also extract location metadata embedded in the images 
sent to correlate the results of the tests with the location of the patient. Thus, a spatial 
‘heat map’ of the disease outbreak can be created. 
6.3 Overview of the POCT system 
 The proposed POCT system consists of three key components 
A protocol for detection of PSA by fluorescent imaging of f-MNPs. 
A digital image processing algorithm for determining the concentration of PSA via 
fluorescent images of f-MNPs obtained with a smartphone. 
A shared ‘cloud server’ platform for performing the analysis and communicating the 
results to designated users. 
A schematic of the POCT system is shown in figure 6-1. 
6.3.1 Importance of dry measurements 
 As we have discussed in chapters 2 and 3, heterogenous medical diagnostics 
protocols involving the interaction of magnetic particles with a solid substrate usually follow 
three basic steps. 
First, beads are introduced on a substrate surface functionalized with biomolecules 
complimentary to the surface functionalization of the beads themselves. 
Next, interactions of magnetic particles with the surface are promoted by magnetic 
actuation of the particles and extraneous particles, attached to the surface by non-
specific interactions are removed from the sensing area by means of some form of 
washing. 
Finally, the magnetic particles remaining on the substrate are detected with either 
magnetic or optical sensors to obtain a quantitative estimate for the biomolecule of 
interest. 
 In protocols involving magnetic field sensors, such as magnetoresistive sensors[3, 
4], all the steps outlined in the previous sub-section are carried under ‘wet conditions’ i.e. 
while the biomolecular reaction is occurring on the sensing area. Various biosensing 
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protocols proposed stress the importance of obtaining real-time information on the 
interaction of the particles with the surface[5, 6]. While such wet measurements can 
provide detailed information about the time scale of interaction of magnetic particles with 
the surface, there are several advantages for decoupling the steps outlined above, so that 
measurements and analysis can be performed independently of the actuation and washing 
steps.  
 Thus, we propose a biosensing system where the measurement step is decoupled 
from actuation and washing step. The measurements can be performed long after the 
biomolecular reaction occurring on the substrate surface has concluded. We call this state, 
when the biomolecular reactions occurring on the sensing surface has ceased, as dry 
state. A biosensing protocol allowing measurements to be performed in dry state simplifies 
the workflow for healthcare professionals in real-world scenarios where a large number of 
patients may have to be tested, so that different people may perform different steps. The 
protocol for biomolecular detection involving dry measurements forms a part of the 
proposed POCT system. The analysis of images obtained is completely automated so that 
once the measurements have been performed, data is uploaded to the cloud server and 
analysis is performed automatically, without requiring any intervention from the user. 
6.3.2 Protocol for detection of PSA 
 The detection of PSA is carried out with a sandwich bioassay as follows: 
First, silicon substrates are functionalized with PSA antibodies (also commonly known as 
anti-PSA in literature). The concentration of antibodies was kept constant across all 
experiments at 6.9 µM. 
Second, f-MNPs are functionalized with PSA. The concentration of the antigens was 
varied across experiments. This step is to be carried out just before the particles are 
introduced on the substrate. 
The functionalized f-MNPs are introduced onto the substrate and a vertical magnetic field 
of 100 gauss (1 gauss = 1x10-4 Tesla) is applied for 30 seconds to promote the 
interaction of the f-MNPs with the substrate surface. 
Next, the substrate is washing thrice in a solution of phosphate-buffered saline and 
deionized water to remove non-specifically bound particles from the substrate. 
After washing, the substrate is considered to be in a dry state i.e. all biomolecular 
reactions are deemed to have been concluded. 
 Figure 6-2 shows a schematic of the protocol described above. 
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Figure 6-1. Schematic fo the proposed POCT system consisting of three steps (a) f-
MNPs functionalized with antibodies are introduced on a substrate and a magnetic field 
is applied for 30 seconds. The substrate is subsequently washed and is then said to be in 
a dry state. (b) The substrate is imaged with a smartphone mounted on a fluorescent 
microscope. (c) The images of fluorescent magnetic nanoparticles are uploaded to a 
central server and analyzed remotely. The results re available within 1 minute and are 
communicated to the relevant people.
 In the next sub-sections we describe the protocols for functionalization of substrate 
as well as for fluorescent magnetic nanoparticles. 
6.3.3 Functionalization of substrate surface 
 Silicon substrates were cleaned with acetone and ethanol and rinsed with deionized 
water for 5 minutes. The substrate surface was made hydrophilic by treatment with oxygen 
plasma for 2 minutes. The hydrophilic substrate was immersed in a solution of PSA 
antibodies for 30 minutes. The concentration of the antibody solution was 6.9 µM. After this 
step, there may be unreacted hydroxyl bonds on the surface of the substrate, which may 
lead to non-specific interactions later on. These excess bonds were capped with a solution 
of PEG5000 (diluted in deionized water to 50% by weight). This concludes the 
functionalization of PSA antibodies on the substrate. In the next section, we show that this 
protocol leads to functionalization of PSA antibodies on the substrate as verified by 
Electron Spectroscopy for Chemical Analysis (ESCA or XPS). 
6.3.4 Functionalization of f-MNPs 
 The f-MNPs obtained from the manufacturer (Tamagawa Seiki Co. Ltd.) were 
already functionalized with PSA antibodies. Thus, the functionalization of f-MNPs with PSA 
antigens could be performed in a single step. We prepared a buffer solution containing 
PSA antigens along with 0.05% Tween 20, 0.4% bovine serum albumin (BSA), 0.4% 
BlockAce and 0.05% ProClin150 in Tris-buffered saline solvent. The buffer solution 
containing PSA antigens was mixed with another solution containing f-MNPs in 1:1 
volumetric ratio. The PSA antibody antigen interaction occurs in the solution, leading to the 
functionalization of antigens on the surface of f-MNPs. The blocking agents BSA and 
BlockAce bond to unoccupied sites on the f-MNPs to prevent the possibility of non-specific 
interaction of the surface with other molecules in the solution. The surface of the f-MNPs 
are hydrophobic and thus, f-MNPs may aggregate due to hydrophobic interactions. Thus, 
Tween 20 is used to reduce hydrophobic interaction between f-MNPs which can lead to 
the formation of clusters of particles. Moreover, to reduce the time available for 
hydrophobic interactions among nanoparticles, the f-MNPs were functionalized with PSA 
antigens just before their introduction onto the surface of the substrate. 
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Figure 6-2. Schematic of PSA detection protocol (a) Antibodies are functionalized onto 
the substrate and f-MNPs functionalized with complimentary antigens interact with the 
substrate (b) The antigens get sandwiched between the two antibodies and the 
fluorescence of the f-MNPs is detected with a smartphone.
6.3.5 Image processing and integration with cloud computer 
 The images of the substrate obtained by the smartphone were analyzed using the 
algorithm described in section 5.3. The objective lens used for these measurements had a 
magnification of 40 x and a numerical aperture of 0.60. Thus, the diffraction limited 
resolution of the optical setup was 
             (6.1) 
The algorithm was implemented to run on a cloud server to which the smartphone can 
connect to upload data and receive results of the analysis. The processing pipeline carried 
out on the cloud computer is shown in figure 6-3. The user uploads the images on to the 
cloud computer. Several users may upload their data simultaneously. A program running 
on the server detects requests for analysis made by users and all images received from 
various users are queued for processing. Each image in the queue is analyzed and the 
results are obtained. The results are then communicated back to the user and optionally 
email alerts are sent to people who have the access privilege to the results of the analysis. 
Δx =
0.61λ
N . A .
=
0.61 × 0.6μm
0.6
= 0.61μm
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Figure 6-3. Schematic of the image processing pipeline on a cloud computer. 
The user uploads the fluorescent images to a central file sharing platform. A 
service running on the cloud server automatically detects new images and 
performs analysis to determine the number of f-MNPs in the image. The results 
are made available to the user within 1 minute and may also be shared with other 
people if necessary.
6.4 Experimental results 
 We will present the results of the experiments in two parts. First, we will show that 
the protocol outlined in section 6.2.3 results in functionalization of PSA antibodies on the 
substrate surface. Then, we will present the results of quantitative estimation of PSA 
antigens with a smartphone using cloud computing. 
6.4.1 Functionalization of PSA on substrate 
 An aluminium X-ray source with accelerating voltage of 10 kV and filament current 
10 mA was used in the measurements presented here. ESCA spectra of two substrates, 
one with functionalization protocol performed on it and another without the 
functionalization protocol (control) were measured and compared. Figure 6-4 shows the 
ESCA spectra of the two substrates. The spectra shown have been corrected for the 
charging of the substrate by referencing the position of carbon 1s to 284.8 eV. The 
substrate which has the functionalization protocol performed on it displays distinctly 
sharper peaks corresponding to carbon 1s and nitrogen 1s than the control. Even after 
care taken during sample preparation and analysis, an adventitious carbon layer was 
formed on the control substrate which leads to a peak corresponding to carbon. However, 
this peak was much smaller than that for the substrate with PSA on it. The peaks 
corresponding to silicon 2s and 2p were higher for the control substrate. This shows that 
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Figure 6-4. ESCA spectra of pure silicon dioxide substrate as well as the one with PSA 
functionalization protocol performed on it. It can be seen that the substrate with PSA 
functionalized on it has peaks corresponding to carbon and nitrogen.
the substrate with PSA functionalization protocol performed on it has a layer of compounds 
of nitrogen and carbon on silicon dioxide layer. The ratios of C/Si and N/Si were calculated 
and are shown in table 1. 
Our results are in agreement with previous reports[7, 8] on functionalization of antibodies 
and show that the carbon to silicon and nitrogen to silicon ratio for the substrate on which 
functionalization protocol was performed was much higher than the control substrate. 
Thus, we conclude that the antibodies are successfully functionalized on the antibodies on 
the substrate following the protocol described in section 6.2.3. 
6.4.2 Quantitative detection of PSA with smartphone 
 The experiments for quantitative detection of PSA were performed for five 
concentrations of PSA antigens: control (0 ng/mL), 0.1 ng/mL, 2.0 ng/mL, 10 ng/mL and 
125 ng/mL. The images taken for each of these five concentrations from the smartphone 
are shown in figure 6-5. The top row in the figure shows the images taken from the 
smartphone while the bottom row shows the locations of particles identified by the cloud 
based image processing pipeline. We see that for the control sample i.e. when antigens 
are not present in the solution (0 ng/mL) very few particles are observed on the substrate. 
For 0.1 ng/mL the number of particles observed on the substrate is much larger than that 
that for control sample. This is reflected in the results of the analysis. For 2 ng/mL, the 
number of particles increases even more. However, on going from 2 ng/mL to 125 ng/mL 
we visually observe that the number of particles does not change significantly, implying 
Table 1. C/Si and N/Si ratios for the two types of substrates
Substrate type C/Si N/Si
Silicon oxide 0.19 0
PSA functionalized 0.49 0.48
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Figure 6-5. Images of the sensing surface obtained from the smartphone for the 
concentration  of PSA antigens shown in the figure. The raw images obtained from the 
smartphone are shown in the top row and the results of analysis performed on cloud 
server are shown in the bottom row. The scale bar shown in the rightmost image in the 
top row corresponds to 50 µm. The scale is the same for all images.
that a saturation of the particle density is observed for antigen concentrations above 2 ng/
mL. 
 We quantify the results obtained in the above figure by taking 50 square windows in 
the images centered at random locations. Each window has an area 100 µm x 100 µm. We 
perform statistical inferences about the number of particles in a 100 µm x 100 µm area 
from these 50 estimates. The results are shown in figure 6-6. As expected from figure 6-5, 
the density of f-MNPs increases up to a concentration of 2.0 ng/mL and saturates 
thereafter. The blue dashed line shows the level 3 standard deviations below the mean 
value for 0.1 ng/mL. In literature, a commonly used metric[9] for calculation of limit of 
detection of a protocol is the level  for the mean, µ and standard deviation σ of the 
control sample. Since the corresponding level for a concentration of 0.1 ng/mL (100 pg/
mL) is well above that for the control sample, we conclude that the limit of detection for the 
PSA detection protocol is 100 pg/mL. The limit of detection of PSA obtained is an order of 
magnitude lower than other approaches in literature using for example, localized surface 
plasmon effect in gold nanoparticles[10]. Moreover, while previously proposed protocols 
for detection of PSA require bulky and sophisticated equipment, our approach uses a 
smartphone and cloud computing for the detection. To the best of our knowledge, this is 
the first report of detection of PSA with a smartphone in less than 3 minutes while 
previously reported smartphone based protocols take about 20 minutes[11].  
 Patients with concentrations of PSA below 4.0 ng/mL are considered to be healthy 
whereas those with higher concentrations are deemed to be at elevated risk of prostate 
cancer. Since the limit of detection of the proposed protocol is well below this limit, the 
POCT medical diagnostics system introduced in this chapter comprising a smartphone, dry 
measurement technique and cloud based digital image processing is clinically relevant. 
μ + 3σ
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Figure 6-6. Calibration curve for PSA biomarker obtained from smartphone images 
shown in figure 6-5. The dashed blue line shows the level 3 standard deviations below 
the mean for 0.1 ng/mL. Since the blue line is above the number of particles estimated 
for control, we conclude that the limit of detection of this method is 0.1 ng/mL.
6.5 Advantages and limitations of the proposed system 
	 The POCT system introduced in this chapter has the following advantages:

The actuation step takes 30 seconds while the washing step takes about 1 minute. 
Measurements of fluorescence images can be performed independently of the washing 
and actuation steps in dry state after the biomolecular reaction has concluded. 
Fluorescent images are obtained with a smartphone and thus, bulky equipment is not 
required. 
Analysis is performed in an automated way, remotely on a cloud computer, thereby 
freeing the user from the task of doing the analysis. 
The results are available in just a minute on an average. 
The results are communicated to the user immediately and can also be shared with other 
public health officials to aggregate real time statistics on the spread of diseases in a 
region. 
The protocol for detection of biomarkers achieves a very low limit of detection of 100 pg/
mL which is an order of magnitude lower than that required for clinically relevant 
detections. 
However, in spite of the advantages mentioned above, the system suffers from the 
following limitations 
The washing step performed in this protocol is performed manually. This can limit the 
reproducibility of results across users as the washing procedure may be subjective. 
The integration of the method with a cloud computer implicitly assumes that internet is 
always available in the locations where analysis is being performed. This is not always 
true for remote locations and may limit the applicability of the proposed approach in 
POCT medical diagnosis. 
6.5 Summary 
 In this chapter, we introduced a point of care medical diagnostics system for 
detection of prostate specific antigen using fluorescent magnetic nanoparticles as labels. 
The POCT system is based on obtaining high resolution fluorescent images from a 
smartphone and utilizes the camera as well as network communication capabilities of the 
smartphone to send data for analysis and receive results. The analysis is performed 
remotely on a cloud computer and the results can be shared in real time with many people. 
The proposed approach achieves clinically relevant limit of detection of 100 pg/mL for 
PSA. 
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7. Results and Discussion: 
Smartphone based point of care 
diagnostics system with 
magnetic micro-particles and 
optical tracking 
7.1 Introduction 
 Smartphone based medical diagnostics protocols have been under intense 
development[1-5] over the past decade due to the advantages of optical imaging, 
communication and processing offered by them. In the previous chapter, we described a 
point of care medical diagnostics system based on fluorescent magnetic nanoparticles and 
smartphone. In addition to magnetic nanoparticles, magnetic micro-particles are widely 
used as labels for biosensing applications and have particular advantages for integration 
with smartphones. In particular, magnetic particles with size of the order of a micro meter 
can easily be resolved with conventional light microscopy with a high signal to noise ratio.  
	 The high signal to noise ratio allows us to use a low exposure time for taking 
images and thus enables us to take series of images of the particles in quick succession. A 
series of images, namely a video, enables us to perform inferences regarding the 
dynamics of the particles and thus about their interaction with the sensing surface. In this 
chapter we show that information about the dynamics of particles allows us to develop a 
point of care diagnostics system for highly sensitive quantitatively detection of 
biomolecules. We present an overview of the various components of the proposed POCT 
system. Our method eliminates the need for a separate washing step which was one of the 
weaknesses of the fluorescent magnetic nanoparticle based system introduced in the 
previous chapter. Promotion of specific interactions and elimination of non-specific 
interactions are performed simultaneously by three dimensional electromagnetic actuation 
of magnetic particles. Optical tracking of the dynamics of thousands of particles over a 
large area (560 µm x 560 µm) with sub-micron resolution allows us to make statistically 
significant inferences about the interaction of particles with the surface. We benchmark the 
proposed approach with a streptavidin-biotin based competitive bioassay and 
experimentally demonstrate a limit of detection of 1 nM with the smartphone. This limit of 
detection is achieved within 2 minutes of application of electromagnetic actuation. Thus, 
the proposed biosensing protocol is highly suitable for POCT applications. 
7.2 Overview of the POCT system 
	 The proposed POCT system has two key components:

(a) Actuation of magnetic particles with three dimensional electromagnetic forces and 
video recording. 
(b) High resolution optical tracking of magnetic particles in the video 
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 Figure 7-1 shows a schematic of the proposed POCT system. As shown in figure 
7-1 (a), the system consists of an electromagnetic actuator fabricated on a silicon nitride 
substrate. Antigens are functionalized on to the substrate surface. Magnetic particles 
(Dynabeads MyOne, diameter 1µm) are functionalized with complimentary antibodies. The 
particles have been incubated in solutions with varying concentrations of complimentary 
antigens. Thus, the antibody sites on the surface of the particles occupied with antigens 
are not available for interacting with the substrate. These ‘free’ antigens thus compete with 
the surface for interaction with magnetic particles. The concentration of free antibodies in 
the solution is varied across experiments while the concentration of antigens on the 
substrate surface is kept constant. Vertical magnetic field (50 Gauss) promotes the 
interaction of the particles with the surface while horizontal dielectrophoretic forces 
dislodge loosely attached non-specifically bound particles from the surface. As shown in 
figure 7-1 (b), optical tracking reveals information about the dynamics of particles and the 
number of particles bound to the surface after a certain time of actuation are counted. The 
percentage of particles bound to the surface is indicative of the concentration of free 
antigens in the solution. The antibodies used for demonstrating the proposed POCT 
system are streptavidin and antigens are biotin. 
7.2.1 Definition of the sensing area 
 The magnetic particles are actuated with a combination of vertical magnetic forces 
and horizontal dielectrophoretic forces. The design of the actuator is as presented in 
chapter 3. Figure 7-2 shows an image of the actuator obtained with a smartphone 
mounted on a microscope objective (magnification 20x, numerical aperture 0.45, please 
refer to section 4.5 for more details). The four straight line electrodes are clearly seen and 
their ends are marked as points A to D and P to S corresponding with the notation used in 
the schematic in figure 7-1 (b). Vertical magnetic field was applied to bring the magnetic 
particles to the substrate. However, horizontal forces were not applied while taking this 
image. We observe several thousand 1 µm particles uniformly distributed across the 
surface. The square region defined by the points AB-RS-DC-QP is considered as the 
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Figure 7-1. Schematic of the proposed POCT system. (a) The system consists of an 
electromagnetic actuator fabricated on a silicon nitride substrate. Antigens are 
functionalized on to the substrate and magnetic particles functionalized with 
complimentary antibodies are introduced on the substrate. ‘Free’ antigens in the solution 
compete with the surface for interaction with magnetic particles (competitive assay). 
Vertical magnetic force promotes interaction of the particles with the surface while 
horizontal dielectrophoretic forces dislodge loosely attached non-specifically bound 
particles from the surface. (b) Optical tracking reveals information about the dynamics of 
particles and the number of particles bound to the surface are counted. The percentage 
of particles bound to the surface is indicative of the concentration of free antigens in the 
solution.
sensing area since the forces for particles within this region are nearly uniform, except at 
the very edges of the sensing area. Magnetic particles outside the square sensing area 
are excluded from the analysis and are not counted towards the signal. The sensing area 
is 560 µm x 560 µm. This is three orders of magnitude larger than the sensing area 
reported for magnetic force[6] based biosensors (at equivalent currents) and an order of 
magnitude larger than that reported for high density magnetoresistive sensors[7] 
7.2.2 Functionalization of substrate 
 The surface of silicon nitride can be functionalized similarly to silicon dioxide 
surface[8]. The substrate surface was cleaned by sonication in acetone and ethanol and 
was subsequently rinsed with deionized water. The surface was made hydrophilic by 
treating it with ozone plasma for 2 minutes. A polydimethyl siloxane (PDMS) reaction well 
(described in chapter 4) with a hydrophilic surface was prepared by plasma treatment as 
well. The reaction well was placed onto the substrate and both of them were heated at 
120℃ for 10 minutes. This led to adhesion of the reaction well onto the substrate. The 
substrate with PDMS well attached onto it was then placed in a solution of ethanol 
containing 0.05% 3-Aminopropyl)triethoxysilane (APTES) by volume for 10 minutes. This 
was followed by baking the substrate for 15 minutes. After baking, the substrate was 
allowed to cool down for a few minutes and then immersed into a solution of dimethyl 
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Figure 7-2. An image of the actuator and magnetic particles taken from a smartphone in 
the absence of electric fields. Magnetic particles of diameter 1 µm are found to be 
uniformly distributed across the substrate. Points A to D and P to S correspond to the 
schematic shown in figure 7-1 (b).
sulfoxide (DMSO) solvent containing 1µM N-hydroxy-succinamide (NHS)-biotin for 1 hour. 
After an hour was finished, the substrate was washed twice with deionized water to 
remove any excess NHS-biotin not attached to the substrate. 
7.2.3 Functionalization of magnetic particles 
 The magnetic particles provided by the manufacturer were already functionalized 
with streptavidin. We prepared four types of solutions of magnetic particles with varying 
concentrations of biotin in the solution. First, a solution, A of magnetic particles with a 
concentration of 2% particles by volume was prepared in deionized water. Four solutions 
B, C, D and E containing 20 µM, 200 nM, 2 nM and 0 nM (control)  concentrations of biotin 
respectively were prepared. The solution A was mixed with equal volumes of B,C, D and E. 
Thus, 500 µL of A and 500 µL of B results in a solution with 1% streptavidin coated 
magnetic particles by volume and 10 µM concentration of free biotin. Similarly, for 
solutions C, D and E. Thus, we obtained four solutions, each containing 1% magnetic 
particles and 10 µM, 100 nM, 1 nM and 0 nM concentrations of free biotin. The solutions 
obtained were incubated in a refrigerator for 12 hours to allow the interaction of biotin with 
streptavidin sites on the surfaces of magnetic particles. 
7.2.4 Application of current and video recording 
 Once the substrate was functionalized and magnetic particle solutions were 
prepared, the substrate was connected to a current source with the printed circuit board 
(PCB) and its holder as described in section 4.4. A 3 µL solution of magnetic particles was 
introduced into the reaction well. The PDMS reaction well was covered with a thin cover 
slip. Sinusoidal currents were then applied to induce forces along the x and y directions. 
The axis notation is as shown in figure 7-1 (b). Note that as described in chapter 3, 
currents applied along electrodes PQ and RS result in a force along the x direction while 
currents applied along electrodes AB and CD result in forces along y direction. Also, 
please note that the points B and C are electrically connected to each other via the PCB, 
with traces of very low resistance so that points B and C have almost no potential 
difference between them. Similarly, points Q and R are connected to each other. We 
applied a current of amplitude 30 mA (peak to peak amplitude 60 mA, root mean square 
(r.m.s.) amplitude 21 mA) at a frequency of 0.5 Hz. The currents along x and y axes had a 
phase difference of 90° between them. Video recording and application of currents were 
started simultaneously. The videos were recorded at 24 frames per second at a resolution 
of 2160 pixels x 3840 pixels (4K). The experiment was performed for 5 minutes. 
7.2.5 Video analysis 
 The experimental video obtained after the previous step is 5 minutes long. Although 
eyehole video can be analyzed as well, experimentally we found that analyzing a few 
Table 1. Splitting of experimental video
Start time ~ end time (mm:ss) Duration (seconds) Label
00:50 ~ 01:00 10 1m
01:50 ~ 02:00 10 2m
02:50 ~ 03:00 10 3m
03:50 ~ 04:00 10 4m
04:50 ~ 05:00 10 5m
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Figure 7-3. Experimental results obtained 
after tracking of particles for a control 
sample. The particles which were detected 
as being attached to the surface are 
marked in red. (a) After 1 minute, 14.6% 
particles were stuck to the surface, (b) After 
2 min, 20.5% particles were stuck, (c) After 
3 minutes, 25.1% particles were stuck, (d) 
After 4 min., 27.6% particles were stuck, 
and (e) After 5 min 27.5% particles were 
found sticking to the surface within the 
sensing area. The area shown in the 
images is 150 µm x 150 µm and is only a 
fraction of the total sensing area. Particle 
trajectories are not shown to make the 
figure easy to understand.
(a) (b)
(c) (d)
(e)
seconds worth of data every minute was sufficient to derive quantitative estimates of 
number of particles interacting with the surface. Thus, we split the video into five parts, 
each of duration 10 seconds as shown in table 1. The video from 50 seconds to 1 minute 
is labelled as ‘1m’ and so on. The rest of the data is not used for analysis. The particles 
and their trajectories are then estimated by the particle tracking algorithm described in 
chapter 5 and the percentage of particles which stick to the surface are calculated. This is 
the signal used for estimating the concentration of free biotin present the solution of 
magnetic particles. 
7.3 Quantitative detection of biotin with smartphone 
 The experimental steps described in the previous section led to a quantitative 
estimation of the fraction of magnetic particles attached to the sensing area.  
 Figure 7-3 shows the results obtained for the control sample (no free biotin). The 
entire sensing area is too large to be shown fully. If figures of the whole sensing area or 
the whole 4K video frames are inserted into this document, the display (or printer) will 
downscale the image automatically to make it compatible with the resolution of the display 
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Figure 7-4. Calibration curves for detection of free biotin via a competitive assay at 
various times from 1 minute to 5 minutes. The vertical axis shows the percentage of 
particles attached to the substrate within the sensing area. Standard deviations are 
shown for n=3 trials. For 1 minute, the averages are close enough that the confidence 
intervals overlap. For 2 minutes, we see that the averages are clearly separated. The 
blue dashed line represents the level 3 standard deviations above the mean for 1 nM. 
Since this level is below the mean of the control sample, we conclude that the proposed 
protocol has a limit of detection of 1 nM.
(or the dots per inch of the printer). This will lead to loss of detail and make the figures 
difficult to understand. 
 Thus, we present high resolution images of the same region in the sensing area 
from 1 minute to 5 minutes from figure 7-3(a) to 7-3 (e). The area shown is 150 µm x 150 
µm. The particles which are identified as being stuck to the surface are marked in red. It 
can be visually observed that the number of particles stuck to the surface increases from 
figure 7-3 (a) to 7-3 (b) and from 7-3 (b) to 7-3 (c). However, the particles stuck to the 
surface do not change significantly from figure 7-3 (c) to 7-3(e). The percentage of 
particles attached to the surface determined by the tracking program is 14.6% after 1 min., 
20.5% after 2 min., 25.1% after 3 min, 27.6% after 4 min. and 27.5% after 5 minutes 
(figure 7-3(a)-(e) respectively). 
 This procedure was performed for all the concentration of free biotin used in this 
study. The resulting calibration curve for biotin detection is shown in figure 7-4. The 
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Figure 7-5. Experimental results obtained by tracking for different concentrations of free 
biotin (a) For control 0 nM, (b) for 1 nM, (c) for 100 nM and (d) for 10 µM. A part of the 
sensing area 150 µm x 150 µm is shown. Particles stuck to the surface are marked red.
standard deviations are shown for 3 trials. We note that the average percentage of 
particles stuck to the surface within the sensing area after 1 minute are not markedly 
different between 10 µM, 100 nM and 1 nM, so that confidence intervals overlap. However, 
after 2 minutes, we find that the averages are well separated and the confidence intervals 
do not overlap. The calculation of limit of detection is performed by considering 3 standard 
deviations away from the mean of the minimum sample concentration other than control. 
Since this is a competitive assay, the control sample has maximum signal as opposed to 
sandwich assays where the control has the minimum signal. Thus, we consider the level 
 for the 1nM curve. As shown by the blue dashed line in figure 7-4, the level 3 
standard deviations away from the mean is below the mean for the control sample, as well 
as the level one standard deviation below the mean of the control sample. Thus, we 
conclude that the limit of detection of the proposed protocol is 1 nM for biotin and is 
achieved after 2 minutes of actuation of magnetic particles. Figure 7-5 shows images of 
the sensing area after tracking has been completed and particles stuck to the surface have 
been identified. These images correspond to the state of the sensing area after 2 minutes. 
From figure 7-5 (a) we see that a large number of particles are stuck to the surface which 
decreases as we move to 7-5(d). Although it is difficult to visually distinguish the difference 
between figure 7-5 (a) and (b) (especially since only a small part of the sensing area is 
shown in the figure), quantitative analysis over the complete sensing area shows that for 
control sample, 20.5% particles were found attached to the surface whereas for 1 nM 
sample, 11.8% particles were found stuck to the surface. 
 Thus, we have experimentally demonstrated detection of free biotin with a 
competitive assay by three dimensional actuation of magnetic particles over a sensing 
area of 560 µm x 560 µm within 2 minutes of actuation by particle tracking. In practice, the 
time required for tracking of videos should also be included in the procedure. When 
tracking is performed on a mid range computer (8 core CPU, 16 GB RAM), it takes 7 
minutes to track each video of 10 seconds. Thus, the time required for obtaining the 
results from the beginning of the protocol is about 9 minutes. While higher sensitivities 
have been reported in literature up to several hundred femto molar concentrations, these 
sensitivities were only achievable with highly expensive and bulky equipment such as 
superconducting quantum interference device (SQUID) or magneto resistive sensors not 
optimized for point of care sensing[9]. 
7.4 Advantages and limitations of the proposed 
approach 
 The particle tracking based point of care testing system introduced in sections 7.1 
to 7.3 has the following advantages: 
Magnetic field accelerates the interaction of the particles with the sensing surface. 
Horizontal dielectrophoretic forces applied to magnetic particles reduce their non-specific 
interactions with the substrate. 
Tracking of particles provides information about the nature of their interaction with the 
surface. 
Inference is carried out for thousands of particles and thus the results obtained are 
statistically significant. 
The proposed method utilizes a smartphone camera. Hence, bulky and expensive 
equipment is not required. 
The proposed biosensing protocol achieves a limit of detection of 1 nM in just 9 minutes 
which is much faster than conventional technology which may require many hours. 
μ + 3σ
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 However, particle tracking based approaches may suffer from some limitations: 
An external magnetic field is required in this protocol. Permanent magnets need to be 
accurately positioned in order to apply the field of 50 gauss. Therefore, careful 
mechanical alignment of the substrate with an external magnet is required. 
The image quality during recording of the video should be uniformly good in order to 
enable accurate tracking. This presents constraints in the experimental procedure as out 
of focus frames or sudden mechanical motion of the camera can completely disorient the 
tracking program and produce inaccurate results. 
The time required for tracking of each video of 10 seconds is about 7 minutes. Thus, 
there is a delay in obtaining the results which may be unsuitable in many POCT 
scenarios where results may be needed as soon as possible. 
7.5 Alternate biosensing protocols 
	 The concept of tracking of particles in a solution can be extended to design other 
types of biosensing protocols. Here, we briefly introduce two other types of protocols which 
also use particle tracking but are different from the one described in the previous sections 
of this chapter.

7.5.1 Brownian motion based biosensing 
 It is well known that magnetic particles suspended in a liquid show brownian 
motion, as described analytically in chapter 3. In the previous section we discussed that 
particle tracking can be used to distinguish between particles exhibiting harmonic 
oscillations from those attached to the surface. However, the same methods can be used 
to distinguish particles exhibiting browning motion from those stuck to the surface. 
Moreover, if the particles are large in size, they tend to interact with the surface by 
gravitational force alone and thus a vertical magnetic force is not necessary. Thus, we 
propose an alternative protocol in which no actuation from either magnetic or electrostatic 
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Figure 7-6. Calibration curve for streptavidin and biotin obtained from distinguishing 
particles showing brownian motion from particles attached to the surface.
forces is applied. The substrate is functionalized with antigens and the particles are 
functionalized with antibodies on which varying amounts of antigens have been 
functionalized, as in the previous protocol. The particles (2.8 µm) are introduced onto the 
substrate and are drawn to the substrate surface due to gravitational forces and interact 
with the substrate via specific antibody antigen interactions. A video of the substrate is 
recorded for 1 minute and the percentage of particles which stop exhibiting brownian 
motion after 1 minute are identified. This is a simple biosensing protocol as it does not 
require fabrication of actuators, nor a magnetic field. The particles are large and thus easy 
to image and track. However, since there is no mechanism for removal of non-specifically 
interacting particles from the substrate, this method is expected to have a much lower limit 
of detection than the protocol involving three dimensional electromagnetic actuation. 
 We performed an experiment to test this protocol for streptavidin and biotin. The 
particles used were Dynabeads M-280 Streptavidin. Silicon nitride substrates were 
functionalized with NHS-biotin (100 µM) as described in section 7.2.2, while the 
streptavidin coated particles were incubated with varying concentrations of biotin in order 
to produce a competitive effect. Particles were introduced onto the surface and allowed to 
interact with the surface due to gravity. No currents or magnetic fields were applied. A 
video of the substrate was taken for 1 minute, the motion of the particles was analyzed 
and the percentage of particles stuck to the surface was calculated. Some preliminary 
results are shown in figure 7-6. As we can see, when the concentration of free biotin is 
very high, about 47% particles get stuck to the surface after 1 minute. However, as the 
concentration of the free biotin decreases, more and more particles get attached to the 
surface. These results show that this method has potential to be used in cases where a 
binary yes/no result is required and accurate quantitative estimation of concentration of 
biomolecules is not required. However, these are preliminary results and more 
experiments need to be performed in order to ascertain the reproducibility of this method. 
7.5.2 Homogenous biosensing 
 Homogenous biosensing protocols[10, 11] do not involve functionalization of 
substrates and the reaction occurs completely within a liquid solution. This simplifies the 
process of biosensing as the steps requiring functionalization of the substrate as well as 
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Figure 7-7. Schematic of the proposed homogenous biosensing protocol. (a) Large 1μm beads 
and small 200 nm beads are actuated under the influence of horizontal dielectrophoretic forces 
and vertical magnetic field. The particle surfaces are functionalized with complimentary 
antibody-antigen pairs (b) Micro meter sized particles which interact with nanometer sized 
particles are expected to show a change in their dynamics, such as a reduced amplitude of 
motion, which can be detected by optical tracking.
washing are eliminated. We build upon the discussion on particle tracking to propose a 
homogenous biosensing protocol based on particle tracking. 
 I have worked with Mr. Taisuke Ono from our research group to develop a 
homogenous biosensing protocol which has the following major advantages: 
Surface functionalization is not required. This considerably decreases the complexity of 
sample preparation and sample refrigeration. 
A vertical magnetic field is not used for actuation and only on-chip dielectrophoretic 
forces are used. Thus, this biosensing protocol can potentially be used with non-
magnetic polystyrene particles, which have much lower cost than their magnetic 
counterparts. 
 The proposed biosensing protocol involves two sets of particles: large particles 
(say, 1 µm in size) functionalized with antibodies as well as small particles (say, 200 nm in 
size) functionalized with complimentary antigens. A solution containing both these particles 
is introduced onto an actuator as described in chapter 3 and dielectrophoretic forces are 
used to actuate the particles. The surface is not functionalized. The relative motion of the 
particles is expected to induce interactions between them and thus, when a biomolecular 
reaction occurs, the motion of the combined assembly of large and small particles is 
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Figure 7-8. Histogram of particle amplitudes for varying concentrations of 200 nm amine 
particles from 0 to 200 μg/mL.
expected to have different motion characteristics from those of the large particles which do 
not have any interaction with complimentary biomolecules on the smaller particles. The 
change in the dynamics of the particles may be detected by optical tracking and may be 
used for quantitative detection of antigens. Figure 7-7 shows a schematic of the proposed 
homogenous biosensing protocol. We tested this method with 1 µm carboxyl (COOH) and 
200 nm amine (NH2) coated particles. The amine particles were not visible in an optical 
image whereas the carboxyl particles were clearly visible and their motion was analyzed 
with optical tracking software described in the previous chapter. The concentration of 
carboxyl particles was kept constant while the concentration of amine particles was varied 
from 0 to 200 µg/mL in the aqueous solution. The amplitude of motion of particles in the 
sensing area was obtained by curve fitting. The amplitudes of particles which were found 
to be oscillating were determined and the distribution of such amplitudes (histogram) was 
plotted. The results are shown in figure 7-8. When the concentration of complementary 
amine particles in the solution is low, the carboxyl particles oscillate at a high amplitude of 
about 9 pixels. As the concentration of mine particles increases, more and more amine 
particles get attached onto the surface of carboxyl particles. Thus the amplitude of motion 
of these particles decreases. Although these are preliminary results, homogenous 
biosensing protocol is much more suitable for real world applications than heterogenous 
biosensing protocol presented in this chapter. Thus, at our lab, we are actively developing 
this method at the moment. 
7.6 Summary 
	 In this chapter we introduced a point of care medical diagnostics system based on 
tracking the motions of thousands of magnetic particles over a large sensing area. The 
proposed system consists of a three dimensional actuation mechanism consisting of a 
vertical magnetic field (50 gauss) which accelerates the interaction of the magnetic 
particles with the sensing surface, and a planar actuator which applies horizontal 
dielectrophoretic forces to reduce non-specific interactions of the particles with the surface. 
We described the procedure for functionalization of the surface of the actuator, application 
of currents, recording of the video and analysis of the motion. We experimentally 
demonstrated a limit of detection of 1 nM biotin with this system in 9 minutes (2 minutes for 
actuation and 7 minutes for analysis of the video). Finally, we described some alternative 
biosensing protocols based on optical tracking of magnetic particles. 
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8. Conclusion and future work 
8.1 Contributions of this research 
 In this work, we reported the development of smartphone based point of care 
medical diagnostics systems utilizing magnetic particles as labels. Our work takes 
advantage of the tremendous improvements in smartphone cameras over the past decade 
driven by trends in consumer photography which have made modern smartphones 
capable of detecting micrometer and nanometer sized particles via light microscopy and 
fluorescence microscopy respectively. We build upon these capabilities fo smartphones 
and develop methods for actuation of magnetic particles over a large area as well as their 
accurate detection and tracking. In particular, we proposed two types of point of care 
(POCT) diagnostics systems: 
8.1.1 Fluorescent magnetic particles based POCT system 
 Fluorescent magnetic nanoparticles (f-MNPs) are promising labels for biosensors 
due to their high surface area to volume ratio, magnetic and fluorescence properties. The 
POCT system based on f-MNPs as labels consists of three key components: 
A protocol for detection of prostate specific antigen (PSA) by fluorescent imaging of f-
MNPs. 
A digital image processing algorithm for determining the concentration of PSA via 
fluorescent images of f-MNPs obtained with a smartphone. 
A shared ‘cloud server’ platform for performing the analysis and communicating the 
results to designated users. 
The proposed method allowed us to achieve a limit of detection of 100 pg/mL in 2.5 
minutes (30 seconds for actuation, 1 minute for washing and about 1 minute for data 
analysis). This is the first reported detection of PSA by a smartphone based biosensing 
system in less than 3 minutes. 
8.1.2 Magnetic micro particles based POCT system 
	 Magnetic micro-particles are well resolved in images obtained by light microscopy. 
Thus a series of images of the substrate surface taken in quick succession contains 
information about the dynamics of each particle which can reveal information about the 
interaction of particles with the sensing area. We proposed a POCT biosensing system 
based on magnetic micro-particles with two key components: 
A three dimensional actuation mechanism for magnetic particles which promote specific 
interactions and inhibits non-specific interactions simultaneously. The actuator is based 
on application of dielectrophoretic forces on particles, due to which the particles exhibit 
harmonic oscillations. 
An algorithm for high resolution optical tracking of magnetic particles in a video taken 
from a smartphone. The optical tracking algorithm is based on template matching for 
spatial localization of particles and a Kalman filter based motion model for accurate 
temporal association of particle trajectories across the frames of the video. 
The proposed method allowed us to achieve a limit of detection of 1 nM for biotin in 9 
minutes (2 minutes for actuation and 7 minutes for optical tracking). This is the first 
smartphone based biosensing protocol using optical tracking of magnetic particles. 
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8.2 Advantages and limitations of this research 
 Here, we present the advantages and limitation of our work for point of care testing 
applications. 
8.2.1 Fluorescent magnetic particles based POCT system 
 The proposed fluorescent magnetic nanoparticle based POCT medical diagnostics 
system has the following advantages: 
The actuation step takes 30 seconds while the washing step takes about 1 minute. This 
is much faster than conventional methods and is suitable for POCT diagnostics. 
Measurements of fluorescence images can be performed independently of the washing 
and actuation steps in dry state after the biomolecular reaction has concluded. 
Fluorescent images are obtained with a smartphone and thus, bulky equipment is not 
required. 
Analysis is performed in an automated way, remotely on a cloud computer, thereby 
freeing the user from the task of doing the analysis. 
The results are available in about a minute on an average. 
The results are communicated to the user immediately and can also be shared with other 
public health officials to aggregate real time statistics on the spread of diseases in a 
region. 
The protocol for detection of biomarkers achieves a very low limit of detection of 100 pg/
mL which is an order of magnitude lower than that required for clinically relevant 
detections and is comparable with other reports on detection of PSA which are not 
suitable for POCT applications. 
 However, in spite of the advantages mentioned above, the system suffers from the 
following limitations: 
The washing step performed in this protocol is performed manually. This can limit the 
reproducibility of results across users as the washing procedure may be subjective. 
The integration of the method with a cloud computer implicitly assumes that internet is 
always available in the locations where analysis is being performed. This is not always 
true for remote locations and may limit the applicability of the proposed approach in 
POCT medical diagnosis. 
8.2.2 Magnetic micro particles based POCT system 
 The proposed particle tracking based point of care testing system has the following 
advantages: 
Magnetic field accelerates the interaction of the particles with the sensing surface. 
Horizontal dielectrophoretic forces applied to magnetic particles reduce their non-specific 
interactions with the substrate, thereby enhancing sensitivity of the method. 
Tracking of particles provides information about the nature of their interaction with the 
surface. 
Inference is carried out for thousands of particles and thus the results obtained are 
statistically significant. 
The proposed method utilizes a smartphone camera. Hence, bulky and expensive 
equipment is not required. 
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The proposed biosensing protocol achieves a limit of detection of 1 nM in just 9 minutes, 
which is much faster than conventional technology such as ELISA which may require 
many hours for detection. 
 However, particle tracking based approaches suffers from some limitations: 
An external magnetic field is required in this protocol. Permanent magnets need to be 
accurately positioned in order to apply the field of 50 gauss. Therefore, careful 
mechanical alignment of the substrate with an external magnet is required. 
The image quality during recording of the video should be uniformly good in order to 
enable accurate tracking. This presents constraints in the experimental procedure as out 
of focus frames or sudden mechanical motion of the camera can completely disorient the 
tracking program and produce inaccurate results. 
The time required for tracking of each video of 10 seconds is about 7 minutes. Thus, 
there is a delay in obtaining the results which may be unsuitable in many POCT 
scenarios where results may be needed as soon as possible. 
8.3 Future work 
8.3.1 Near term 
 In the near term, the key areas of focus are the following: 
The proposed biosensing protocols need to be verified with other antibody antigen pairs 
than those presented in this work. 
Currently, only one type of biomolecular detection test can be performed with either of 
the proposed biosensing systems. However, for practical applications it is desirable to 
perform tests for several antibody-antigen interactions at the same time. Thus, the 
proposed systems need to be extended to allow multiple detections simultaneously. 
We have developed a homogenous biosensing protocol which removes the need for 
functionalizing surfaces as well as the need for magnetic particles. These features make 
the homogenous biosensing protocol very attractive for real-world use. A major focus of 
our research in the near term will be to further develop the homogenous biosensing 
protocol and verify its functioning with biomarkers of clinical relevance. 
8.3.2 Intermediate to long term 
 In the intermediate and long term, two keywords become important, namely, 
Artificial Intelligence (AI) and Internet of Things (IoT). In the future, I envisage that 
most of the algorithms introduced in this work will be replaced by AI based algorithms 
which can process data for different protocols and account for variations among 
smartphone cameras resulting from a large scale deployment of the POCT systems 
proposed in this work. Enhanced connectivity by fifth generation (5G) mobile 
communication technology will enable Internet of Things (IoT) and the biosensors 
developed may be available to the user as an IoT device. Figure 8-1 shows the schematic 
of a futuristic point of care diagnostics system. The system encapsulates the biosensor as 
an Internet of Things (IoT) device. The IoT sensor is connected to a cloud based analysis 
system by high speed 5G communication. The cloud analysis system contains an Artificial 
Intelligence (AI) based algorithm which performs the analysis and keeps a record of the 
results. The results are also shared with a doctor or other healthcare professionals, as 
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needed. As AI based algorithms become better at analyzing data, additional features may 
be enabled by such systems without replacement or modification of the sensor hardware, 
which will become available to the user as a software upgrade, much like app updates are 
available for smartphones today. 
I hope that the research presented in this thesis will play a role in realizing this future. 
8.4 A library of diagnostic protocols 
 In this thesis, I have focused on two diagnostic protocols described in chapters 6 
and 7. However, towards the end of chapter 7, I introduced two new diagnostic protocols, 
both based on particle tracking. Thus, overall, I have introduced four point of care 
diagnostic protocols based on: 
Fluorescent magnetic nanoparticles and mechanical washing (Chapter 6). 
Heterogenous biosensing method using magnetic micro particles and harmonic motion 
(substrate surface functionalized, sections 7.2 and 7.3) 
Potentially non-magnetic micro particles, non-magnetic nanoparticles and harmonic 
motion (homogenous method, section 7.5.2) 
Non-magnetic micro particle (large size) exhibiting brownian motion on a functionalized 
surface (brownian motion method, section 7.5.1) 
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Figure 8-1. A schematic of a futuristic medical diagnostics system which encapsulates the 
biosensor as an Internet of Things (IoT) device. The IoT sensor is connected to a cloud based 
analysis system by high speed 5G communication. The cloud analysis system contains an 
Artificial Intelligence (AI) based algorithm which performs the analysis and keeps a record of the 
results. The results are also shared with a doctor or other healthcare professionals.
 Each of these methods have their strengths and limitations and together they form a 
‘library’ of point of care diagnostic protocols which can all be performed on a smartphone. 
For a given real diagnostic scenario, the choice of the protocol would depend on the 
requirements from the test. The strengths and weaknesses of the four diagnostic protocols 
presented in this thesis are summarized graphically in figure 8-2. 
 The simplest method among the four is that based on brownian motion since it does 
not require any electronics for actuating the particles. Large particles attach to the 
substrate due to gravitational force acting on the particles. However, this method is 
expected to have a low sensitivity. Thus, it may be suitable for simple cases where just a 
Yes/No result is required. 
 The second simplest method is one of homogenous biosensing which does not 
require functionalization of the substrate but does require electronics for actuation. 
Although more experiments are currently being performed, initial results show that this 
method is expected to have a high sensitivity. 
 The protocol using fluorescent particles and manual washing has a higher 
complexity than either of the above two approaches since it requires functionalization of 
the substrate as well as a magnet for actuation of particles. There is some added 
complexity arising due to the use of fluorescent particles since these particles aggregate 
and form clusters due to their ferromagnetic properties. However, in spite of some 
complexity, this protocol has very good sensitivity with a limit of detection of 100 pg/mL for 
PSA. 
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Figure 8-2. A graphical representation of the strengths and weaknesses of the four diagnostics 
protocols presented in this thesis
 Finally, the heterogenous biosensing protocol based on harmonic oscillation of 
magnetic particles, described in chapter 7 has high complexity since it requires 
functionalization as well as electronics for actuation. This protocol also has high sensitivity. 
 It is important to note that although I have used the term ‘high complexity’ to 
describe some of these protocols, these are relative classifications and all of these 
protocols are much easier to use than conventional bioassays. 
8.5 A new parameter for evaluating POCT technologies 
 Throughout this thesis and in a multitude of research papers published in the field of 
point of care diagnostics, the aim is to develop low-cost and portable medical diagnostics 
systems which can be used by unskilled personnel. The parameters researchers use to 
determine the suitability of a POCT technology are: limit of detection, time of assay and 
cost. Are these parameters enough? 
 Consider the following real world scenario. A POCT device is being used in a village 
in India by a public health worker (AWC worker introduced in Chapter 1), who is treating 
several children. A mature POCT device which has been proven to work in clinical settings 
may still fail in the hands of this worker due to the following reasons: 
The biosensing chip may fall onto the floor making the surface dirty. 
Dust may settle on the chip if it is placed in open environment even for a few minutes. 
A piece of foreign contaminant such as a piece of PDMS (polymer) may get stuck onto 
the sensing area of the biosensing chip. 
A magnet may be placed nearby which may not be visible in a cluttered environment. 
The scenarios described above are very realistic based on my own experience as a 
patient at public health centers in India. When a POCT technology is deployed into the real 
world, many more potential sources of error will come up which researchers cannot 
anticipate at the moment. These sources of error are broadly of two types (a) errors due to 
wrong handling by the user, and (b) errors due to the harshness of the environment. 
 Researchers are well aware of the reasons why the errors listed above would result 
in unreliable measurements and that such substrates should not be used for clinical tests. 
However, it may not be possible to train all public health workers equally on the various 
ways in which such extrinsic errors may creep into the measurements and why these 
errors adversely affect diagnostic measurements. Conventional medical diagnostic 
technologies such as ELISA and SPR avoid such extrinsic errors because they are 
operated by professionals with years of training and because rigorous quality control 
standards are enforced by federal regulatory agencies on pathology laboratories. Such 
rigorous quality control cannot be enforced on illiterate and uneducated public health 
workers. Research on adoption of new innovations has shown that a lot of new 
technologies that offer objective benefits over older technologies fail during the early 
stages (of the so called ’S curve’ of technology adoption[1]) because users do not 
understand the nuances associated with them. For example, an intensive two-year 
campaign in the village of Los Molinos in Peru to convince villagers to boil water before 
drinking failed because villagers could not understand the concept of germs[2]. They 
wondered “If germs are so small that they cannot be seen or felt, how can they hurt a 
grown person?”. This is not an isolated case and research on diffusion of technology is 
filled with may such case studies. In a world where something as simple as the importance 
of boiling water is difficult to communicate to rural, uneducated people, can we really 
expect to educate public health workers coming from these backgrounds on the various 
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ways in which a POCT device may give erroneous results? Thus, in future, researchers 
working on POCT will eventually have to ask the question: 
 If a village woman performs a complex bioassay with our POCT device, can 
her results be trusted for making decisions about life and death of a patient? 
 I believe that the user of the device cannot be trusted to find her own errors and 
thus, a POCT device must be able to detect such errors on its own in an automated 
fashion. Such requirements from POCT technologies are not discussed in research papers 
today. However, they should be taken into account early on during the design of the 
technology to avoid POCT technologies from falling into the ‘valley of death’ after having 
achieved a high technology readiness level (TRL)[3]. Thus, I propose that one of the 
most important parameters for evaluating a POCT technology should be whether 
extrinsic errors can be automatically detected, apart from the usual parameters like 
sensitivity, limit of detection, time of assay and cost currently used in literature. 
 In this context, it is noteworthy that several leading contenders of POCT technology 
fall short on this parameter. Technologies such as magnetoresistive (GMR) sensors, 
surface plasmon resonance (SPR) sensors and diffraction grating sensors provide only a 
single number as their result. GMR sensors provide voltage reading, SPR and diffraction 
based sensors provide only reflectance curve and peak shift as output. The actual state of 
the sensing area which is producing those results is not directly known but is inferred from 
the results. Thus, out of the four realistic error scenarios listed above, GMR sensors can 
detect only one error when a magnet is present nearby. Other sources such as dust or 
polymers do not have magnetic signature and will not be detected. Similarly, SPR and 
diffraction grating based sensors, will not be able to detect these errors since dust particles 
and polymer contaminants (being several microns) are much larger than the wavelength of 
light being used to probe the surface. 
 The POCT system I have presented in Chapter 7, which involves recording a video 
of the sensing area directly and analyzing the dynamics of magnetic particles for several 
seconds, performs significantly better on this front. Any contaminant such as dust, polymer 
or other types of foreign substances from the environment would be directly visible in the 
video and thus be detected. An unwanted magnet nearby would cause a change in the 
dynamics of the magnetic particles from the expected harmonic oscillations and thus could 
also be detected. Notably, all of these detections can be automated in the cloud using 
object detection, semantic segmentation and anomaly detection algorithms (discussed in 
more detail in the next section) which are at the forefront of artificial intelligence today. 
 While I do not claim that all possible extrinsic errors can be detected by this system 
(mostly because all possible sources of such errors are not known at this stage), the 
POCT diagnostics system presented in this thesis is much more suitable for real-
world application than many other competing technologies as discussed earlier. My 
system has this advantage because I adopted a different approach to developing POCT 
diagnostics by building the system around innate strengths of a smartphone rather than by 
miniaturizing an existing system based on conventional technology to interface with a 
smartphone. 
8.6 The Role of Artificial Intelligence in point of care 
diagnostics 
 In chapter 5, I explained the importance of automation in point of care diagnostics. 
There are two ways in which automation will improve diagnostics in the future. The first 
way is to augment the functionality of hardware with software so that data obtained from 
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low cost hardware can be processed in such a way as to approximate what would have 
been obtained if more expensive hardware were used. A good example of this is the so 
called ‘super resolution’ problem in computer vision. A low cost microscope is unable to 
produce high quality, aberration free images like a state of the art microscope. However, if 
examples of images are collected from both microscopes, one can train Artificial 
Intelligence (AI) algorithms to produce an approximation for a high quality image from a 
low quality image. Thus, once such an algorithm has been trained, one can obtain high 
quality images from potentially very low cost microscopes. The second way in which 
automation, and more specifically AI can improve diagnostics is by finding statistical 
correlations between quantities which human experts have not found yet. 
8.6.1 AI based tracking algorithm 
 In chapter 5, I presented an algorithm for large scale tracking of particles in a 4K 
video. This algorithm is based on so called ‘classical’ computer vision algorithms. There 
are a few limitations of classical algorithms. One of the well known limitations is that of 
generalization. The algorithm uses a template to identify particles in an image. When this 
algorithm is deployed on a large scale for many smartphones with different camera quality, 
a few problems will have to be resolved: 
Should we use different templates for different smartphone cameras? 
If the video is not well focused, can we still use it? 
If contaminants are present on the sensing area, can we trust that measurement? 
 These problems cannot be fully solved with classical computer vision algorithms as 
the combinations of all these factors are too numerous to be programmed individually into 
a system. Thus, a program which learns to adapt to cameras of varying quality, different 
focus levels, and which detects possible errors is required. AI algorithms are best suited to 
match this challenge. Here, I will present a solution which addresses the first two 
problems: that of different smartphones and unfocused video. 
 An algorithm which can detect particles from a number of different smartphones and 
even in unfocused videos was developed. It consists of an artificial neural network, more 
specifically a convolutional neural network (CNN) which performs the task of semantic 
segmentation[4]. A 4K video frame is provided as input to the algorithm and it 
outputs a probability map of a particle distribution in the video frame. Each pixel of 
the probability map has a value between 0 and 1 where 1 represents that the model is 
completely certain that a the pixel contains a particle. A 0 at a certain pixel position 
denotes that the model is certain that no particle is present at at pixel. 
 A 4K video frame of size 2160x3840x3 is broken down into 64 patches of size 
270x480x3. This patch is padded with zeros along the first axis to create a 272x480x3 
tensor. This tensor is an RGB image which is passed through a convolutional neural 
network whose architecture is shown in figure 8-3. 
 The CNN applies four convolutional layers with increasing number of filters in each 
layer and with a stride of 2x2 which results in downscaling of the image at each successive 
layer. After four convolutional layers, the tensor size is 17x30x256. From here on, I apply 
transposed convolution also known as devolution layers[5], with decreasing number of 
deconvolution filters and with a stride of 2x2, which results in upscaling of the tensor. 
Inspired from U-Net architecture[6], I concatenate tensors in the latter half of the network 
with those in the first half of the network and compatible shapes. The last deconvolution 
layer has 2 filters and thus outputs a 272x480x2 tensor. The first channel of this tensor is 
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the probability that the pixel is background while the second channel is the probability that 
the pixel has a particle in it. Both these probabilities sum to 1 for each pixel. Depth wise 
separable convolutions[7] were used in the first half of the network to reduce 
computational cost of the network. At each layer, the x and y positions of each pixel are 
concatenated with the input tensor, in order to provide the network with more information 
about the position of the pixels. This approach is known as CoordConv[8] and has been 
shown to improve accuracy and intersection over union (IOU) scores for semantic 
segmentation models such as Faster-RCNN. The convolution and deconvolution kernels 
have the size 3x3 for all layers. Batch normalization[9] is used at all layers. For 
deconvolution layers, the batch norm is applied after concatenation. Leaky ReLu[10] 
activation function (with α=0.3) is used at all layers except at the last one where pixel-wise 
softmax is used. At the output, softmax cross-entropy loss is calculated and Adam 
optimizer[11] is used to train the model using the standard back-propagation algorithm. 
The learning rate starts initially at 5x10-5 and decays at each epoch by a factor of 2 in 
order to accelerate convergence of the optimizer. 
 Modern CNN models require vast datasets containing hundreds of thousands of 
images to be trained. In most domains of computer vision, large, open datasets are 
available to train and benchmark new algorithms[12]. However, as stated in Chapter 5, 
there is almost no research on computer vision algorithms for magnetic particles. Thus, the 
biggest hurdle in getting the AI algorithm to train is that there is no data (examples of 
image and corresponding probability map) to train the above neural network on. I achieved 
a breakthrough in this by generating a synthetic dataset. I extracted templates of 
magnetic particles from experimental data and superimposed them on frames of empty 
substrates which did not have any particles on them. Since the superimposition was done 
in software, the exact position of the particle was known. Based on this information, I 
generated the corresponding probability map for the image. This is a computationally 
expensive process. Thus, generation of synthetic data was implemented in Cython and 
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Figure 8-3. Architecture of semantic segmentation model used to detect particles in a video.
compiled to C code to improve the speed of execution. I used this procedure to generate 
about 370,000 synthetic frame patches and their corresponding probability maps. This 
training data was used to train the network described earlier for 5 epochs. 
 This method of using synthetic data works extremely well in practice. Figure 8-4 
shows a synthetic frame and its corresponding probability map generated by this program. 
It can be seen that the synthetic frame has sharp boundaries at the edges of magnetic 
particles and it is clear to human observers that this is not a naturally occurring image. 
 Even though the data used for training is artificial, the resulting trained network 
works very well on real videos obtained from smartphones. Figure 8-5 shows the results 
on some real images obtained with a smartphone. In figure 8-5 (a), a polymer contaminant 
in the image is ignored by the algorithm as shown in figure 8-5(b) (the output at the 
corresponding position is very low or dark). In figure 8-5(c), all the particles in the image 
are successfully detected in the output of the network shown in figure 8-5 (d). In figure 
8-5(e), a prominent gold pattern is present on the substrate. This pattern is ignored by the 
network (figure 8-5(f)) as it has learnt from synthetic data that the presence of gold pattern 
does not necessarily signify the presence of magnetic particles. The particles on or near 
the pattern are successfully detected. There are a few important things to note from the 
above discussion: 
The output of the network is much cleaner than the output of the template matching 
algorithm (a representative example of the latter is shown in figure 5-3). Thus, a 
maximum a posteriori threshold of 0.5 can be used for inference in all videos regardless 
of the smartphone camera or image quality. 
Although in the example above, there is only one type of particle, this algorithm can 
easily be modified to detect several different types of particles and to automatically 
identify them as being different from each other. This may be useful in the future. 
The key breakthrough here is that from the perspective of the researcher, very few real 
images are required to train a robust segmentation network. A few frames of 4K videos 
contain several thousand particles which can be extracted automatically and 
superimposed on images of empty substrates to create several orders of magnitude 
more training data than what one started out with. This effectively solves the problem of 
lack of datasets which has hampered research into computer vision algorithms for 
magnetic particle research. 
As more smartphones are used for research, only a few ‘seed images’ will be required to 
be taken from newer smartphones to generate more training data and creating a 
software which adapts to a variety of smartphones and sensor characteristics. 
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Figure 8-4 A synthetic frame patch (left) and its corresponding probability map (right) generated 
to train the neural network shown in figure 8-3. (bright represents high probability that a particle 
is present)
 As stated earlier, one of the biggest strengths of the diagnostics protocols 
presented in this thesis is that contaminants of any size shape and magnetic property can 
be detected. If enough training data is present, the semantic segmentation network can 
also be trained to look for such objects in the sensing area.  
 Although the above discussion does not include a quantitative comparison between 
classical algorithms and the new semantic segmentation algorithm, it serves as a starting 
point for training more capable AI algorithms which can handle a large number of variable 
conditions which are bound to occur in real-world applications. I have uploaded the 
program implementing the neural network described above to a repository on GitHub[13]. 
This code is currently private and may be open sourced in the future. 
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(a)
(c)
(e)
(b)
(d)
(f)
Figure 8-5. Examples of output of the neural network trained on synthetic data on real images. 
Left images are the inputs and right images are the predicted probability maps (bright 
represents high probability that a particle is present). The network has successfully learnt to 
distinguish noise in the images, such as the region in blue circle in (a), which commonly lead to 
false positives with traditional computer vision algorithms. This is one of the many advantages 
of deep neural networks.
8.6.2 Looking into the eyes to find heart diseases 
 The rise of artificial intelligence has led to some startling discoveries in the field of 
medical diagnostics. Google has been working to implement AI in medical diagnostics 
through its life sciences division, Verily. People suffering from diabetes are at risk of going 
blind due to diabetic retinopathy (DR). The diagnosis for DR is usually performed by 
ophthalmologists (eye doctors). An image of the eye’s retina, taken from a specialized 
camera can enable ophthalmologists to identify diseased individuals. Working with Aravind 
Medical Research Foundation in India, researchers at Google collected a large dataset of 
retinal images from a large number of patients and had them graded by ophthalmologists 
by severity of disease. They then used those examples to train an AI algorithm to predict 
the severity of the disease given the image. A convolutional neural network trained on this 
data achieved a high accuracy of prediction for severity of the disease and even 
surpassed several professional doctors[14]. 
 Based on what I have just discussed in the previous sub-section, this is not a very 
surprising result on its own. However, what happened next is very interesting and holds 
great lessons for the future of AI in point of care diagnostics. 
 A young engineer joined the research team working on DR. In order to let her get 
familiarized with the dataset and machine learning algorithms, her supervisor gave her a 
toy problem of teaching an AI algorithm to predict the gender of the patient from an image 
of their eye. There is no research anywhere in medical literature suggesting that male and 
female retinas are different and thus, they expected that any algorithm would achieve a 
50% accuracy (obtained by random ‘male’ or ‘female’ prediction). However, to their 
surprise, an AI algorithm trained on this dataset picked up small differences between the 
retinal images of males and females, such as, small differences between the width of veins 
in the retina. Rather than 50% expected by the researchers, the AI algorithm achieved an 
accuracy of 97%! It is important to understand the significance of this development. 
Throughout the history of medical research, human experts with years of training had 
missed some patterns among male and female retinas, which could be discovered only 
with the help of AI when enough data became available to train a good algorithm. 
 Eventually, the team started looking for other possible metrics which could be 
predicted with these retinal images. They found that they could reliably predict not only 
gender but also age, blood pressure, smoking status (smoker/non-smoker) and whether 
the patient had suffered any major cardiac events in the past. Putting all these things 
together, these researchers showed that it was possible to predict cardiovascular risk 
factors just from the images of eyes[15]. Why were these researchers able to predict such 
seemingly unrelated metrics from retinal images and what lessons does this hold for the 
future of point of care diagnostics? 
 From the perspective of systems biology, complex biological systems such as 
human bodies are extremely complicated networks of gene expressions and proteins. 
Within these complicated networks, it is very difficult to find causality for a given effect. 
However, correlations exist in plenty. Thus, the field of proteomics (the study of proteins) 
generally involves large scale statistical study of gene expressions (for example figure 6 of 
[16]) to find statistical correlations between expressions of different genes. What the 
researchers at Google discovered was probably a large scale manifestation of correlations 
between genes involved in diabetes and eye function and those involved in cardiovascular 
diseases. 
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 This has important lessons for POCT. A POCT device deployed on a large scale will 
not only help in diagnosing diseases in people at an early stage, but also become tools for 
collection of so called big data about the health of large populations. Once such large 
scale data is collected, researchers could begin to uncover previously unanticipated 
correlations. For example, although biotin is not considered a serious biomarker for 
diseases today, it is well known that biotin deficiency in humans causes hair loss, anemia, 
birth defects and fungal infections[17], implying that the level of biotin in human body is 
correlated with these health issues although it does not have a causal relationship with 
these diseases. These correlative relationships have not been discovered yet since there 
is no large scale dataset on the level of biotin in humans and their other health 
parameters. The Google researchers collected data from about 280,000 patients. In future, 
POCT devices could enable such large scale data collection for biotin deficiency and the 
levels of biotin from such a large population could tell us more about different diseases 
that we cannot anticipate at the moment. Thus, just like Google researchers demonstrated 
testing of heart diseases from retinal images, it might become possible one day to test 
for seemingly unrelated health conditions by measuring the level of biotin in a 
person. I have used biotin as an example since in the previous chapter, I have presented 
results for detection of biotin, but, of course, such correlations could be discovered for 
other biomarkers as well. Such diagnosis of correlative factors could be the performed 
much more quickly than diagnosis of causative factors. 
 To summarize, in the future, point of care diagnostics will benefit significantly from 
advances in artificial intelligence algorithms. In turn, point of care diagnostics could 
accelerate the development of artificial intelligence algorithms for healthcare by enabling 
the curation of large datasets necessary to discover previously unanticipated correlations 
between various health factors. 
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